You are on page 1of 86

List of European Pharmacopoeia Reference Standards

Order
Reference Standard
Code
Y0001561 Abacavir sulfate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
20 mg
1

Information

Monograph Leaflet

Storage

2589

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001552 Abacavir for peak identification

10 mg

2589

Yes

+5C 3C

79

Y0001551 Abacavir for system suitability

10 mg

2589

Yes

+5C 3C

79

Y0000055 Acamprosate calcium - reference spectrum

n/a

79

Y0000116 Acamprosate impurity A

50 mg

3-aminopropane-1-sulphonic acid

1585

Yes

+5C 3C

79

Y0000500 Acarbose

100 mg

See leaflet ; Batch 2 is valid until 31 August 2015

2089

Yes

+5C 3C

79

Y0000354 Acarbose for identification

10 mg

2089

Yes

+5C 3C

79

Y0000427 Acarbose for peak identification

20 mg

2089

Yes

+5C 3C

79

A0040000 Acebutolol hydrochloride

50 mg

0871

Yes

+5C 3C

79

Y0000359 Acebutolol impurity B

10 mg

-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]
acetamide (diacetolol)

0871

Yes

+5C 3C

79

Y0000127 Acebutolol impurity C

20 mg

N-(3-acetyl-4-hydroxyphenyl)butanamide

0871

Yes

+5C 3C

79

Y0000128 Acebutolol impurity I

0.004 mg

N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]
butanamide

0871

Yes

+5C 3C

79

Y0000056 Aceclofenac - reference spectrum

n/a

79

Y0000085 Aceclofenac impurity F

15 mg

benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate

1281

Yes

+5C 3C

79

Y0000086 Aceclofenac impurity H

10 mg

[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]
acetic acid

1281

Yes

+5C 3C

79

Y0001094 Aceclofenac for peak identification

10 mg

1281

Yes

+5C 3C

79

Y0000810 Acemetacin

100 mg

1686

Yes

+5C 3C

79

Y0000811 Acemetacin impurity A

10 mg

1686

Yes

+5C 3C

79

Y0000842 Acemetacin impurity mixture

0.06 mg

1686

Yes

+5C 3C

79

A0070000 Acesulfame potassium

50 mg

1282

Yes

+5C 3C

79

A0070020 Acesulfame potassium impurity B

15 mg

1282

Yes

+5C 3C

79

A0100000 Acetazolamide

100 mg

0454

Yes

+5C 3C

79

Y0001084 Acetazolamide for system suitability

0.0068 mg

Y0000002 Acetylcholine chloride

50 mg

A0150000 Acetylcysteine

50 mg

A0152000 Acetylcysteine impurity C

10 mg

See leaflet; N,N'-diacetyl-L-cystine ; Batch 8 is valid until 31 October 2014

A0153000 Acetylcysteine impurity D

10 mg

Y0000565 -Acetyldigoxin

50 mg

Y0000642 -Acetyldigoxin for peak identification

10 mg

A0200000 Acetylsalicylic acid

15 mg

Y0001460 Acetylsalicylic acid for peak identification

10.3 mg

Y0001462 Acetylsulfadiazine

0.002 mg

A0208000 N-Acetyltryptophan

125 mg

A0202000 N-Acetyltyrosine

200 mg

Council of Europe, all rights reserved 2015

1585

Batch 2 is valid until 31 January 2015


propoxy]phenyl]

1281

4-chlorobenzoic acid

see leaflet; 5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide

0454

Yes

+5C 3C

79

1485,1971

Yes

-20C 5C

79

0967

Yes

+5C 3C

79

0967

Yes

+5C 3C

79

N,-diacetyl-L-cysteine ; Batch 5 is valid until 28 May 2015

0967

Yes

+5C 3C

79

See leaflet CHO

2168

Yes

+5C 3C

79

2168

Yes

+5C 3C

79

0309

Yes

+5C 3C

79

0309

Yes

+5C 3C

79

0294

Yes

+5C 3C

79

1383

Yes

+5C 3C

79

1384

Yes

+5C 3C

79

Batch 1 is valid until 31 May 2015

Batch 1 is valid until 30 November 2014

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000693 Acholeplasma laidlawii BRP

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
1 ml
1

Information

Monograph Leaflet
20607

Yes

Storage

Extra
Price
charges
120
-80C 10C
d

A0220000 Aciclovir

75 mg

0968

Yes

+5C 3C

79

Y0001271 Aciclovir for peak identification 1

0.303 mg

Batch 2 is valid until 30 November 2014

0968

Yes

+5C 3C

79

Y0001269 Aciclovir for peak identification 2

0.004 mg

Batch 2 is valid until 31 December 2014

0968

Yes

+5C 3C

79

Y0001264 Aciclovir for system suitability

10 mg

0968

Yes

+5C 3C

79

A0225000 Acitretin

100 mg

1385

Yes

+5C 3C

79

Y0001463 Actaea racemosa HRS

1200 mg

2069

Yes

+5C 3C

79

Y0001543 Actaea racemosa for assay CRS

300 mg

2069

Yes

+5C 3C

79

Y0001464 Actaea racemosa dry extract for system suitability HRS

1200 mg

2069

Yes

-20C 5C

79

Y0001121 Adapalene

100 mg

See leaflet CHO

2445

Yes

+5C 3C

79

Y0001120 Adapalene impurity C

6 mg

1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane ; Batch 2 is valid until 30


September 2014

2445

Yes

+5C 3C

79

Y0001119 Adapalene for peak identification

2.022 mg

2445

Yes

+5C 3C

79

A0230000 Adenine

50 mg

0800

Yes

+5C 3C

79

A0230200 Adenosine

50 mg

1486

Yes

+5C 3C

79

Y0000110 Adipic acid

50 mg

1586

Yes

+5C 3C

79

Y0000882 Adrenaline

5 mg

2303

Yes

+5C 3C

79

Y0000740 Adrenaline impurity mixture

0.0045 mg

0254,2303

Yes

+5C 3C

79

Y0000883 Adrenaline with impurity F

10 mg

2303

Yes

+5C 3C

79

A0300000 Adrenaline tartrate

100 mg

0254

Yes

+5C 3C

79

Y0000707 Adrenaline tartrate with impurity A

15 mg

0254

Yes

+5C 3C

79

Y0001724 Agnus castus fruit dry extract

350 mg

see leaflet

2309, 2147

Yes

-20C 5C

79

A0325000 Alanine

60 mg

This reference standard will be deleted from mono 0614 on july 2015 1st

0614, 0752

Yes

+5C 3C

79

New A0325100 Albendazole

50 mg

Batch 1 is valid until 31 December 2015

1386

Yes

+5C 3C

79

50 mg

1285

Yes

-20C 5C

79

1286

Yes

-20C 5C

e(d)

300

1286

Yes

-20C 5C

e(d)

79

79

Yes

+5C 3C

79

A0325200 Alcuronium chloride


New A0325450 Alfacalcidol

See leaflet CHO


See leaflet CHNO; Monoammonium glycyrrhizate

Batch 2 is valid until 30 November 2014

5 mg

Y0001601 Alfacalcidol for system suitability

2.5 mg

A0325451 Alfacalcidol - reference spectrum

n/a

A1225000 Alfadex

150 mg

A0325500 Alfentanil hydrochloride - reference spectrum

n/a

1062

79

A0325800 Alfuzosin hydrochloride

10 mg

1287

Yes

+5C 3C

79

Y0000832 Alfuzosin for system suitability

10 mg

1287

Yes

+5C 3C

79

Y0001583 Alimemazine hemitartrate

15 mg

2650

Yes

+5C 3C

79

Y0001581 Alimemazine for system suitability

5 mg

2650

Yes

+5C 3C

79

A0349000 Allantoin

60 mg

1288

Yes

+5C 3C

79

100 mg

0576

Yes

+5C 3C

79

New A0350000 Allopurinol


Council of Europe, all rights reserved 2015

See leaflet ; Batch 8 is valid until 31 October 2015

1286
See leaflet [CH0]

See leaflet ; Batch 2 is valid until 31 October 2015


2

1070,1487

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
A0350010 Allopurinol impurity A
A0350020 Allopurinol impurity B

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
2
10 mg
1 5-amino-1H-pyrazole-4-carboxamide
3
10 mg
1 5-formylamino-1H-pyrazole-4-carboxamide

Monograph Leaflet

Storage

0576

Yes

+5C 3C

Extra
Price
charges
79
a

0576

Yes

+5C 3C

79

A0350030 Allopurinol impurity C

10 mg

5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide

0576

Yes

+5C 3C

79

New A0350040 Allopurinol impurity D

15 mg

ethyl 5-amino-1H-pyrazole-4-carboxylate ; Batch 3 is valid until 30 September


2015

0576

Yes

+5C 3C

79

A0350050 Allopurinol impurity E

20 mg

ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate

0576

Yes

+5C 3C

79

A0351000 Allylstrychnine bromide

10 mg

1285

Yes

-20C 5C

79

Y0000235 Almagate

25 mg

2010

Yes

+5C 3C

79

Y0000255 Almagate - reference spectrum

n/a

79

A0357000 Alprazolam - * psy

100 mg

1065

Yes

+5C 3C

79

A0360000 Alprenolol hydrochloride

100 mg

0628,0876

Yes

+5C 3C

79

Y0000054 Alprostadil

50 mg

see leaflet

Y0000606 Altizide

150 mg

See leaflet CHClNOS

Y0000843 Altizide impurity B

15 mg

3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene

Y0000687 Alverine citrate

5 mg

Y0000607 Alverine impurity D

10 mg

Y0000595 Alverine for peak identification

0.125 mg

A0363000 Amantadine hydrochloride

100 mg

A0363700 Ambroxol hydrochloride

125 mg

A0900000 Amfetamine sulfate - reference spectrum

A0365000 Amidotrizoic acid dihydrate

Y0001461 Amidotrizoic acid for system suitability

0.08 mg

A0368000 Amikacin

200 mg

See leaflet

Y0001467 Amikacin impurity I

20 mg

(2S)-4-amino-2-hydroxybutanoic acid

Y0001117 Amikacin for system suitability

10 mg

A0365900 Amikacin sulfate

200 mg

A0370000 Amiloride hydrochloride

100 mg

Y0000020 Amiloride impurity A

20 mg

Y0000173 4-Aminobenzoic acid

60 mg

A0420000 Aminocaproic acid

50 mg

A0460000 7-Aminodesacetoxycephalosporanic acid

20 mg

A0496000 Aminoglutethimide

125 mg

A0496005 Aminoglutethimide impurity A

20 mg

A0496020 Aminoglutethimide impurity D

10 mg

A0575000 Amiodarone hydrochloride

100 mg

Council of Europe, all rights reserved 2015

See leaflet

2010

1488

Yes

-20C 5C

79

0370,2185

Yes

+5C 3C

79

2185

Yes

+5C 3C

79

2156

Yes

+5C 3C

79

2156

Yes

+5C 3C

79

2156

Yes

-20C 5C

79

0463

Yes

+5C 3C

79

1489

Yes

+5C 3C

79

n/a

0368

79

100 mg

0873

Yes

+5C 3C

79

0873

Yes

+5C 3C

79

1289,1290

Yes

+5C 3C

79

1289, 1290

Yes

+5C 3C

79

1289,1290

Yes

+5C 3C

79

1290

Yes

+5C 3C

79

0651

Yes

+5C 3C

79

0651

Yes

+5C 3C

79

1687

Yes

+5C 3C

79

0874

Yes

+5C 3C

79

0708,0813

Yes

+5C 3C

79

1291

Yes

+5C 3C

79

(3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)

1291

Yes

+5C 3C

79

3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione);
(azoglutethimide)

1291

Yes

+5C 3C

79

0803

Yes

+5C 3C

79

N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine

The batch 3 is not suitable for use in the assay in monograph 1290:07/2012.
Amikacin CRS A0368000 is also needed. See leaflet.
methyl-3,5-diamino-6-chloropyrazine-2-carboxylate

Cefadroxyl impurity B

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000129 Amiodarone impurity D
Y0000130 Amiodarone impurity E

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
3
20 mg
1 (2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone
3
20 mg
1 (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

Monograph Leaflet

Storage

0803

Yes

+5C 3C

Extra
Price
charges
79
a

0803

Yes

+5C 3C

79

A0590000 Amisulpride

10 mg

1490

Yes

+5C 3C

79

Y0001534 Amisulpride for system suitability

1.0015 mg

1490

Yes

+5C 3C

79

Y0000563 Amitriptyline hydrochloride

10 mg

0464

Yes

+5C 3C

79

Y0000049 Amlodipine besilate

150 mg

See leaflet

1491

Yes

+5C 3C

79

Y0001068 Amlodipine impurity A

15 mg

3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

1491

Yes

+5C 3C

79

Y0001069 Amlodipine impurity B

15 mg

3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5dicarboxylate

1491

Yes

+5C 3C

79

Y0001070 Amlodipine impurity G

15 mg

dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate

1491

Yes

+5C 3C

79

Y0001067 Amlodipine for peak identification

15 mg

1491

Yes

+5C 3C

79

Y0000302 Ammonio methacrylate copolymer(type A) - reference


spectrum

n/a

2081

79

Y0000303 Ammonio methacrylate copolymer(type B) - reference


spectrum

n/a

2082

79

A0650000 Amobarbital - * psy

500 mg

0594

Yes

79

A0700000 Amobarbital sodium - * psy

500 mg

0166

Yes

+5C 3C

79

A0800000 Amoxicillin trihydrate

200 mg

See leaflet CHNOS

0167,0168,0
260,
0577,0578,0
813,
1140,1653

Yes

+5C 3C

79

Y0001521 Amoxicillin trihydrate for performance verification

5000 mg

See leaflet

20232, 20512

Yes

+5C 3C

79

Y0000005 Amphotericin B

100 mg

See leaflet ; Batch 4 is valid until 30 September 2015

1292

Yes

-20C 5C

79

Y0001361 Amphotericin B for microbiological assay

100 mg

See leaflet

20702

Yes

-20C 5C

79

Y0001014 Amphotericin B for peak identification

10 mg

1292

Yes

-20C 5C

79

A1000000 Ampicillin (anhydrous)

220 mg

0167,0168,0
578,
1168,1169

Yes

+5C 3C

79

A1100000 Ampicillin trihydrate

150 mg

0168,0260,0
577,
0578,0808,2
211, 2212

Yes

+5C 3C

79

Y0001244 Amylmetacresol

285 mg

2405

Yes

+5C 3C

79

Y0001245 Amylmetacresol for peak identification

10 mg

2405

Yes

+5C 3C

79

Y0001522 Anastrozole

100 mg

See leaflet CHN

2406

Yes

+5C 3C

79

Y0001531 Anastrozole impurity E

10 mg

2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)

2406

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet CHNOS

See leaflet CHO

+5C 3C

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001386 Angelica dahurica root HRS

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
160 mg
1

Y0001385 Angelica pubescens root

500 mg

A1200000 Anhydrotetracycline hydrochloride

15 mg

Y0001466 Anhydrous Docetaxel

15 mg

A1210000 Antazoline hydrochloride

Y0001465 Apomorphine hydrochloride hemihydrate

Y0001471 Apomorphine impurity B (morphine sulfate) * - narc


A1220000 Alpha-apo-oxytetracycline
A1230000 Beta-apo-oxytetracycline
Y0001154 Aprotinin for system suitability
A1250000 Aprotinin solution BRP
A1269000 L-Arabinitol

Information

Monograph Leaflet
2556

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

2557

Yes

+5C 3C

79

0210,0211,1
654

Yes

+5C 3C

79

2593

Yes

+5C 3C

79

50 mg

0972

Yes

+5C 3C

79

15 mg

0136

Yes

+5C 3C

79

40 mg

0136

Yes

+5C 3C

90

20 mg

0198

Yes

+5C 3C

79

20 mg

2.7 mg

0.5 ml

10 mg

Y0000806 Arbutin

100 mg

See leaflet CHO

A1270000 Arginine

50 mg

see leaflet

Y0000304 Arginine aspartate

20 mg

A1271000 Arginine hydrochloride

Y0001649 Aripiprazole
Y0001650 Aripiprazole impurity F

See leaflet

See leaflet; morphine sulfate


See leaflet CHNO
See leaflet

0198

Yes

+5C 3C

79

0580, 0579

Yes

+5C 3C

79

0579,0580

Yes

+5C 3C

79

1381

Yes

+5C 3C

79

1054

Yes

+5C 3C

79

0806, 1654,
2114, 2566

Yes

+5C 3C

79

2096

Yes

+5C 3C

79

60 mg

0805,0885,0
998

Yes

+5C 3C

79

170 mg

See leaflet

2617

Yes

+5C 3C

79

10 mg

7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]-3,4-dihydroquinolein-2
(1H)-one

2617

Yes

+5C 3C

79

n/a

140 mg

See leaflet

20821

Yes

+5C 3C

79

Y0001185 Aristolochic acid I

11 mg

See leaflet

20821

Yes

+5C 3C

79

Y0001175 Aristolochic acid for system suitability

1 mg

20821

Yes

+5C 3C

79

Y0000079 Articaine hydrochloride

200 mg

Batch 2 is valid until 30 June 2015

1688

Yes

+5C 3C

79

Y0000080 Articaine impurity A

25 mg

methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2- carboxylate ;
Batch 2 is valid until 31 December 2014

1688

Yes

+5C 3C

79

Y0000081 Articaine impurity E

10 mg

methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]
thiophene-2-carboxylate ; Batch 1 is valid until 31 August 2014

1688

Yes

+5C 3C

79

Y0001091 Artichoke leaf dry extract HRS

60 mg

2389

Yes

-20C 5C

79

A1300000 Ascorbic acid

100 mg

Vitamin C

0253,0958,1
791

Yes

+5C 3C

79

Y0001024 Ascorbic acid impurity C

20 mg

see leaflet CHO; D-xylo-hex-2-ulosonic acid (D-sorbosonic acid) ; Batch 2


is valid until 31 May 2015

0253,1791

Yes

+5C 3C

79

Y0001170 Ascorbic acid impurity D

10 mg

methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate)

0253,1791

Yes

+5C 3C

79

Y0000800 Ascorbyl palmitate

10 mg

0807

Yes

+5C 3C

79

Y0000305 Asparagine monohydrate

60 mg

2086

Yes

+5C 3C

79

Y0001323 Aristolochia

Council of Europe, all rights reserved 2015

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
A1320000 Aspartame

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
40 mg
1

Information

A1321000 Aspartame impurity A

10 mg

A1330000 Aspartic acid

50 mg

Y0001171 Astragaloside IV

40 mg

A1340000 Atenolol

100 mg

Y0001089 Atenolol for system suitability

5 mg

Y0001586 Atomoxetine hydrochloride

110 mg

See leaflet CHClNO

Y0001588 Atomoxetine impurity B

10 mg

Y0001589 Atomoxetine impurity D

5 mg

Y0001587 Atomoxetine for impurity A identification

Y0001327 Atorvastatin calcium trihydrate

Y0001328 Atorvastatin impurity A

Y0001329 Atorvastatin impurity B

Y0001330 Atorvastatin impurity C


Y0001331 Atorvastatin impurity D

Monograph Leaflet

Storage

0973

Yes

+5C 3C

Extra
Price
charges
79
a

0973

Yes

+5C 3C

79

0750,0797

Yes

+5C 3C

79

2435

Yes

-20C 5C

79

0703

Yes

+5C 3C

79

0703

Yes

+5C 3C

79

2640

Yes

+5C 3C

79

(3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1amine

2640

Yes

+5C 3C

79

(3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1amine

2640

Yes

+5C 3C

79

10 mg

N-methyl-3-phenoxy-3-phenylpropan-1-amine

2640

Yes

+5C 3C

79

150 mg

See leaflet CHCaFNO

2191

Yes

+5C 3C

79

10 mg

desfluoroatorvastatin

2191

Yes

+5C 3C

79

10 mg

3-epi-atorvastatin

2191

Yes

+5C 3C

79

10 mg

fluoroatorvastatin ; Batch 1 is valid until 30 August 2014

2191

Yes

+5C 3C

79

10 mg

3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2carboxamide

2191

Yes

+5C 3C

79

Y0001332 Atorvastatin impurity E

10 mg

ent-atorvastatin

2191

Yes

+5C 3C

79

Y0001572 Atovaquone

270 mg

See leaflet CHClO

2192

Yes

+5C 3C

79

Y0001573 Atovaquone for system suitability

10 mg

2192

Yes

+5C 3C

79

Y0000424 Atracurium besilate

120 mg

1970

Yes

+5C 3C

79

Y0000503 Atracurium for impurity F identification

5 mg

1970

Yes

+5C 3C

79

Y0000504 Atracurium for peak identification

5 mg

1970

Yes

+5C 3C

79

Y0000878 Atropine

30 mg

2056

Yes

+5C 3C

79

Y0000816 Atropine impurity B

10 mg

0068,2056

Yes

+5C 3C

79

Y0000845 Atropine for peak identification

0.25 mg

0068,2056

Yes

+5C 3C

79

A1400000 Atropine sulfate

20 mg

0068

Yes

+5C 3C

79

Y0000029 Azaperone

50 mg

1708

Yes

+5C 3C

79

A1500000 Azathioprine

100 mg

0369

Yes

+5C 3C

79

Y0001240 Azathioprine impurity A

10 mg

1-methyl-4-nitro-1H-imidazol-5-amine

0369

Yes

+5C 3C

79

Y0001246 Azathioprine impurity G

5 mg

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine
(thiamiprine)

0369

Yes

+5C 3C

79

Y0000326 Azelastine hydrochloride

25 mg

1633

Yes

+5C 3C

79

Y0000327 Azelastine impurity B

5 mg

1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane

1633

Yes

+5C 3C

79

Y0000328 Azelastine impurity D

5 mg

4-(4-chlorobenzyl)phthalazin-1(2H)-one

1633

Yes

+5C 3C

79

5 mg

3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one
6

Y0000329 Azelastine impurity E


Council of Europe, all rights reserved 2015

2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine)


See leaflet CHO

see leaflet CHNOS

(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate
(noratropine)

79
1633
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000306 Azithromycin

Reference Standard

Y0000307 Azithromycin impurity A

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
4
200 mg
1 See leaflet CHNO
2
10 mg
1 6-demethylazithromycin

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1649

Yes

+5C 3C

1649

Yes

+5C 3C

79

1649

Yes

+5C 3C

79

Y0000637 Azithromycin for peak identification

15 mg

Batch 2 is valid until 31 August 2014

Y0000641 Azithromycin for system suitability

0.05 mg

Batch 6 is valid until 30 November 2014

1649

Yes

+5C 3C

79

Y0000285 B19 virus DNA for NAT testing BRP

150 mg

See leaflet

0557,
1527,1646

Yes

-20C 5C

e(d)

242

B0070000 Bacampicillin hydrochloride

120 mg

See leaflet CHClNOS

0808,0852

Yes

+5C 3C

79

B0100000 Bacitracin zinc

150 mg

See leaflet ; Batch 2 is valid until 28 February 2015

0465,0466,2
0702

Yes

-20C 5C

79

B0200000 Baclofen

50 mg

0653

Yes

+5C 3C

79

B0200050 Baclofen impurity A

60 mg

(4RS)-4-(4-chlorophenyl)pyrrolidin-2-one ; Batch 3 is valid until 30 April 2015

0653

Yes

+5C 3C

79

Y0001273 Baicalin

10 mg

See leaflet CHO

2438

Yes

+5C 3C

79

B0250000 Bambuterol hydrochloride

100 mg

1293

Yes

+5C 3C

79

B0300000 Barbital - * psy

500 mg

0170

Yes

+5C 3C

79

Y0001525 Basic butylated methacrylate copolymer

20 mg

1975

Yes

+5C 3C

79

B0305000 Beclometasone dipropionate anhydrous

150 mg

0654,1449,
1709

Yes

+5C 3C

79

Y0000469 Beclometasone dipropionate for peak identification

10 mg

0654,1709

Yes

+5C 3C

79

Y0000352 Beclometasone dipropionate for system suitability

15 mg

0654,1709

Yes

+5C 3C

79

Y0001073 Beclometasone dipropionate impurities F and N

0.052 mg

0654,1709

Yes

+5C 3C

79

Y0000351 Beclometasone dipropionate monohydrate

10 mg

1709

Yes

+5C 3C

79

Y0001607 Belamcanda chinensis rhizome HRS

110 mg

2561

Yes

+5C 3C

79

Y0001025 Benazepril hydrochloride

160 mg

See leaflet CHClNO

2388

Yes

+5C 3C

79

10 mg

[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5tetrahydro-1H-1-benzazepin-1-yl]acetic acid ; Batch 1 is valid until 30


November 2015

2388

Yes

+5C 3C

79

Y0001038 Benazepril for system suitability

0.016 mg

2388

Yes

+5C 3C

79

B0400000 Bendroflumethiazide

100 mg

0370

Yes

+5C 3C

79

Y0000564 Bendroflumethiazide impurity A

5 mg

0370

Yes

+5C 3C

79

B0470000 Benperidol

100 mg

1010,1172,1
254, 1708

Yes

+5C 3C

79

B0477000 Benserazide hydrochloride

50 mg

1173

Yes

+5C 3C

79

B0477010 Benserazide impurity A

20 mg

(2RS)-2-amino-3-hydroxy-2-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide

1173

Yes

+5C 3C

79

Y0001071 Benserazide impurity C

10 mg

(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide

1173

Yes

+5C 3C

79

Y0001079 Benserazide for peak identification

10 mg

1173

Yes

+5C 3C

79

New Y0001026 Benazepril impurity A

Council of Europe, all rights reserved 2015

See leaflet CHClO

4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001064 Benzaldehyde

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
150 mg
1

Y0001060 Benzalkonium chloride for system suitability

B0490000 Benzarone
B0500000 Benzathine benzylpenicillin
Y0000775 Benzbromarone
B0550000 Benzethonium chloride

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0372,0371,1
740

Yes

+5C 3C

0371,0372

Yes

+5C 3C

79

20 mg

10 mg

(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

1393

Yes

+5C 3C

79

200 mg

See leaflet

0373

Yes

+5C 3C

79

10 mg

1393

Yes

+5C 3C

79

100 mg

0974

Yes

+5C 3C

79

B0600000 Benzocaine

50 mg

0011,1088

Yes

+5C 3C

79

Y0001470 Benzoic acid

30 mg

0934

Yes

+5C 3C

79

Y0000647 Benzophenone

40 mg

1784

Yes

+5C 3C

79

Y0000167 Benzyl alcohol

70 mg

0256,0371,0
372,1827

Yes

+5C 3C

79

B0670000 Benzyl benzoate - reference spectrum

n/a

79

B0680000 S-Benzylmercaptoacetyltriglycin

10 mg

1372

Yes

+5C 3C

79

B0700000 Benzylpenicillin potassium

100 mg

0113,0148,0
149

Yes

+5C 3C

79

B0900000 Benzylpenicillin sodium

200 mg

See leaflet CHNNaOS

0113,0114,0
148, 0149

Yes

+5C 3C

79

Y0001149 Berberine chloride

20 mg

See leaflet CHClNO

1831,2500

Yes

+5C 3C

79

B0950000 Betadex

200 mg

See leaflet [CHO]

1070,1487,1
804

Yes

+5C 3C

79

Y0000391 Betahistine dihydrochloride

50 mg

1665

Yes

+5C 3C

79

B0990000 Betahistine mesilate

50 mg

Batch 1 is valid until 30 April 2015

1071

Yes

+5C 3C

79

B1000000 Betamethasone

60 mg

Batch 4 is valid until 30 June 2015

0312,0354,0
388, 0811

Yes

+5C 3C

79

B1030000 Betamethasone acetate

100 mg

0548,0975

Yes

+5C 3C

79

B1040000 Betamethasone dipropionate

150 mg

0809

Yes

+5C 3C

79

Y0001416 Betamethasone dipropionate for peak identification

10 mg

0809

Yes

+5C 3C

79

Y0001418 Betamethasone dipropionate for system suitability

10 mg

0809

Yes

+5C 3C

79

B1045000 Betamethasone sodium phosphate

100 mg

0549,0810

Yes

+5C 3C

79

B1054000 Betamethasone 17-valerate

100 mg

0322,0811

Yes

+5C 3C

79

B1055000 Betamethasone 21-valerate

15 mg

0811

Yes

+5C 3C

79

Y0001027 Betamethasone valerate for system suitability

25 mg

0811

Yes

+5C 3C

79

Y0001065 Betamethasone valerate impurity mixture

0.018 mg

0811

Yes

+5C 3C

79

B1103000 Betaxolol hydrochloride

60 mg

1072

Yes

+5C 3C

79

B1103100 Betaxolol impurity A

10 mg

(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol

1072

Yes

+5C 3C

79

Y0001354 Betaxolol impurity C

5 mg

2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane

1072

Yes

-20C 5C

79

Y0001360 Betaxolol for peak identification

15 mg

1072

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet

0705

See leaflet CHFO

Batch 3 is valid until 30 November 2014

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
B1115000 Bezafibrate

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
100 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1394

Yes

+5C 3C

2196

Yes

+5C 3C

79

2196

Yes

+5C 3C

79

2123

Yes

+5C 3C

79

1395

Yes

+5C 3C

79

Y0001444 Bicalutamide

100 mg

Y0001448 Bicalutamide for system suitability

15 mg

Y0001078 Bicisate labelling kit

24 mg

B1110000 Bifonazole

50 mg

Y0001421 Bifonazole for system suitability

10 mg

1395

Yes

+5C 3C

79

Y0001059 Bilberry dry extract

250 mg

See leaflet

2394

Yes

-20C 5C

79

New Y0001788 Bilberry dry extract HRS

See leaflet CHFNOS

Batch 1 is valid until 30 September 2015

250 mg

see leaflet

2394

Yes

-20C 5C

B1116000 Biotin

20 mg

Vitamin H

1073

Yes

+5C 3C

79

B1120000 Biperiden hydrochloride

60 mg

1074

Yes

+5C 3C

79

B1121000 Biperiden impurity A

20 mg

1074

Yes

+5C 3C

79

B1140000 Bisacodyl

50 mg

0595

Yes

+5C 3C

79

Y0000608 Bisacodyl for peak identification

10 mg

0595

Yes

+5C 3C

79

Y0000694 Bisacodyl for system suitability

5 mg

0595

Yes

+5C 3C

79

Y0000812 Bisoprolol fumarate

50 mg

1710

Yes

+5C 3C

79

Y0000877 Bisoprolol for peak identification

1.007 mg

Bisoprolol for system suitability method A CRS has been renamed as


Bisoprolol for peak identification CRS.

1710

Yes

+5C 3C

79

Y0000813 Bisoprolol for system suitability

1.003 mg

Bisoprolol for system suitability method B CRS has been renamed as


Bisoprolol for system suitability CRS

1710

Yes

+5C 3C

79

B1141000 Bleomycin sulfate

7 mg

See leaflet

0976,20702

Yes

-20C 5C

79

New Y0000434 Boldine

(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3(piperidin-1-yl)propan-1-ol (endo form)

Batch 1 is valid until 30 September 2014

79

30 mg

See leaflet

1396, 1816

Yes

+5C 3C

79

B1142000 Bordetella pertussis mouse antiserum BRP

0.5 mg

See leaflet

See leaflet,
20716

Yes

-20C 5C

90

Y0001634 Brimonidine for system suitability

1.3 mg

2760

Yes

+5C 3C

79

Y0001658 Brimonidine tartrate

5 mg

B1143000 Bromazepam - * psy

60 mg

Y0000645 Bromazepam for system suitability - * psy

10 mg

B1145000 Bromhexine hydrochloride

100 mg

New Y0001757 Bromhexine for system suitability

2760

Yes

+5C 3C

79

0778,0879

Yes

+5C 3C

79

0879

Yes

+5C 3C

79

0706

Yes

+5C 3C

79

0706

Yes

+5C 3C

79

0706

Yes

+5C 3C

79

Batch 3 is valid until 31 May 2015

n/a

15 mg

Y0000200 Bromhexine impurity C

15 mg

B1150000 Bromocriptine mesilate

30 mg

0596

Yes

-20C 5C

79

Y0000677 Bromocriptine mesilate for system suitability

5 mg

0596

Yes

-20C 5C

79

B1152000 Bromperidol

100 mg

0616,1178

Yes

+5C 3C

79

B1152050 Bromperidol decanoate

60 mg

1397,1431

Yes

+5C 3C

79

B1153000 Brompheniramine maleate

100 mg

0977,1196

Yes

+5C 3C

79

Y0000468 Brotizolam - * psy

10 mg

2197

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

N-(2-aminobenzyl)-N-methylcyclohexanamine

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000470 Brotizolam impurity B

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]
diazepine (demethylbrotizolam)

Y0001196 Brucine

40 mg

see leaflet

B1157300 Budesonide

110 mg

See leaflet CHO

Y0001148 Budesonide for system suitability

10 mg

B1156000 Bufexamac

100 mg

Y0001729 Bufexamac impurity A

10 mg

4-butoxyphenylacetic acid

Y0001730 Bufexamac impurity B

15 mg

methyl 2-(4-butoxyphenyl)acetate

B1157400 Buflomedil hydrochloride

100 mg

Y0001731 Bufexamac impurity C

15 mg

Y0001732 Bufexamac impurity D

10 mg

2-(4-butoxyphenyl)acetamide

B1157410 Buflomedil impurity B

20 mg

4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one

Y0001529 Buflomedil for peak identification

0.45 mg

B1158000 Bumetanide

150 mg

Y0000309 Bumetanide impurity A

5 mg

3-nitro-4-phenoxy-5-sulphamoylbenzoic acid

Y0000310 Bumetanide impurity B

5 mg

3-amino-4-phenoxy-5-sulphamoylbenzoic acid

B1160000 Bupivacaine hydrochloride

100 mg

New Y0000088 Bupivacaine impurity B

20 mg

Y0000089 Bupivacaine impurity E

20 mg

Y0001575 Bupivacaine impurity F

Y0001108 Buprenorphine - * psy

Y0001122 Buprenorphine for system suitability - * psy


Y0001109 Buprenorphine hydrochloride - * psy
B1168000 Buserelin

Storage

Extra
Price
charges
79
a

2197

Yes

+5C 3C

2513,2514

Yes

+5C 3C

79

1075

Yes

+5C 3C

79

1075

Yes

+5C 3C

79

1179

Yes

+5C 3C

79

1179

Yes

+5C 3C

79

1179

Yes

+5C 3C

79

1398

Yes

+5C 3C

79

1179

Yes

+5C 3C

79

1179

Yes

+5C 3C

79

1398

Yes

+5C 3C

79

1398

Yes

+5C 3C

79

1076

Yes

+5C 3C

79

1076

Yes

+5C 3C

79

1076

Yes

+5C 3C

79

0541, 2335

Yes

+5C 3C

79

(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide ; Batch 2 is valid until


30 October 2015

0541

Yes

+5C 3C

79

6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide ; Batch 2 is valid until 30


November 2014

0541

Yes

+5C 3C

79

70 mg

2,6-dimethylaniline

0541

Yes

+5C 3C

79

10 mg

1180

Yes

+5C 3C

79

10 mg

1180,1181

Yes

+5C 3C

79

10 mg

1181

Yes

+5C 3C

79

1077

Yes

-20C 5C

79

-20C 5C

79

2 mg

New Y0001740 Buserelin for peak identification

1 mg

New B1168020 D-His-Buserelin

See leaflet CHNO

1077

0.5 mg

Y0000131 Buspirone hydrochloride

5 mg

Y0000471 Buspirone for system suitability

2.018 mg

B1170000 Busulfan

50 mg

Y0001487 Butyl methacrylate

100 mg

Y0001304 Butyl methanesulfonate

30 L

B1217000 Butyl parahydroxybenzoate

100 mg

See leaflet

Y0001357 Butyl parahydroxybenzoate impurity E

15 mg

2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)

B1212000 Butylhydroxyanisole

60 mg

Council of Europe, all rights reserved 2015

Monograph Leaflet

Batch 1 is valid until 30 November 2015

1077

Yes

-20C 5C

79

1711

Yes

+5C 3C

79

1711

Yes

+5C 3C

79

0542

Yes

+5C 3C

79

1975

Yes

+5C 3C

79

20537,2053
8, 20539,
20540
0881,1216

Yes

+5C 3C

79

Yes

+5C 3C

79

0881

Yes

+5C 3C

79

0880

Yes

+5C 3C

79

Batch 1 is valid until 30 September 2014

10

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
B1215000 Butylhydroxytoluene

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
50 mg
1 Plastic additive 07

Information

Y0000472 Cabergoline

160 mg

See leaflet ; Batch 1 is valid until 28 February 2015

C0100000 Caffeine

70 mg

See leaflet; 04/2008:0267

Y0000787 Caffeine for system suitability

10 mg

New C0166000 Calcifediol

5 mg

C0166001 Calcifediol - reference spectrum

n/a

Y0000499 Calcipotriol (anhydrous) - reference spectrum

n/a

Y0000473 Calcipotriol monohydrate

10 mg

See leaflet ; Batch 4 is valid until 31 December 2015

Monograph Leaflet

Storage

0581,30103,
30105,3010
6, 30107

Yes

+5C 3C

1773

Yes

-20C 5C

79

0267,0268,1
504,2412

Yes

+5C 3C

79

0267, 0268

Yes

+5C 3C

79

1295

Yes

-20C 5C

e(d)

150

79

1295
2011
See leaflet CHO

Extra
Price
charges
79
a

2011,2284

79

Yes

+5C 3C

79

Y0000474 Calcipotriol monohydrate - reference spectrum

n/a

79

C0200000 Calcitonin (salmon)

11

1 mg

See leaflet

0471

Yes

-20C 5C

79

Y0000632 Calcitonin-Gly

1 ml

About 0.9 mg per ml

0471

Yes

-20C 5C

79

C0200010 N-acetyl-cys1-calcitonin

0.1 mg

See leaflet ; Batch 4 is valid until 31 March 2015

0471

Yes

-20C 5C

79

See leaflet ; Batch 8 is valid until 31 December 2015

0883

Yes

-20C 5C

e(d)

New C0225000 Calcitriol

2284

10 mg

C0226000 Calcitriol - reference spectrum

n/a

C0249000 Calcium ascorbate - reference spectrum

n/a

C0250000 Calcium folinate

130 mg

C0299000 Calcium glucoheptonate

60 mg

C0300000 Calcium gluconate

100 mg

C0340000 Calcium levulinate dihydrate

250 mg

C0350000 Calcium oxalate monohydrate

500 mg

C0400000 Calcium pantothenate

50 mg

C0405000 Camphor (racemic)

50 mg

Batch 1 is valid until 30 August 2014

Y0001388 Candesartan cilexetil

60 mg

Y0001387 Candesartan cilexetil for peak identification

10 mg

Y0001389 Candesartan cilexetil for system suitability

10 mg

New C0410000 Canrenone

0883
1182
See leaflet

0978,1606

Yes

1000

79

79

+5C 3C

79

1399

Yes

+5C 3C

79

0172,0658,0
979,1399,21
61,2162,216
4,2364

Yes

+5C 3C

79

1296

Yes

+5C 3C

79

See leaflet

20234

Yes

+5C 3C

79

Batch 3 is valid until 30 April 2015

0470

Yes

+5C 3C

79

0655,1400

Yes

+5C 3C

79

2573

Yes

+5C 3C

79

2573

Yes

+5C 3C

79

2573

Yes

+5C 3C

79

Calcium digluconate

15 mg

Batch 3 is valid until 31 December 2015

0688

Yes

+5C 3C

79

Y0001642 Capecitabine

150 mg

See leaflet CHFNO

2762

Yes

+5C 3C

79

Y0001643 Capecitabine impurity A

5 mg

2762

Yes

+5C 3C

79

Y0001644 Capecitabine impurity B

5 mg

2762

Yes

+5C 3C

79

Y0001645 Capecitabine impurity D

10 mg

2762

Yes

+5C 3C

79

C0426000 Caprylic acid

100 mg

1401,1471

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

Batch 1 is valid until 31 August 2014


11

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000671 Capsaicin

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
2
50 mg
1 See leaflet CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8methylnon-6-enamide

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1859,2336,2
337, 2529

Yes

+5C 3C

1079

Yes

+5C 3C

79

C0430000 Captopril

10 mg

Y0001219 Captopril impurity B

10 mg

See leaflet CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]


pyrrolidine-2-carboxylic acid

1079

Yes

+5C 3C

79

Y0001220 Captopril impurity C

10 mg

See leaflet CHOS; (2RS)-2-methyl-3-sulphanylpropanoic acid

1079

Yes

+5C 3C

79

Y0001221 Captopril impurity D

10 mg

See leaflet CHBrO; (2RS)-3-bromo-2-methylpropanoic acid

1079

Yes

+5C 3C

79

Y0000435 Captopril impurity E

10 mg

(2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid

1079

Yes

+5C 3C

79

Y0001450 Captopril impurity J

10 mg

See leaflet CHNOS; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]


pyrrolidine-2-carboxylic acid (acetylcaptopril)

1079

Yes

+5C 3C

79

Y0001182 Captopril for system suitability

20 mg

1079

Yes

+5C 3C

79

Y0000113 Carbachol

50 mg

1971

Yes

+5C 3C

79

C0450000 Carbamazepine

200 mg

See leaflet CHNO

0543

Yes

+5C 3C

79

Y0000033 Carbamazepine impurity A

10 mg

10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11dihydrocarbamazepine)

0543

Yes

+5C 3C

79

C0451000 Carbasalate calcium - reference spectrum

n/a

1185

79

Y0001161 Carbasalate impurity B

5 mg

1185

Yes

+5C 3C

79

C0455000 Carbenicillin sodium

50 mg

0956

Yes

-20C 5C

79

C0460000 Carbidopa

50 mg

0755

Yes

+5C 3C

79

Y0001713 Carbidopa for system suitability

10 mg

0755

Yes

+5C 3C

79

Y0001716 Carbidopa impurity mixture

0.008 mg

0755

Yes

+5C 3C

79

C0465000 Carbimazole

120 mg

0884

Yes

+5C 3C

79

C0470000 Carbocisteine

60 mg

0885

Yes

+5C 3C

79

C0499900 Carbon dioxide - reference spectrum

n/a

0375

79

C0550000 Carboplatin - reference spectrum

n/a

1081

79

Y0000475 Carboprost trometamol

40 mg

79

Y0000536 Carboprost trometamol - reference spectrum

n/a

79

Y0000035 Carisoprodol

50 mg

Y0000036 Carisoprodol impurity A

10 mg

Y0001214 Carmellose

10 mg

C0580004 Carmustine - reference spectrum

n/a

C0580010 Carmustine impurity A

20 mg

Y0000846 Carprofen

30 mg

Y0000884 Carprofen for system suitability

5 mg

Y0000192 Carteolol hydrochloride - reference spectrum

Y0000193 Carteolol for system suitability

Y0001427 Carvedilol
Council of Europe, all rights reserved 2015

50 mg

See leaflet CHNOS

See leaflet CHNO

1712

Yes

-20C 5C

1712
1689

Yes

+5C 3C

79

1689

Yes

+5C 3C

79

2360

Yes

+5C 3C

79

79

1187

Yes

-20C 5C

79

2201

Yes

+5C 3C

79

2201

Yes

+5C 3C

79

n/a

1972

79

30 mg

1972

Yes

+5C 3C

79

(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate ; Batch 1 is valid until 28 February 2015

1187
1,3-bis(2-chloroethyl)urea

12

79
1745
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000075 Carvedilol - reference spectrum

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
n/a
1

Y0000103 Carvedilol impurity C

Y0001426 Carvedilol for system suitability


C0600000 Casein BRP

Information

Monograph Leaflet

Storage

1745

Extra
Price
charges
79
l

15 mg

(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)
propan-2-ol

1745

Yes

+5C 3C

10 mg

Batch 1 is valid until 30 April 2015

1745

Yes

+5C 3C

79

100000 mg

0350

Yes

+5C 3C

131

C0630000 Cefaclor

450 mg

0986

Yes

+5C 3C

79

C0640000 Delta-3-Cefaclor

20 mg

0986

Yes

-20C 5C

79

C0650000 Cefadroxil

250 mg

see leaflet

0260,0577,0
813,2342

Yes

+5C 3C

79

C0675000 Cefalexin monohydrate

150 mg

See leaflet ; Batch 3 is valid until 31 August 2015

0708,0814

Yes

+5C 3C

79

C0682000 Cefalotin sodium

170 mg

See leaflet ; Batch 2 is valid until 31 July 2014

0987

Yes

+5C 3C

79

Y0000505 Cefalotin for impurity B identification

10 mg

0987

Yes

+5C 3C

79

C0682300 Cefamandole nafate

125 mg

See leaflet CHNNaOS

1402

Yes

+5C 3C

79

Y0000240 Cefapirin sodium

100 mg

See leaflet CHNNaOS

1650

Yes

+5C 3C

79

C0682400 Cefatrizine propylene glycol

150 mg

see leaflet CHNOS ; Batch 1 is valid until 31 March 2015

1403

Yes

+5C 3C

79

C0682410 Cefatrizine impurity A

60 mg

7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8- oxo-5-thia-1azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole)

1403

Yes

+5C 3C

79

C0682800 Cefazolin

150 mg

See leaflet CHNOS

0988

Yes

+5C 3C

79

Y0000633 Cefepime dihydrochloride monohydrate

150 mg

See leaflet ; Batch 1 is valid until 31 August 2014

2126

Yes

+5C 3C

79

Y0001336 Cefepime impurity E

10 mg

(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

2126

Yes

-20C 5C

79

Y0000634 Cefepime dihydrochloride monohydrate for system


suitability

15 mg

2126

Yes

+5C 3C

79

C0684000 Cefixime

200 mg

See leaflet CHNOS

1188

Yes

-20C 5C

79

C0684750 Cefoperazone dihydrate

100 mg

See leaflet CHNOS

1404

Yes

+5C 3C

79

C0684800 Cefoperazone sodium - reference spectrum

n/a

79

C0685000 Cefotaxime sodium

20 mg

Batch 4 is valid until 31 July 2014

0708,0989

Yes

+5C 3C

79

Y0000420 Cefotaxime acid

80 mg

See leaflet CHNOS

0989

Yes

+5C 3C

79

Y0000506 Cefotaxime for peak identification

10 mg

0989

Yes

+5C 3C

79

C0688000 Cefoxitin sodium

100 mg

0990

Yes

+5C 3C

79

Y0001496 Cefoxitin for peak identification

15 mg

0990

Yes

+5C 3C

79

Y0001305 Cefpodoxime proxetil

70 mg

2341

Yes

-20C 5C

79

Y0001318 Cefpodoxime proxetil for impurity H identification

10 mg

2341

Yes

-20C 5C

79

Y0001306 Cefpodoxime proxetil for peak identification

10 mg

2341

Yes

-20C 5C

79

Y0001371 Cefprozil

120 mg

See leaflet

2342

Yes

+5C 3C

79

Y0001372 Cefprozil impurity A

20 mg

(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
(p-hydroxyphenylglycine)

2342

Yes

+5C 3C

79

Y0001367 Cefprozil for peak identification

10 mg

2342

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet CHClNOS

1404

See leaflet CHNNaOS


See leaflet CHNOS

13

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001368 Cefprozil impurity mixture

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
10 mg
1

Information

C0690000 Cefradine

300 mg

Y0000568 Cefradine for peak identification

15 mg

Y0001174 Cefradine impurity mixture

0.04 mg

C0690500 Ceftazidime

200 mg

Y0001111 Ceftazidime for peak identification

10 mg

C0691000 Ceftriaxone sodium

100 mg

See leaflet CHNNaOS

C0692000 Ceftriaxone impurity A

10 mg

C0694990 Cefuroxime axetil

60 mg

C0695000 Cefuroxime sodium

150 mg

Y0001445 Celecoxib

200 mg

Y0001446 Celecoxib impurity A

Y0001447 Celecoxib impurity B

Y0000311 Celiprolol hydrochloride


Y0000312 Celiprolol impurity I

See leaflet

Monograph Leaflet

Storage

Extra
Price
charges
79
a

2342

Yes

+5C 3C

0167,0168,0
578,
0708,0814

Yes

+5C 3C

79

0814

Yes

+5C 3C

79

0814

Yes

+5C 3C

79

1405, 2344

Yes

+5C 3C

79

1405, 2344

Yes

+5C 3C

79

0991

Yes

+5C 3C

79

E-isomer

0991

Yes

+5C 3C

79

See leaflet CHNOS

1300

Yes

+5C 3C

79

See leaflet CHNNaOS

0988,0992

Yes

+5C 3C

79

See leaflet ; Batch 1 is valid until 30 September 2015

2591

Yes

+5C 3C

79

10 mg

4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide

2591

Yes

+5C 3C

79

10 mg

4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide ; Batch 1 is valid until 30 June 2015

2591

Yes

+5C 3C

79

10 mg

1632

Yes

+5C 3C

79

0.02 mg

1632

Yes

+5C 3C

79

Y0000239 Celiprolol for peak identification

20 mg

1632

Yes

+5C 3C

79

Y0000784 Cellulose acetate

40 mg

0887

Yes

+5C 3C

79

Y0001585 Cellulose acetate butyrate

60 mg

1406

Yes

+5C 3C

79

Y0001054 Cellulose acetate phthalate

10 mg

0314

Yes

+5C 3C

79

C0700000 Cephaeline hydrochloride

15 mg

0081,0093,
0094,1530,1
875

Yes

+5C 3C

79

C0980650 Cetirizine dihydrochloride

100 mg

1084

Yes

+5C 3C

79

C0980651 Cetirizine impurity A

10 mg

(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine

1084

Yes

+5C 3C

79

Y0001197 Cetirizine for peak identification

1.01 mg

Batch 1 is valid until 30 September 2014

1084

Yes

+5C 3C

79

C0984100 Cetostearyl isononanoate - reference spectrum

n/a

79

C0990000 Cetyl alcohol

300 mg

0540,0702,0
801,
0802,0847,0
969, 1411

Yes

+5C 3C

79

Y0000073 Cetyl palmitate 15

60 mg

1906

Yes

+5C 3C

79

Y0000074 Cetyl palmitate 95

50 mg

1906

Yes

+5C 3C

79

C1000000 Cetylpyridinium chloride

20 mg

0379

Yes

+5C 3C

79

C1050000 Chenodeoxycholic acid

125 mg

1189,1275

Yes

+5C 3C

79

Y0000104 Chitosan hydrochloride

30 mg

1774

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet CHNOS

1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea

1085
See leaflet CHO

14

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
C1100000 Chlorambucil

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
100 mg
1

Information

Monograph Leaflet

Storage

0137

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001298 Chlorambucil for system suitability

10 mg

0137

Yes

+5C 3C

79

Y0001299 Chlorambucil with impurity G

10 mg

0137

Yes

+5C 3C

79

C1200000 Chloramphenicol

500 mg

0071,0473,0
709

Yes

+5C 3C

79

C1300000 Chloramphenicol dipalmitate

100 mg

0473

Yes

+5C 3C

79

C1350000 Chloramphenicol disodium disuccinate

25 mg

0709

Yes

+5C 3C

79

C1400000 Chloramphenicol palmitate isomer

100 mg

0473

Yes

+5C 3C

79

C1425000 Chloramphenicol sodium succinate

30 mg

0709

Yes

+5C 3C

79

C1435000 Chlorcyclizine hydrochloride

100 mg

1086

Yes

+5C 3C

79

C1450000 Chlordiazepoxide - * psy

50 mg

0656,1974

Yes

+5C 3C

79

C1500000 Chlordiazepoxide hydrochloride - * psy

100 mg

Y0000476 Chlordiazepoxide impurity A

10 mg

C1510000 Chlorhexidine

50 mg

C1520000 Chlorhexidine diacetate

10 mg

C1540000 Chlorhexidine dihydrochloride

50 mg

Y0001545 Chlorhexidine for system suitability

15 mg

Y0001653 Chlormadinone acetate

120 mg

Y0001656 Chlormadinone acetate impurity G

20 mg

Y0001638 Chlormadinone acetate for system suitability

10 mg

Y0000569 Chlorogenic acid

25 mg

C1650000 Chloroquine sulfate

200 mg

C1700000 Chlorothiazide

10 mg

Batch 2 is valid until 31 May 2015

C1800000 Chlorphenamine maleate

20 mg

Batch 1 is valid until 31 October 2014

Y0000436 Chlorphenamine impurity A

0.01 mg

Y0000437 Chlorphenamine impurity C

10 mg

C1900000 Chlorpromazine hydrochloride

200 mg

Y0000507 Chlorpromazine impurity A

15 mg

Y0000479 Chlorpromazine impurity D

10 mg

Y0000508 Chlorpromazine impurity E

Y0001449 Chlorpromazine impurity F

Council of Europe, all rights reserved 2015

See leaflet CHClNNaO


Batch 1 is valid until 31 January 2015

0474

Yes

+5C 3C

79

0474,0656

Yes

+5C 3C

79

0658

Yes

+5C 3C

79

01/2015:0657

Yes

+5C 3C

79

0659

Yes

+5C 3C

79

0658, 0657,
0659

Yes

+5C 3C

79

2702

Yes

+5C 3C

79

2702

Yes

+5C 3C

79

2702

Yes

+5C 3C

79

Yes

+5C 3C

79

0544,0545

Yes

+5C 3C

79

0394

Yes

+5C 3C

79

0386,0977,1
084, 1196

Yes

+5C 3C

79

2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)
ethyl]butanenitrile

0386

Yes

+5C 3C

79

(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine

0386

Yes

+5C 3C

79

0475

Yes

+5C 3C

79

3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide)

0475

Yes

+5C 3C

79

3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine
(demethylchlorpromazine)

0475

Yes

+5C 3C

79

10 mg

2-chloro-10H-phenothiazine

0475

Yes

+5C 3C

79

2 mg

3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine

0475

Yes

+5C 3C

79

7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide

See leaflet

See leaflet CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5- 1821,1822,1


trihydroxycyclohexanecarboxylic acid
823,
1824,1866,1
897, 2389

15

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C1905000 Chlorpropamide

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
100 mg
1

Information

C1905020 Chlorpropamide impurity B

50 mg

1,3-Dipropylurea

C1915000 Chlorprothixene hydrochloride

50 mg

See leaflet ; Batch 4 is valid until 31 January 2015

C1950000 Chlortalidone

150 mg

See leaflet CHClNOS

Y0000779 Chlortalidone for peak identification

1.017 mg

C2000000 Chlortetracycline hydrochloride

100 mg

New Y0001451 Chlortetracycline for system suitability

10 mg

C2100000 Cholecalciferol

480 mg

See leaflet CHO ; Vitamin D3

C2150000 Cholecalciferol for system suitability

1 mL

New C2155000 Cholesterol

100 mg

C2158000 Cholic acid

60 mg

Y0000280 Chondroitin sulfate sodium

250 mg

Y0000593 Chondroitin sulfate sodium (marine)

100 mg

C2160000 Chymotrypsin BRP

100 mg

See leaflet

Y0001553 Ciclesonide

150 mg

See leaflet CHO

Y0001554 Ciclesonide containing impurity A

15 mg

Y0001555 Ciclesonide impurity B

10 mg

Y0001556 Ciclesonide impurity C

Y0000040 Ciclopirox
C2162701 Ciclopirox impurity A
C2162702 Ciclopirox impurity B
C2162700 Ciclopirox olamine

Monograph Leaflet

Storage

1087

Yes

+5C 3C

Extra
Price
charges
79
a

1087

Yes

+5C 3C

79

0815,1365

Yes

+5C 3C

79

0546

Yes

+5C 3C

79

0546

Yes

+5C 3C

79

See leaflet

0173

Yes

+5C 3C

79

Batch 1 is valid until 31 October 2015

0173

Yes

+5C 3C

79

0072, 0574,
0575, 0598,
1192, 1193,
2398

Yes

-20C 5C

79

0072,0082,0
574,
0575,0598

Yes

-20C 5C

79

0593, 0993,
2397

Yes

+5C 3C

79

1189

Yes

+5C 3C

79

2064,2090

Yes

+5C 3C

79

2064

Yes

+5C 3C

79

0476,0694

Yes

+5C 3C

79

2703

Yes

+5C 3C

79

(2S)-2-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-21-yl 2-methylpropanoate (S-epimer of ciclesonide)

2703

Yes

+5C 3C

79

(2R)-2-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-3,20-dione

2703

Yes

+5C 3C

79

10 mg

(2R)-2-[(1RS)-cyclohex-3-enyl]-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo
[4,5:16,17]pregna-1,4-diene-21-yl 2-methylpropanoate

2703

Yes

+5C 3C

79

100 mg

1407

Yes

+5C 3C

79

40 mg

()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid

1302,1407

Yes

+5C 3C

79

20 mg

6-cyclohexyl-4-methyl-2H-pyran-2-one

1302,1407

Yes

-20C 5C

79

150 mg

1302

Yes

+5C 3C

79

C2163000 Ciclosporin

120 mg

0994

Yes

+5C 3C

79

Y0000361 Ciclosporin for system suitability

5 mg

0994

Yes

+5C 3C

79

C2170000 Cilastatin sodium

10 mg

1408

Yes

+5C 3C

79

Y0001651 Cilastatin for system suitability 1

5 mg

1408

Yes

+5C 3C

79

Y0001652 Cilastatin for system suitability 2

5 mg

1408

Yes

+5C 3C

79

C2174000 Cilazapril

50 mg

1499

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet ; Batch 3 is valid until 30 October 2015

See leaflet HO(CHNNaOS)

See leaflet

16

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C2174002 Cilazapril impurity A

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
25 mg
1 1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]
amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1499

Yes

+5C 3C

1499

Yes

+5C 3C

79

0756

Yes

+5C 3C

79

C2174005 Cilazapril impurity D

10 mg

C2175000 Cimetidine

50 mg

C2175500 Cimetidine hydrochloride

100 mg

1500

Yes

+5C 3C

79

Y0001130 Cimetidine for peak identification

10 mg

0756, 1500

Yes

+5C 3C

79

Y0001146 Cimetidine for system suitability

0.5085 mg

0756, 1500

Yes

+5C 3C

79

C2177000 Cinchocaine hydrochloride

60 mg

1088

Yes

+5C 3C

79

Y0000176 Cineole

180 mg

1973

Yes

+5C 3C

79

C2180000 Cinnarizine

100 mg

0816

Yes

+5C 3C

79

Y0000362 Ciprofibrate

5 mg

2013

Yes

+5C 3C

79

Y0000363 Ciprofibrate for system suitability

5 mg

2013

Yes

+5C 3C

79

Y0000198 Ciprofloxacin

20 mg

C2190000 Ciprofloxacin hydrochloride

100 mg

Y0000199 Ciprofloxacin hydrochloride for peak identification

15 mg

C2190050 Ciprofloxacin impurity A

25 mg

7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic
acid (fluoroquinolonic acid)

C2210000 Cisplatin

100 mg

Y0001018 Cisplatin impurity A

15 mg

Y0001019 Cisplatin impurity B

15 mg

Y0001008 Citalopram hydrobromide

5 mg

Y0001007 Citalopram hydrochloride

5 mg

Y0000855 Citalopram for system suitability

A1202000 Citric acid (anhydrous)

C2219000 Citric acid monohydrate


Y0000639 Cladribine
Y0000610 Cladribine impurity C
Y0000609 Cladribine for peak identification

(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid

See leaflet

1089

Yes

+5C 3C

79

0888,1353

Yes

+5C 3C

79

0888,1089

Yes

+5C 3C

79

0888,1089,2
229

Yes

+5C 3C

79

See leaflet [PtCl(NH)] ; Batch 5 is valid until 30 June 2015

0599

Yes

+5C 3C

79

trans-diamminedichloroplatinum (II)

0599

Yes

+5C 3C

79

See leaflet [PtCl(NH)]-; amminetrichloroplatinate(-)

0599

Yes

+5C 3C

79

2288

Yes

+5C 3C

79

2203

Yes

+5C 3C

79

0.065 mg

2203,2288

Yes

+5C 3C

79

50 mg

0455

Yes

+5C 3C

79

50 mg

0456

Yes

+5C 3C

79

50 mg

See leaflet CHClNO

2174

Yes

+5C 3C

79

5 mg

2-chloro-7H-purin-6-amine

2174

Yes

+5C 3C

79

10 mg

2174

Yes

+5C 3C

79

Y0000320 Clarithromycin

160 mg

1651

Yes

+5C 3C

79

Y0000321 Clarithromycin for peak identification

40 mg

1651

Yes

+5C 3C

79

Y0001193 Clazuril

10 mg

1714

Yes

+5C 3C

79

Y0000269 Clazuril for system suitability

10 mg

1714

Yes

+5C 3C

79

C2221000 Clebopride malate

100 mg

1303

Yes

+5C 3C

79

C2223000 Clemastine fumarate

100 mg

1190

Yes

+5C 3C

79

Y0001613 Clemastine for system suitability

0.165 mg

1190

Yes

+5C 3C

79

C2248000 Clenbuterol hydrochloride

30 mg

1409

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet CHNO

17

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C2248010 Clenbuterol impurity B
C2250000 Clindamycin hydrochloride

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
2
10 mg
1 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone
4
200 mg
1 See leaflet

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1409

Yes

+5C 3C

0582

Yes

+5C 3C

79

0996

Yes

+5C 3C

79

C2269000 Clindamycin phosphate

250 mg

Y0001680 Clindamycin phosphate for system suitability

10 mg

0996

Yes

+5C 3C

79

Y0000364 Clioquinol

5 mg

2111

Yes

+5C 3C

79

Y0000205 Clobazam - reference spectrum

n/a

79

Y0000241 Clobazam impurity A

10 mg

7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione

1974

Yes

+5C 3C

79

Y0000559 Clobetasol propionate

40 mg

See leaflet CHClFO

2127

Yes

+5C 3C

79

Y0000571 Clobetasol impurity J

0.4 mg

(17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)

2127

Yes

+5C 3C

79

Y0000570 Clobetasol for peak identification

2 mg

2127

Yes

+5C 3C

79

C2285000 Clobetasone butyrate

50 mg

1090

Yes

+5C 3C

79

Y0001137 Clobetasone butyrate for system suitability

30 mg

1090

Yes

+5C 3C

79

Y0000888 Clodronate disodium tetrahydrate

5 mg

1777

Yes

+5C 3C

79

Y0000885 Clodronate impurity D

5 mg

1777

Yes

+5C 3C

79

Y0000313 Clofazimine

150 mg

2054

Yes

+5C 3C

79

Y0000358 Clofazimine for system suitability

10 mg

2054

Yes

+5C 3C

79

C2300000 Clofibrate

0.5 ml

C2320000 Clomifene citrate

50 mg

C2332000 Clomifene citrate for performance test

50 mg

C2360000 Clomipramine hydrochloride

100 mg

Y0000132 Clomipramine impurity C

10 mg

Y0000133 Clomipramine impurity D

10 mg

Y0000134 Clomipramine impurity F

C2385000 Clonazepam - * psy

Y0000286 Clonazepam - reference spectrum

n/a

C2385015 Clonazepam impurity B

5 mg

C2400000 Clonidine hydrochloride

100 mg

Y0000801 Clonidine impurity B

20 mg

Y0000833 Clopamide

40 mg

Y0000848 Clopamide for system suitability

10 mg

Y0001333 Clopidogrel hydrogen sulfate

60 mg

Y0001335 Clopidogrel impurity A

10 mg

(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid ;
Batch 1 is valid until 30 April 2015

Y0001334 Clopidogrel for system suitability

100 mg

Batch 1 is valid until 31 August 2015

Council of Europe, all rights reserved 2015

see leaflet

1974

(chloromethylene)bis(phosphonic acid)

0318

Yes

+5C 3C

79

0997,1046

Yes

+5C 3C

79

0997

Yes

+5C 3C

79

0889

Yes

+5C 3C

79

See leaflet CHClN; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine

0889

Yes

+5C 3C

79

See leaflet CHClN; 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]


azepin-5-yl)-N,N-dimethylpropan-1-amine

0889

Yes

+5C 3C

79

5 mg

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

0889

Yes

+5C 3C

79

50 mg

1974,0415

Yes

+5C 3C

79

79

0890

Yes

+5C 3C

79

0477

Yes

+5C 3C

79

0477

Yes

+5C 3C

79

1747

Yes

+5C 3C

79

1747

Yes

+5C 3C

79

2531

Yes

+5C 3C

79

2531

Yes

+5C 3C

79

2531

Yes

+5C 3C

79

See leaflet CHClNO

0890
3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one
1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole

18

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000392 Closantel sodium dihydrate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
20 mg
1

Information

Monograph Leaflet
1716

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

Y0000393 Closantel for system suitability

20 mg

1716

Yes

+5C 3C

79

C2424400 Clostridia (multi-component) rabbit antiserum(for


vaccines-vet.use)BRP

1 mg

See leaflet

0362,0363,0
364, 0697

Yes

-20C 5C

90

C2424550 Clostridium tetani guinea pig antiserum (for vaccines human use) BRP

1 mg

See leaflet

20708

Yes

-20C 5C

90

C2424500 Clostridium tetani guinea pig antiserum (for vaccines vet. use) BRP

1 mg

See leaflet

See leaflet,
0697

Yes

-20C 5C

90

C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.


use) BRP

1 mg

See leaflet

See leaflet,
0697

Yes

-20C 5C

90

C2430000 Clotrimazole

100 mg

0757

Yes

+5C 3C

79

Y0000818 Clotrimazole impurity E

15 mg

0757

Yes

+5C 3C

79

Y0000849 Clotrimazole for peak identification

1.005 mg

0757

Yes

+5C 3C

79

C2450000 Cloxacillin sodium

200 mg

0661, 0663,
0668, 2260,
2346

Yes

+5C 3C

79

C2460000 Clozapine

60 mg

1191

Yes

+5C 3C

79

Y0000758 Clozapine for peak identification

0.41 mg

Batch 1 is valid until 31 January 2015

1191

Yes

+5C 3C

79

Y0001472 Coagulation Factors V, VIII, XI and XIII plasma

1 mg

See leaflet

0903,1646,2
0740,20722

Yes

-20C 5C

90

Y0000162 Cocaine hydrochloride - reference spectrum

n/a

79

C2480000 Cocoyl caprylocaprate

40 mg

Y0000722 Codeine - * narc

20 mg

C2500000 Codeine - reference spectrum

n/a

Y0000334 Codeine impurity A

15 mg

C2500100 Codeine hydrochloride dihydrate - reference spectrum

n/a

1412

C2510000 Codergocrine mesilate

60 mg

Y0001500 Coix seed HRS

1300 mg

C2580000 Colchicine

15 mg

Y0000209 Colchicine for system suitability

Y0000374 Colestyramine

C2600000 Colistimethate sodium


Y0000277 Colistin sulfate

see leaflet

0073
1411

Yes

+5C 3C

79

0076,0777,1
839,1840,18
41
0074,0075

Yes

+5C 3C

79

79

0074,0075,0
076, 1412

Yes

+5C 3C

79

79

1416,2060

Yes

+5C 3C

79

2454

Yes

+5C 3C

79

0758

Yes

+5C 3C

79

10 mg

0758

Yes

+5C 3C

79

10 mg

1775

Yes

+5C 3C

79

20 mg

See leaflet

0319,20702

Yes

+5C 3C

79

25 mg

See leaflet

0320

Yes

-20C 5C

79

C2700000 Colistin sulfate for microbiological assay

25 mg

See leaflet; For microbiological assay only

0320

Yes

-20C 5C

79

C2725000 Copovidone - reference spectrum

n/a

0891

79

New Y0001748 Copper tetramibi tetrafluoroborate

15 mg

2547

g(c)

79

Council of Europe, all rights reserved 2015

See leaflet

7,8-didehydro-4,5 alpha-epoxy-3,6 alpha-dimethoxy-17-methylmorphinan ;


Batch 3 is valid until 31 October 2014

19

Yes

-20C 5C

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C2800000 Cortisone acetate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
6
250 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0321,0736,0
767

Yes

+5C 3C

0036

Yes

+5C 3C

79

2120

Yes

+5C 3C

79

0892

Yes

+5C 3C

79

C2900000 Cotton wool standard for neps

1000 mg

Y0000438 Coumarin

110 mg

Y0001053 Crospovidone

5 mg

C2970000 Crotamiton

100 mg

see leaflet CHNO ; Batch 2 is valid until 30 June 2015

1194

Yes

-20C 5C

79

C2970005 Crotamiton impurity A

35 mg

See leaflet; N-ethyl-N-(2-methylphenyl)but-3-enamide ; Batch 3 is valid until


31 August 2014
Batch 4 is valid until 30 September 2015

1194

Yes

-20C 5C

79

Y0001061 Cyanidin chloride

25 mg

See leaflet CHClO

C3000000 Cyanocobalamin

20 mg

Vitamin B12 ; Batch 4 is valid until 28 February 2015

C3090000 Cyclizine hydrochloride

50 mg

Y0000886 Cyclizine impurity A

15 mg

1-methylpiperazine

Y0000887 Cyclizine impurity B

15 mg

diphenylmethanol (benzhydrol)

C3200000 Cyclobenzaprine hydrochloride

100 mg

C3230000 Cyclohexa-1,4-dienylglycine

15 mg

C3245000 Cyclopentolate hydrochloride

50 mg

Y0001088 Cyclopentolate for system suitability

20 mg

C3250000 Cyclophosphamide

50 mg

C3280000 Cyproheptadine hydrochloride

15 mg

Y0001095 Cyproheptadine impurity C

5 mg

C3283000 Cyproterone acetate

30 mg

Y0001390 Cyproterone acetate for peak identification

5 mg

Y0001223 Cyproterone impurity mixture

C3290000 Cysteine hydrochloride monohydrate

C3300000 Cystine
C3350000 Cytarabine

See leaflet CHO

2394

Yes

+5C 3C

79

0269,0270,0
547,
0710,1505

Yes

+5C 3C

79

1092

Yes

+5C 3C

79

1092

Yes

+5C 3C

79

1092

Yes

+5C 3C

79

0408,0464

Yes

+5C 3C

79

0814

Yes

-20C 5C

79

1093

Yes

+5C 3C

79

1093

Yes

+5C 3C

79

0711

Yes

+5C 3C

79

0817,0846

Yes

+5C 3C

79

0817

Yes

+5C 3C

79

1094

Yes

+5C 3C

79

1094

Yes

+5C 3C

79

0.01 mg

1094

Yes

+5C 3C

79

100 mg

0895

Yes

+5C 3C

79

100 mg

0998

Yes

+5C 3C

79

150 mg

0760

Yes

+5C 3C

79

Y0000733 Dacarbazine

20 mg

1691

Yes

+5C 3C

79

Y0000734 Dacarbazine impurity A

20 mg

See leaflet CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2azahypoxanthine)

1691

Yes

+5C 3C

79

Y0000735 Dacarbazine impurity B

10 mg

See leaflet; 5-amino-1H-imidazole-carboxamide

1691

Yes

+5C 3C

79

New D0070000 Dalteparin sodium

(2R)-amino(cyclohexa-1,4-dienyl)acetic acid (d-dihydrophenylglycine)


Batch 1 is valid until 30 November 2014
Batch 1 is valid until 31 July 2015

250 mg

Batch 2 is valid until 30 November 2015

1195

Yes

+5C 3C

79

Y0000600 Danaparoid sodium

10.5 mg

See leaflet ; Batch 1 is valid until 30 September 2015

2090

Yes

+5C 3C

79

D0100000 Dapsone

100 mg

0077

Yes

+5C 3C

79

D0125000 Daunorubicin hydrochloride

120 mg

See leaflet CHClNO

0662

Yes

+5C 3C

79

D0120000 Daunorubicinone

10 mg

Daunorubicin aglycone

0662

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

20

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
D0160000 Deferoxamine mesilate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
30 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0896

Yes

+5C 3C

1221

Yes

+5C 3C

79

D0201000 Dehydrohexetidine

50 mg

Y0000611 Dembrexine hydrochloride monohydrate

10 mg

2169

Yes

+5C 3C

79

Y0001707 Demeclocycline for system suitability

10 mg

0176

Yes

+5C 3C

79

D0300000 Demeclocycline hydrochloride

100 mg

see leaflet

0211,0210,0
176,
0173,1654

Yes

+5C 3C

79

15 mg

Batch 2 is valid until 31 October 2015

0179,0274,0
490,
0552,1098

Yes

+5C 3C

79

New D0350000 N-Demethylerythromycin A

2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]
hexan-1-amine

Y0000228 Demethylflumazenil - reference spectrum

n/a

1917

79

D0406200 Deptropine citrate

60 mg

1308

Yes

+5C 3C

79

D0430000 Dequalinium chloride

50 mg

1413

Yes

+5C 3C

79

D0431000 Dequalinium chloride for performance test

50 mg

1413

Yes

+5C 3C

79

Y0001321 Dermatan sulfate and oversulfated chondroitin sulfate

1 mL

0332,0333

Yes

-20C 5C

79

D0480000 Desacetylvinblastine

1 mg

1276

Yes

-80C 10C

79

Y0000879 Desflurane - reference spectrum

n/a

79

Y0000807 Desflurane impurity A

1 mL

1666

Yes

+5C 3C

79

D0500000 Desipramine hydrochloride

100 mg

0481

Yes

+5C 3C

79

D0600000 Deslanoside

150 mg

See leaflet CHO

0482

Yes

+5C 3C

79

Y0001584 Desloratadine

100 mg

See leaflet ; Batch 1 is valid until 30 September 2015

2570

Yes

+5C 3C

79

D0630000 Desmethylmetrifonate

30 mg

1133

Yes

+5C 3C

79

Y0001582 Desloratadine for system suitability

5 mg

2570

Yes

+5C 3C

79

D0650000 Desmopressin

0.94 mg

See leaflet CHNOS

0712

Yes

-20C 5C

79

Y0000509 Desogestrel

50 mg

See leaflet CHO

1717

Yes

+5C 3C

79

Y0000510 Desogestrel for system suitability

10 mg

1717

Yes

+5C 3C

79

D0400000 Desoxycortone acetate

100 mg

0322, 1327

Yes

+5C 3C

79

Y0000001 Detomidine hydrochloride

100 mg

1414

Yes

+5C 3C

79

D0660020 Detomidine impurity B

20 mg

1414

Yes

+5C 3C

79

D0700000 Dexamethasone

50 mg

0312,0388,0
548,
0768,1376,2
237,0549

Yes

+5C 3C

79

Y0001593 Dexamethasone for peak identification

10 mg

0388

Yes

+5C 3C

79

Y0001177 Dexamethasone for system suitability

10 mg

0388

Yes

+5C 3C

79

D0710000 Dexamethasone acetate

100 mg

0548,0933,0
975, 2237

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet

1666
1,1'-oxybis(1,2,2,2-tetrafluoroethane) ; Batch 1 is valid until 30 September
2015

(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol

21

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001169 Dexamethasone acetate impurity E

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
0.013 mg 1 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl
acetate

Monograph Leaflet

Storage

0548

Yes

+5C 3C

Extra
Price
charges
79
a

Y0000538 Dexamethasone isonicotinate

10 mg

2237

Yes

+5C 3C

79

Y0000511 Dexamethasone isonicotinate for impurity C identification

10 mg

2237

Yes

+5C 3C

79

D0718000 Dexamethasone pivalate

50 mg

1327

Yes

+5C 3C

79

D0720000 Dexamethasone sodium phosphate

130 mg

0549,0735,0
810

Yes

+5C 3C

79

Y0001477 Dexamethasone sodium phosphate for peak


identification

10 mg

0549

Yes

+5C 3C

79

D0720800 Dexchlorpheniramine maleate

60 mg

D0730000 Dexpanthenol

5 mg

D0731000 Dextran

25 mg

D0731005 Dextran 1

50 mg

D0733000 Dextran 4 for calibration

50 mg

D0734000 Dextran 10 for calibration

D0735000 Dextran 40 for calibration

D0738000 Dextran 40 for performance test


D0739000 Dextran 60/70 for performance test

See leaflet

1196

Yes

+5C 3C

79

0761

Yes

+5C 3C

79

0999,1000,1
001

Yes

+5C 3C

79

See leaflet; Average molecule mass : 930-1000


Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%

1506

Yes

+5C 3C

79

See leaflet

20239

Yes

+5C 3C

79

50 mg

See leaflet

20239

Yes

+5C 3C

79

50 mg

See leaflet

20239

Yes

+5C 3C

79

50 mg

20239

Yes

+5C 3C

79

50 mg

20239

Yes

+5C 3C

79

D0736000 Dextran 70 for calibration

50 mg

See leaflet

20239

Yes

+5C 3C

79

D0737000 Dextran 250 for calibration

50 mg

See leaflet

20239

Yes

+5C 3C

79

D0732000 Dextran Vo

10 mg

20239

Yes

+5C 3C

79

Y0000744 Dextranomer

50 mg

2238

Yes

+5C 3C

79

D0740000 Dextromethorphan hydrobromide

100 mg

0020

Yes

+5C 3C

79

Y0000261 Dextromethorphan impurity A

5 mg

0020

Yes

+5C 3C

79

Y0001058 Dextropropoxyphene hydrochloride - * narc

10 mg

0713

Yes

+5C 3C

79

Y0001150 Dextropropoxyphene for system suitability - * narc

5 mg

0713

Yes

+5C 3C

79

Y0001595 Diacerein

150 mg

See leaflet CHO

2409

Yes

+5C 3C

79

Y0001596 Diacerein impurity B

20 mg

see leaflet

2409

Yes

+5C 3C

79

Y0001597 Diacerein impurity mixture

0.014 mg

2409

Yes

-20C 5C

79

Y0000454 Diacetylfluorescein

100 mg

1213

Yes

+5C 3C

79

D0940000 Diazepam - * psy

30 mg

0022

Yes

+5C 3C

79

Y0000596 Diazepam for system suitability - * psy

0.5 mg

0022

Yes

+5C 3C

79

D0950000 Diazoxide

50 mg

0550

Yes

+5C 3C

79

D0970000 Dibenzocycloheptene

20 mg

0817

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

Batch 4 is valid until 30 November 2014

ent-3-methoxymorphinan

See leaflet

22

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
D1000000 Dibenzosuberone

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
30 mg
1

Information

Monograph Leaflet

Storage

0464,0817,0
941

Yes

+5C 3C

Extra
Price
charges
79
a

Y0000480 Dibrompropamidine diisetionate

10 mg

2300

Yes

+5C 3C

79

Y0000481 Dibrompropamidine for system suitability

20 mg

2300

Yes

+5C 3C

79

D1010000 Dibutyl phthalate

1 ml

0762

Yes

+5C 3C

79

Y0001620 2,4-dichlorobenzyl alcohol

250 mg

2410

Yes

+5C 3C

79

Y0001621 2,4-Dichlorobenzyl alcohol impurity A

25 mg

2410

Yes

+5C 3C

79

Y0001622 2,4-Dichlorobenzyl alcohol impurity C

25 mg

2410

Yes

+5C 3C

79

Y0000275 Dichlorodiaminocyclohexaneplatinum

15 mg

2017

Yes

+5C 3C

79

Y0000264 Diclazuril for veterinary use - reference spectrum

n/a

1718

79

Y0000259 Diclazuril for system suitability

20 mg

1718

Yes

+5C 3C

79

D1039990 Diclofenac potassium

100 mg

1508

Yes

+5C 3C

79

S0765000 Diclofenac sodium

100 mg

1002,1281

Yes

+5C 3C

79

D1040000 Diclofenac impurity A

0.005 mg

1281

Yes

+5C 3C

79

Y0001635 Diclofenac for system suitability

1.002 mg

1002

Yes

+5C 3C

79

D1050000 Dicloxacillin sodium

250 mg

0661, 0663,
0668, 2346

Yes

-20C 5C

79

D1060000 Dicycloverine hydrochloride

100 mg

1197

Yes

+5C 3C

79

Y0000439 Didanosine

10 mg

2200

Yes

+5C 3C

79

Y0000441 Didanosine impurity A

10 mg

1,7-dihydro-6H-purin-6-one (hypoxanthine)

2200

Yes

+5C 3C

79

Y0000442 Didanosine impurity G

10 mg

9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'dideoxyadenosine)

2200

Yes

+5C 3C

79

Y0000440 Didanosine for system suitability

10 mg

2200

Yes

+5C 3C

79

D1200000 Dienestrol

150 mg

0484

Yes

+5C 3C

79

D1410000 Diethyl phthalate

1 ml

0897

Yes

+5C 3C

79

D1300000 Diethylcarbamazine citrate

250 mg

0271

Yes

+5C 3C

79

Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum

n/a

79

D1500000 Diethylstilbestrol

100 mg

0484

Yes

+5C 3C

79

D1600000 Diethylstilbestrol dimethyl ether

10 mg

0484

Yes

+5C 3C

79

D1700000 Diethylstilbestrol monomethyl ether

10 mg

0484

Yes

+5C 3C

79

Y0001423 Difloxacin hydrochloride

60 mg

2239

Yes

+5C 3C

79

Y0001429 Difloxacin impurity G

15 mg

2239

Yes

+5C 3C

79

D1750000 Diflunisal

30 mg

D1800000 Digitoxin

200 mg

See leaflet CHO

Y0000640 Digoxigenin

10 mg

D1900000 Digoxin

30 mg

Council of Europe, all rights reserved 2015

See leaflet CHClO

1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one
See leaflet CHClNNaOS

See leaflet CHO


See leaflet CHNO

1198
See leaflet CHO

7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
acid

0864

Yes

+5C 3C

79

0078,0117

Yes

+5C 3C

79

See leaflet

0079

Yes

+5C 3C

79

See leaflet CHO

0079

Yes

+5C 3C

79

23

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000554 Digoxin for peak identification

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
10 mg
1

Information

Monograph Leaflet
0079

Storage

Extra
Price
charges
79
a

Yes

+5C 3C

79

Yes

+5C 3C

79

79

1512

Yes

-20C 5C

79

1416,2060

Yes

+5C 3C

79

0551

Yes

+5C 3C

79

D1940001 Dihydralazine sulfate (hydrated) - reference spectrum

n/a

1310

Y0000232 Dihydralazine for system suitability

10 mg

1310

Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum

n/a

Y0000053 17 alpha-dihydroequilin

10 mg

D1945000 Dihydroergocristine mesilate

250 mg

D1950000 Dihydroergotamine mesilate

50 mg

Y0000831 Dihydroergotamine for peak identification

10 mg

0551

Yes

+5C 3C

79

D1952000 Dihydroergotamine tartrate

150 mg

0600

Yes

+5C 3C

79

D1954000 Dihydrostreptomycin sulfate

25 mg

See leaflet CHNOS

0485

Yes

-20C 5C

79

Y0000544 Dihydrotachysterol

30 mg

See leaflet CHO

2014

Yes

-20C 5C

e(d)

79

Y0000482 Dihydrotachysterol for system suitability

5 mg

2014

Yes

-20C 5C

e(d)

79

D1980000 Diltiazem hydrochloride

300 mg

1004

Yes

+5C 3C

79

Y0001439 Diltiazem impurity F

10 mg

(2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3dihydro-1,5-benzothiazepin-4(5H)-one

1004

Yes

+5C 3C

79

Y0001141 Diltiazem for system suitability

10 mg

Replaces Diltiazem impurity A CRS

1004

Yes

+5C 3C

79

D2000000 Dimenhydrinate

100 mg

0601

Yes

+5C 3C

79

Y0001103 Dimenhydrinate for peak identification

1 mg

0601

Yes

+5C 3C

79

Y0000234 N,N-Dimethylacetamide - reference spectrum

n/a

1667

79

New D2050000 Dimethyl sulfoxide

1776
See leaflet
Batch 3 is valid until 31 March 2015

1 mL

Y0001489 2-(Dimethylamino)ethyl methacrylate

50 mg

D2200000 Dimeticone

200 mg

D2205000 Dimetindene maleate

50 mg

D2255000 Dinoprost trometamol

60 mg

D2250000 Dinoprostone

100 mg

D2250015 Dinoprostone impurity C

10 mg

(E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2 ; (5E)-PGE2)

Y0000094 Diosmin

70 mg

See leaflet ; Batch 3 is valid until 31 August 2014

Y0000095 Diosmin for system suitability

5 mg

D2600000 Diphenhydramine hydrochloride

100 mg

Y0000135 Diphenhydramine impurity A

10 mg

Y0001415 Diphenoxylate hydrochloride - * narc

15 mg

D2630000 Diphenoxylate hydrochloride - reference spectrum

Y0001430 Diphenoxylate for system suitability - * narc

Y0000258 Diphtheria toxin BRP

1 ml

Council of Europe, all rights reserved 2015

0763

Yes

+5C 3C

79

1975

Yes

+5C 3C

79

0138,1470

Yes

+5C 3C

79

1417

Yes

+5C 3C

79

See leaflet CHNO

1312

Yes

-20C 5C

79

See leaflet CHO

1311

Yes

-20C 5C

79

1311,1488

Yes

-20C 5C

240

1611

Yes

+5C 3C

79

1611

Yes

+5C 3C

79

0023,0601

Yes

+5C 3C

79

0023,0601

Yes

+5C 3C

79

0819

Yes

+5C 3C

79

n/a

0819

79

10 mg

0819

Yes

+5C 3C

79

See leaflet,
0443

Yes

+5C 3C

90

Batch 2 is valid until 31 October 2015


See leaflet

2-(diphenylmethoxy)-N-methylethanamine ; Batch 3 is valid until 31


December 2014

See leaflet
24

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
D2700000 Diphtheria vaccine (adsorbed) BRP

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
4
32 mg
1 See leaflet

Information

Monograph Leaflet

Storage

Extra
Price
charges
90
c

See leaflet,
20706

Yes

-20C 5C

1719

Yes

+5C 3C

79

Yes

+5C 3C

79

79

Y0000376 Dipivefrine hydrochloride

100 mg

Y0000394 Dipivefrine for system suitability

10 mg

1719

D2750100 Dipotassium clorazepate - reference spectrum

n/a

0898

D2800000 Diprophylline

100 mg

0486

Yes

+5C 3C

79

D2850000 Dipyridamole

50 mg

1199

Yes

+5C 3C

79

Y0000802 Dipyridamole for peak identification

2.04 mg

D2880000 Dirithromycin

100 mg

D2900000 Disodium edetate

100 mg

D2920000 Disopyramide

100 mg

D2922000 Disopyramide phosphate

D2950000 Disulfiram

D2953000 Dithranol
D2953025 Dithranol impurity C

D2953050 Dithranol impurity D


D2954000 Dobutamine hydrochloride
Y0001239 Dobutamine impurity mixture
Y0001133 Docetaxel trihydrate

See leaflet CHClNO

1199

Yes

+5C 3C

79

1313

Yes

+5C 3C

79

0232

Yes

+5C 3C

79

1006

Yes

+5C 3C

79

100 mg

1005

Yes

+5C 3C

79

100 mg

0603

Yes

+5C 3C

79

55 mg

Batch 2 is valid until 31 March 2015

1007

Yes

+5C 3C

79

15 mg

See leaflet; Dithranol-dimer


4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione ; Batch 3 is
valid until 30 September 2014

1007

Yes

+5C 3C

79

20 mg

1-hydroxyanthracen-9(10H)-one

1007

Yes

+5C 3C

79

100 mg

1200

Yes

+5C 3C

79

0.1 mg

160 mg

Y0001155 Docetaxel for system suitability

10 mg

Y0001452 Docetaxel impurity E

15 mg

5,20-epoxy-4-(acetyloxy)-1,7,10,13-tetrahydroxy-9-oxotax-11-en-2-yl
benzoate (10-desacetyl-baccatin III)

D2954600 Docosahexaenoic acid ethyl ester

150 mg

See leaflet

Y0001567 Docusate sodium

10 mg

Y0000365 Dodecyl gallate

30 mg

D2955000 Domperidone

D2957000 Domperidone maleate

D2960000 Dopamine hydrochloride


Y0000612 Dopexamine dihydrochloride

See leaflet CHNO

1200

Yes

-20C 5C

79

2449, 2593

Yes

+5C 3C

79

2449,2593

Yes

+5C 3C

79

2593

Yes

+5C 3C

79

20429

Yes

-20C 5C

79

1418

Yes

+5C 3C

79

2078

Yes

+5C 3C

79

150 mg

1009

Yes

+5C 3C

79

150 mg

1008

Yes

+5C 3C

79

20 mg

0664,1200

Yes

+5C 3C

79

10 mg

1748

Yes

+5C 3C

79

Y0000613 Dopexamine impurity B

10 mg

2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol

1748

Yes

-20C 5C

79

Y0000614 Dopexamine impurity F

10 mg

4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benz -ene-1,2-diol

1748

Yes

-20C 5C

79

Y0000726 Dorzolamide hydrochloride

50 mg

2359

Yes

+5C 3C

79

Y0000727 Dorzolamide impurity A

5 mg

2359

Yes

+5C 3C

79

Y0000750 Dorzolamide for system suitability

5 mg

2359

Yes

+5C 3C

79

100 mg

D2962000 Dosulepin hydrochloride


Council of Europe, all rights reserved 2015

See leaflet CHNO.3HO

Batch 1 is valid until 31 August 2014

(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulphonamide 7,7-dioxide

25

79
1314
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
D2962005 Dosulepin impurity A

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
2
30 mg
1 (E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1314

Yes

+5C 3C

1201

Yes

+5C 3C

79

D2963000 Doxapram hydrochloride

50 mg

Y0000208 Doxapram impurity B

10 mg

(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one

1201

Yes

+5C 3C

79

Y0000553 Doxazosin mesilate

60 mg

See leaflet

2125

Yes

+5C 3C

79

Y0000551 Doxazosin impurity D

10 mg

6,7-dimethoxyquinazoline-2,4(1H,3H)-dione

2125

Yes

+5C 3C

79

Y0000552 Doxazosin impurity F

15 mg

2-chloro-6,7-dimethoxyquinazolin-4-amine

2125

Yes

+5C 3C

79

Y0000838 Doxepin hydrochloride

5 mg

1096

Yes

+5C 3C

79

Y0000851 Doxepin for system suitability

1 mg

1096

Yes

+5C 3C

79

D2975000 Doxorubicin hydrochloride

150 mg

See leaflet CHClNO

0714,0662,1
590

Yes

-20C 5C

79

D3000000 Doxycycline hyclate

50 mg

see leaflet ; Batch 4 is valid until 30 September 2015

Yes

+5C 3C

79

Y0001714 Doxycycline for system suitability

10 mg

04/2015:027
2,
04/2015:082
0
0272,0820

Yes

+5C 3C

79

Y0001562 Doxylamine hydrogen succinate

60 mg

1589

Yes

+5C 3C

79

Y0000163 Doxylamine hydrogen succinate - reference spectrum

n/a

1589

79

Y0001492 Doxylamine for system suitability

110 mg

Batch 1 is valid until 28 February 2015

D3100000 Droperidol

150 mg

Batch 2 is valid until 31 May 2015

Y0001105 Drospirenone

60 mg

Y0001115 Drospirenone impurity E

0.06 mg

Y0001718 Drospirenone for peak identification

10 mg

Y0001453 Duloxetine hydrochloride

120 mg

See leaflet CHClNOS

Y0001455 Duloxetine impurity A

10 mg

(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine ;
Batch 1 is valid until 30 November 2014

Y0001454 Duloxetine for system suitability

40 mg

Y0001598 Dutasteride

150 mg

Y0001603 Dutasteride for system suitability

10 mg

Y0001004 Dydrogesterone

50 mg

See leaflet CHO

Y0001005 Dydrogesterone impurity A

6 mg

Y0001006 Dydrogesterone impurity B

5 mg

Y0000249 Ebastine - reference spectrum

n/a

Y0000247 Ebastine impurity C

10 mg

4-(diphenylmethoxy)piperidine

Y0000248 Ebastine impurity D

10 mg

1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one

Y0001236 Econazole

10 mg

Y0000254 Econazole for system suitability

20 mg

Council of Europe, all rights reserved 2015

1589

Yes

+5C 3C

79

1008,1009,1
010, 1172

Yes

+5C 3C

79

See leaflet CHO

2404

Yes

+5C 3C

79

3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa
[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone)

2404

Yes

+5C 3C

79

2404

Yes

+5C 3C

79

2594

Yes

+5C 3C

79

2594

Yes

+5C 3C

79

2594

Yes

+5C 3C

79

2641

Yes

+5C 3C

79

2641

Yes

+5C 3C

79

2357

Yes

+5C 3C

79

9,10-pregna-4,6,8(14)-triene-3,20-dione

2357

Yes

+5C 3C

79

pregna-4,6-diene-3,20-dione

2357

Yes

+5C 3C

79

79

2015

Yes

+5C 3C

79

2015

Yes

+5C 3C

79

2049

Yes

+5C 3C

79

0665,2049

Yes

+5C 3C

79

See leaflet

2015

26

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
E0050000 Econazole nitrate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
3
100 mg
1

Y0001738 Edrophonium chloride

10 mg

E0085000 Eicosapentaenoic acid ethyl ester

200 mg

Y0000537 Emedastine difumarate

10 mg

Y0000512 Emedastine impurity E

10 mg

E0100000 Emetine hydrochloride

100 mg

E0109000 Enalapril maleate

E0110000 Enalapril for system suitability


Y0001211 Enalapril impurity mixture
Y0000615 Enalaprilat dihydrate
Y0000678 Enalaprilat impurity G

Information

Monograph Leaflet
0513,0665,0
921, 0935,
1017,1018

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

2106

Yes

+5C 3C

79

20429

Yes

-20C 5C

79

2242

Yes

+5C 3C

79

2242

Yes

+5C 3C

79

0081,0093,
0094,1530,1
875

Yes

+5C 3C

79

50 mg

1420

Yes

+5C 3C

79

20 mg

1420

Yes

+5C 3C

79

0.06 mg

1420

Yes

+5C 3C

79

100 mg

1749

Yes

+5C 3C

79

0.005 mg

1749

Yes

+5C 3C

79

Y0000629 Enalaprilat for system suitability

10 mg

1749

Yes

+5C 3C

79

E0150000 Endotoxin standard BRP

10 mg

20614, 20630

Yes

-20C 5C

79

Y0000136 Enilconazole

60 mg

1720

Yes

+5C 3C

79

Y0000137 Enilconazole impurity E

20 mg

1720

Yes

+5C 3C

79

E0180000 Enoxaparin sodium

200 mg

1097

Yes

+5C 3C

79

E0180500 Enoxolone

100 mg

1511

Yes

+5C 3C

79

Y0001259 Enrofloxacin

5 mg

2229

Yes

+5C 3C

79

Y0001160 Enrofloxacin for system suitability

10 mg

2229

Yes

+5C 3C

79

Y0001249 Entacapone

160 mg

See leaflet CHNO

2574

Yes

+5C 3C

79

Y0001250 Entacapone impurity A

10 mg

Z isomer of entacapone

2574

Yes

+5C 3C

79

E0200000 Enterokinase BRP

200 mg

0350

Yes

+5C 3C

79

E0300000 Ephedrine hydrochloride - * Drug Precursor

150 mg

See leaflet ; Batch 2 is valid until 31 January 2015

Yes

+5C 3C

79

E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor

50 mg

0487,0488,0
489,1367,24
51
0715

Yes

+5C 3C

79

E0400000 4-Epianhydrotetracycline hydrochloride

20 mg

See leaflet

0210,0211,1
654

Yes

+5C 3C

79

Y0001139 Epinastine hydrochloride

20 mg

2411

Yes

+5C 3C

79

Y0001128 Epinastine for system suitability

10 mg

E0530000 4-Epioxytetracycline

40 mg

See leaflet CHNO

E0550000 Epirubicin hydrochloride

100 mg

See leaflet CHClNO

E0600000 4-Epitetracycline hydrochloride

30 mg

Council of Europe, all rights reserved 2015

See leaflet CHO


1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole.

(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2
(1H)-yl]-4-phenylbutanoic acid
See leaflet
(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol

27

2411

Yes

+5C 3C

79

0198,0199

Yes

+5C 3C

79

0662,0714,1
590

Yes

-20C 5C

79

0210,0211,1
654

Yes

+5C 3C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001704 Eplerenone

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
75 mg
1 see leaflet CHO

Information

Monograph Leaflet

Storage

2765

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001706 Eplerenone for peak identification

10 mg

2765

Yes

+5C 3C

79

Y0001705 Eplerenone for system suitability

10 mg

2765

Yes

+5C 3C

79

P1609010 trans-Epoxyphytomenadione

5 mg

1036

Yes

+5C 3C

79

E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77


Horse Antiserum BRP

1 mg

See leaflet; Common standard OIE


Strain A/eq/Newmarket/77

See leaflet,
0249

Yes

-20C 5C

90

E0850021 Eq Influenza Subtype 2 American-like/Newmarket


Horse Antiserum BRP

1 mg

See leaflet; Common standard OIE


Strain A/eq/Newmarket/1/93

See leaflet,
0249

Yes

-20C 5C

90

Y0000712 Eq Influenza Subtype 2 American-like/South Africa


Horse Antiserum BRP

1 mg

See leaflet

See leaflet,
0249

Yes

-20C 5C

90

E0850022 Eq Influenza Subtype 2 European-like/Newmarket


Horse Antiserum BRP

1 mg

See leaflet; Common standard OIE


Strain A/eq/Newmarket/2/93

See leaflet,
0249

Yes

-20C 5C

90

Y0000052 Equilin

15 mg

See leaflet CHO

1512

Yes

-20C 5C

79

Y0001325 Equisetum palustre

200 mg

E0900000 Ergocalciferol

500 mg

E1000000 Ergometrine maleate - * Drug Precursor

50 mg

E1100000 Ergosterol

20 mg

E1200000 Ergotamine tartrate - * Drug Precursor

100 mg

Y0000051 Erysipelas ELISA coating antigen BRP

0.4 mg

See leaflet

Y0000177 Erythritol

1000 mg

See leaflet CHO

E1400000 Erythromycin estolate

100 mg

E1500000 Erythromycin ethylsuccinate

10 mg

E1500800 Erythromycin stearate

50 mg

E1305000 Erythromycin A

250 mg

New E1310000 Erythromycin B

50 mg

E1320000 Erythromycin C

E1300000 Erythromycin for microbiological assay


E1515000 Erythropoietin BRP
Y0001725 Erythropoietin for physicochemical tests
Council of Europe, all rights reserved 2015

1825

Yes

+5C 3C

79

0082,0574,0
575,
0598,1192,1
193, 2398

Yes

-20C 5C

79

0223

Yes

+5C 3C

79

0082

Yes

-20C 5C

79

0224, 0551

Yes

+5C 3C

79

See leaflet,
0064

Yes

-20C 5C

90

1803

Yes

+5C 3C

79

0552

Yes

+5C 3C

79

0274

Yes

+5C 3C

79

0490

Yes

+5C 3C

79

See leaflet

0179,0274,0
293,
0490,0552,1
098

Yes

-20C 5C

79

See leaflet ; Batch 3 is valid until 31 December 2015

0179,0274,0
490,
0552,1098

Yes

-20C 5C

79

50 mg

See leaflet

0179,0274,0
490,
0552,1098

Yes

-20C 5C

79

250 mg

See leaflet

20702

Yes

-20C 5C

79

15 mg

see leaflet ; Batch 3 is valid until 30 June 2015

1316

Yes

-20C 5C

150

0.1 mg

1316

Yes

-20C 5C

150

See leaflet; Vitamin D2

28

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001611 Esculetin

Reference Standard

Y0001612 Esculin

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
25 mg
1 See leaflet CHO
1
25 mg
1 See leaflet CHO

Information

Monograph Leaflet

Storage

2452

Yes

+5C 3C

2452

Yes

+5C 3C

Extra
Price
charges
79
a
a

79

79

+5C 3C

79

+5C 3C

79

Yes

+5C 3C

79

Yes

+5C 3C

79

0139

Yes

+5C 3C

79

0139

Yes

+5C 3C

79

1614

Yes

+5C 3C

79

0821,1203

Yes

+5C 3C

79

10 mg

0821

Yes

+5C 3C

79

50 mg

1614

Yes

+5C 3C

79

50 mg

1203

Yes

+5C 3C

79

20 mg

See leaflet; 9,11-didehydroestriol

1203

Yes

+5C 3C

79

15 mg

See leaflet

1512,0140

Yes

+5C 3C

79

100 mg

0457

Yes

+5C 3C

79

Y0001263 Etacrynic acid for system suitability

10 mg

0457

Yes

+5C 3C

79

E1830000 Etamsylate

30 mg

1204

Yes

+5C 3C

79

E1840000 Ethacridine lactate monohydrate

50 mg

1591

Yes

+5C 3C

79

E1850000 Ethambutol hydrochloride

250 mg

0553

Yes

+5C 3C

79

Y0000803 Ethambutol for system suitability

10 mg

0553

Yes

+5C 3C

79

A1202800 Ethanol (anhydrous) - reference spectrum

n/a

1318

79

E1860100 Ethanol 96% - reference spectrum

n/a

E1900000 Ethinylestradiol

200 mg

Y0001124 Ethinylestradiol for system suitability

1.0124 mg

E2000000 Ethionamide

Y0001686 Ethionamide for system suitability

E2150000 Ethosuximide
E2250000 Ethosuximide impurity A
E2195000 Ethyl acetate - reference spectrum
Y0000617 Ethyl indole-3-carboxylate
E2425000 Ethyl parahydroxybenzoate

Y0000324 Esketamine hydrochloride - reference spectrum

n/a

Y0000338 Esketamine impurity D - * narc

10 mg

1742

Yes

Y0001660 Esomeprazole magnesium dihydrate

15 mg

2787

Yes

Y0001028 Esomeprazole magnesium trihydrate

5 mg

2372

Y0000749 Essential oil

1000 mg

2098

E1600000 Estradiol benzoate

250 mg

Y0000852 Estradiol benzoate for system suitability

10 mg

Y0000045 Estradiol butyrate

10 mg

E1620000 Estradiol hemihydrate

100 mg

Y0000314 Estradiol for peak identification

Y0000046 Estradiol valerate

E1680000 Estriol
E1680005 Estriol impurity A
E1700000 Estrone
E1800000 Etacrynic acid

Council of Europe, all rights reserved 2015

1742
(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)

Batch 1 is valid until 31 December 2014

79

0140, 0821,
0940, 0926

1317
Yes

+5C 3C

79

0140

Yes

+5C 3C

79

100 mg

0141

Yes

+5C 3C

79

10 mg

0141

Yes

+5C 3C

79

30 mg

0764

Yes

+5C 3C

79

30 mg

0764

Yes

+5C 3C

79

n/a

0899

79

10 mg

2102

Yes

+5C 3C

79

150 mg

0409,0431,0
900,
1262,1263,2
134

Yes

+5C 3C

79

See leaflet ; Batch 4 is valid until 30 November 2014

(2RS)-2-ethyl-2-methylbutanedioic acid

See leaflet CHO

29

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001633 Ethylcellulose

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
100 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0822

Yes

+5C 3C

1351

Yes

+5C 3C

79

1272,1383

Yes

+5C 3C

79

E2202000 1-N-Ethylgaramine sulfate

50 mg

See leaflet

E2205500 1,1'-Ethylidenebistryptophan

0.002 mg

See leaflet CHNO

E2300000 Ethylmorphine hydrochloride - reference spectrum

n/a

0491

79

E2400000 Ethylnicotinamide

150 mg

0233

Yes

+5C 3C

79

Y0000572 Etidronate disodium

10 mg

1778

Yes

+5C 3C

79

E2450000 Etifenin

25 mg

0585

Yes

+5C 3C

79

E2451000 Etilefrine hydrochloride

75 mg

1205

Yes

+5C 3C

79

E2451010 Etilefrine impurity A

20 mg

1205

Yes

+5C 3C

79

E2470000 Etodolac

60 mg

1422

Yes

+5C 3C

79

E2470050 Etodolac impurity H

10 mg

1422

Yes

+5C 3C

79

Y0000768 Etodolac for peak identification

10 mg

1422

Yes

+5C 3C

79

E2499900 Etofenamate

40 mg

1513

Yes

+5C 3C

79

E2499914 Etofenamate impurity G

25 mg

1513

Yes

+5C 3C

79

E2499901 Etofenamate for peak identification

20 mg

1513

Yes

+5C 3C

79

E2500000 Etofylline

100 mg

0486

Yes

+5C 3C

79

E2503000 Etomidate

50 mg

1514

Yes

+5C 3C

79

E2503004 Etomidate impurity B

25 mg

methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate

1514

Yes

+5C 3C

79

E2600000 Etoposide

150 mg

See leaflet ; Batch 6 is valid until 31 August 2015

0823

Yes

+5C 3C

79

Y0001365 Etoposide for system suitability

10 mg

0823

Yes

+5C 3C

79

Y0001605 Eucommia bark HRS

2100 mg

2412

Yes

+5C 3C

79

E5000000 Eugenol

500 l

1100

Yes

+5C 3C

79

F0005000 Famotidine

100 mg

1012

Yes

+5C 3C

79

Y0000409 Famotidine impurity D

10 mg

3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide

1012

Yes

+5C 3C

79

Y0000382 Famotidine for system suitability

15 mg

Batch 1 is valid until 31 March 2015

1012

Yes

+5C 3C

79

Y0000556 Febantel

150 mg

See leaflet ; Batch 1 is valid until 30 November 2014

2176

Yes

+5C 3C

79

Y0000660 Febantel for system suitability

10 mg

2176

Yes

+5C 3C

79

Y0000731 Felbinac

10 mg

2304

Yes

+5C 3C

79

Y0000732 Felbinac impurity A

20 mg

2304

Yes

+5C 3C

79

F0030000 Felodipine

120 mg

1013

Yes

+5C 3C

79

Y0000415 Felypressin

0.994 mg

See leaflet CHNOS

1634

Yes

-20C 5C

79

F0040000 Fenbendazole

150 mg

Batch 2 is valid until 31 July 2014

1208,1458

Yes

+5C 3C

79

F0040010 Fenbendazole impurity A

20 mg

methyl(1-benzimidazol-2-yl)carbamate

1208

Yes

+5C 3C

79

F0040020 Fenbendazole impurity B

25 mg

methyl[5(6)-chlorobenzimidazol-2-yl]carbamate

1208

Yes

+5C 3C

79

F0041000 Fenbufen

100 mg

1209

Yes

+5C 3C

79

F0048000 Fenofibrate

100 mg

1322

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

2-ethylamino-1-(3-hydroxyphenyl)ethanone
2-(7-ethylindol-3-yl)ethanol

2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate

4-acetyl biphenyl

See leaflet CHClO


30

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
F0048005 Fenofibrate impurity A

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
4
15 mg
1 (4-chlorophenyl)(4-hydroxyphenyl)methanone ; Batch 3 is valid until 30
September 2014

Monograph Leaflet

Storage

1322

Yes

+5C 3C

Extra
Price
charges
79
a

F0048010 Fenofibrate impurity B

10 mg

2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)

1322

Yes

+5C 3C

79

F0048035 Fenofibrate impurity G

25 mg

1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]
oxy]-2-methylpropanoate

1322

Yes

+5C 3C

79

F0050000 Fenoterol hydrobromide

50 mg

see leaflet ; Batch 2 is valid until 31 December 2014

0901

Yes

+5C 3C

79

Y0000756 Fenoterol for peak identification

1.2 mg

0901

Yes

+5C 3C

79

F0054990 Fentanyl - reference spectrum

n/a

1210

79

F0055000 Fentanyl citrate - reference spectrum

n/a

1103

79

Y0001509 Fentanyl for system suitability - * narc

15 mg

F0060000 Fenticonazole nitrate

50 mg

F0060040 Fenticonazole impurity D

0.01 mg

F0100000 Ferrous gluconate

100 mg

Y0001013 Ferulic acid

20 mg

See leaflet CHO

Y0000789 Fexofenadine hydrochloride

60 mg

Y0000751 Fexofenadine impurity A

5 mg

Y0000752 Fexofenadine impurity B

0.01 mg

Y0000753 Fexofenadine impurity C

Y0001173 Filgrastim
New Y0000090 Finasteride

Batch 1 is valid until 31 October 2014


()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)
benzyl]imidazolium nitrate

1210,1103

Yes

+5C 3C

79

1211

Yes

+5C 3C

79

1211

Yes

+5C 3C

79

0493

Yes

+5C 3C

79

1834,2558

Yes

+5C 3C

79

See leaflet CHClNO

2280

Yes

+5C 3C

79

2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2methylpropanoic acid

2280

Yes

+5C 3C

79

2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]
phenyl]-2-methylpropanoic acid

2280

Yes

+5C 3C

79

5 mg

(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)
phenyl]butan-1-ol

2280

Yes

+5C 3C

79

0.2 mL

See leaflet ; Batch 1 is valid until 31 July 2014

2206

Yes

-80C 10C

79

See leaflet ; Batch 2 is valid until 31 October 2015

1615

Yes

+5C 3C

79

1615

Yes

+5C 3C

79

120 mg

Y0001604 Finasteride for peak identification

15 mg

Y0000736 Flavoxate hydrochloride

10 mg

1692

Yes

+5C 3C

79

Y0000737 Flavoxate impurity A

10 mg

3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid

1692

Yes

+5C 3C

79

Y0000738 Flavoxate impurity B

10 mg

ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate

1692

Yes

+5C 3C

79

F0120000 Flecainide acetate

10 mg

1324

Yes

+5C 3C

79

F0120005 Flecainide impurity A

50 mg

3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5a]pyridine

1324

Yes

+5C 3C

79

F0120010 Flecainide impurity B

25 mg

(RS)-(piperidin-2-yl)methanamine

1324

Yes

+5C 3C

79

Y0001274 Flecainide for system suitability

10 mg

1324

Yes

+5C 3C

79

Y0001606 Fleeceflower root HRS

300 mg

2433

Yes

+5C 3C

79

Y0000138 Flubendazole

25 mg

1721

Yes

+5C 3C

79

Y0000139 Flubendazole for system suitability

20 mg

1721

Yes

+5C 3C

79

Y0000892 Flucloxacillin magnesium octahydrate

5 mg

2346

Yes

+5C 3C

79

Y0000889 Flucloxacillin impurity C

5 mg

2346

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

6-aminopenicillanic acid
31

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000890 Flucloxacillin impurity D
Y0000891 Flucloxacillin impurity E

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
5 mg
1 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid
1
5 mg
1 6-aminopenicillanic acid flucloxacillin amide

Monograph Leaflet
2346

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

2346

Yes

-20C 5C

79

0661,0663,0
668,2346

Yes

-20C 5C

79

Batch 1 is valid until 31 May 2015

2287

Yes

+5C 3C

79

See leaflet; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4 triazol-1-yl)propan-2-ol

2287

Yes

+5C 3C

79

5 mg

1,1'-(1,3-phenylene)di-1H-1,2,4-triazole

2287

Yes

+5C 3C

79

10 mg

2287

Yes

+5C 3C

79

100 mg

0766

Yes

+5C 3C

79

0.3 mg

0766

Yes

+5C 3C

79

120 mg

1781

Yes

+5C 3C

79

15 mg

1781

Yes

+5C 3C

79

F0180000 Fludrocortisone acetate

100 mg

0767

Yes

+5C 3C

79

F0188000 Flumazenil - reference spectrum

n/a

1326

79

Y0000335 Flumazenil impurity B

5 mg

+5C 3C

79

F0189000 Flumequine

60 mg

F0189020 Flumequine impurity B

0.1 mg

F0188500 Flumetasone pivalate

100 mg

F0189900 Flunarizine dihydrochloride

Y0000265 Flunarizine dihydrochloride - reference spectrum

Y0000266 Flunarizine dihydrochloride for system suitability


F0190000 Flunitrazepam - * psy
Y0000169 Flunitrazepam - reference spectrum
Y0000443 Flunixin meglumine

F0150000 Flucloxacillin sodium

250 mg

See leaflet CHClFNNaOS

Y0000557 Fluconazole

50 mg

Y0000573 Fluconazole impurity B

10 mg

Y0000574 Fluconazole impurity C

Y0000558 Fluconazole for peak identification

F0175000 Flucytosine

Y0001262 Flucytosine for system suitability

Y0000419 Fludarabine phosphate


Y0001536 Fludarabine for system suitability

see leaflet ; Batch 2 is valid until 30 April 2015

1326

Yes

1517

Yes

+5C 3C

79

1517

Yes

+5C 3C

79

1327

Yes

+5C 3C

79

100 mg

0816

Yes

+5C 3C

79

n/a

1722

79

20 mg

1722

Yes

+5C 3C

79

100 mg

1280

Yes

+5C 3C

79

n/a

0717

79

10 mg

1696

Yes

+5C 3C

79

Y0000444 Flunixin impurity B

10 mg

2-methyl-3-(trifluoromethyl)aniline

1696

Yes

+5C 3C

79

Y0000445 Flunixin impurity C

55 mg

ethyl 2-chloropyridine-3-carboxylate

1696

Yes

+5C 3C

79

F0200000 Fluocinolone acetonide

110 mg

see leaflet ; Batch 3 is valid until 31 August 2014


Batch 4 is valid until 31 March 2015

0494

Yes

+5C 3C

79

Y0001711 Fluocinolone acetonide for peak identification

10 mg

0494

Yes

+5C 3C

79

Y0001710 Fluocinolone acetonide for system suitability

10 mg

0494

Yes

+5C 3C

79

F0230000 Fluocortolone pivalate

100 mg

1212

Yes

+5C 3C

79

Y0000796 Fluorescein

120 mg

See leaflet CHO

2348

Yes

+5C 3C

79

Y0000804 Fluorescein impurity C

0.01 mg

2-(2,4-dihydroxybenzoyl)benzoic acid

2348

Yes

+5C 3C

79

F0245000 Fluoresceine sodium - reference spectrum

n/a

79

40 mg

F0250000 Fluorouracil
Council of Europe, all rights reserved 2015

ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]
benzodiazepine-3-carboxylate ; Batch 1 is valid until 30 September 2015
ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]
quinolizine-2-carboxylate

1213
32

79
0611,0766
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000762 Fluorouracil impurity A
Y0000763 Fluorouracil impurity B

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)
1
15 mg
1 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)

Monograph Leaflet

Storage

0611

Yes

+5C 3C

Extra
Price
charges
79
a

0611

Yes

+5C 3C

79

10 mg

pyrimidine-2,4(1H,3H)-dione (uracil)

0611

Yes

+5C 3C

79

10 mg

2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)

0611

Yes

+5C 3C

79

0.0002 mg

0611

Yes

+5C 3C

79

F0253000 Fluoxetine hydrochloride

250 mg

See leaflet

1104

Yes

+5C 3C

79

F0253020 Fluoxetine impurity B

10 mg

methyl(3-phenylpropyl)amine ; Batch 5 is valid until 30 April 2015

1104

Yes

+5C 3C

79

F0253030 Fluoxetine impurity C

5 mg

()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine

1104

Yes

+5C 3C

79

Y0000064 Flupentixol dihydrochloride

100 mg

See leaflet

1693

Yes

+5C 3C

79

Y0000067 Flupentixol impurity D

15 mg

2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]
piperazin-1-yl]ethoxy]ethanol ; Batch 1 is valid until 31 December 2014

1693

Yes

+5C 3C

79

Y0000078 Flupentixol impurity F

25 mg

See leaflet CHFNOS; 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9Hthioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol

1693

Yes

+5C 3C

79

F0260000 Fluphenazine decanoate

60 mg

1014,1015

Yes

+5C 3C

79

F0280000 Fluphenazine dihydrochloride

50 mg

0904,1014

Yes

+5C 3C

79

Y0000708 Fluphenazine impurity mixture

0.07 mg

0904

Yes

+5C 3C

79

Y0000009 Fluphenazine enantate

100 mg

1014,1015

Yes

+5C 3C

79

Y0000298 Fluphenazine octanoate

20 mg

1014,1015

Yes

+5C 3C

79

Y0000299 Fluphenazine sulfoxide

10 mg

0904,1014,1
015

Yes

+5C 3C

79

Y0000211 Flurazepam monohydrochloride - reference spectrum

n/a

0905

79

F0285200 Flurbiprofen

50 mg

F0285202 Flurbiprofen impurity A

25 mg

Y0000236 Fluspirilene

20 mg

Y0000375 Fluspirilene impurity C

10 mg

8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8triazaspiro[4.5]decan-4-one

F0285600 Flutamide

100 mg

See leaflet

Y0001591 Flutamide for system suitability

10 mg

Y0000284 Fluticasone propionate

100 mg

5 mg

5 mg

Y0000764 Fluorouracil impurity C

Y0000765 Fluorouracil impurity F


Y0000791 Fluorouracil impurity mixture

New Y0001754 Fluticasone propionate for impurity C identification


Y0000221 Fluticasone impurity D

New Y0001755 Fluticasone propionate for impurity G identification

(2RS)-2-(biphenyl-4-yl)propanoic acid

See leaflet CHFOS

1519

Yes

+5C 3C

79

1519

Yes

+5C 3C

79

1723

Yes

+5C 3C

79

1723

Yes

+5C 3C

79

1423

Yes

+5C 3C

79

1423

Yes

+5C 3C

79

1750

Yes

+5C 3C

79

+5C 3C

79

1750

Yes

+5C 3C

79

1750
S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate
(S-methyl derivative) ; Batch 2 is valid until 31 December 2014

5 mg

1750

Yes

+5C 3C

79

F0290000 Flutrimazole

100 mg

1424

Yes

+5C 3C

79

F0290010 Flutrimazole impurity B

60 mg

1424

Yes

+5C 3C

79

Y0001090 Fluvastatin sodium

110 mg

2333

Yes

+5C 3C

79

Y0001082 Fluvastatin for system suitability

0.5 mg

2333

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol

33

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000854 Fluvoxamine maleate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
5 mg
1

Information

Monograph Leaflet

Storage

1977

Yes

+5C 3C

Extra
Price
charges
79
a

Y0000853 Fluvoxamine for system suitability

1.004 mg

1977

Yes

+5C 3C

79

Y0000916 Fluvoxamine impurity D

10 mg

5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one

1977

Yes

+5C 3C

79

Y0000386 Foeniculin for peak identification

100 mg

Anise oil

0804

Yes

+5C 3C

79

F0300000 Folic acid

300 mg

See leaflet CHNO

0067

Yes

+5C 3C

79

Y0001242 Folic acid impurity A

15 mg

(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-lglutamic acid)

0067

Yes

+5C 3C

79

Y0001243 Folic acid impurity D

70 mg

4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
(pteroic acid) ; Batch 2 is valid until 28 February 2015

0067

Yes

+5C 3C

79

Y0001629 Follitropin

0.2 mL

See leaflet

2285, 2286

Yes

-20C 5C

79

Y0001627 Follitropin for peptide mapping and glycan analysis

0.5 mL

2285

Yes

-20C 5C

79

F0372000 Formoterol fumarate dihydrate

10 mg

1293,1724

Yes

+5C 3C

79

Y0000339 Formoterol for impurity I identification

10 mg

1724

Yes

+5C 3C

79

Y0000340 Formoterol fumarate for system suitability

10 mg

F0380000 Formylfolic acid

30 mg

F0389000 Foscarnet sodium hexahydrate

50 mg

F0389004 Foscarnet impurity B

10 mg

Y0001222 Foscarnet impurity D

50 mg

Y0001213 Foscarnet impurity mixture

0.012 mg

Y0000782 Fosfomycin calcium

F0399950 Fosfomycin sodium - reference spectrum

F0400000 Fosfomycin trometamol


Y0001227 Fosinopril sodium

1724

Yes

+5C 3C

79

0978,1606

Yes

-20C 5C

79

1520

Yes

+5C 3C

79

1520

Yes

+5C 3C

79

1520

Yes

+5C 3C

79

1520

Yes

+5C 3C

79

10 mg

1328

Yes

+5C 3C

79

n/a

1329

79

1500 mg

60 mg

Y0001228 Fosinopril impurity A

5 mg

Y0001229 Fosinopril impurity B

5 mg

Y0001230 Fosinopril impurity C

Y0001231 Fosinopril impurity D

See leaflet CHNO; 10-Formylfolic acid


disodium (ethoxyoxydophosphanyl)formate

1425

Yes

+5C 3C

79

1751

Yes

+5C 3C

79

(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]
pyrrolidine-2-carboxylic acid

1751

Yes

+5C 3C

79

(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751

Yes

+5C 3C

79

10 mg

mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751

Yes

+5C 3C

79

10 mg

(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751

Yes

+5C 3C

79

Y0001232 Fosinopril impurity I

5 mg

[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]
acetic acid

1751

Yes

+5C 3C

79

Y0001233 Fosinopril impurity K

5 mg

(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic
acid

1751

Yes

+5C 3C

79

Y0001212 Fosinopril impurity mixture

0.02 mg

1751

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet

34

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
F0450000 Framycetin sulfate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
6
25 mg
2 See leaflet

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0180,0197,2
0702

Yes

-20C 5C

0177,0178,0
187,
0188,0204,0
209,
0924,1061,1
570

Yes

+5C 3C

79

2443

Yes

+5C 3C

79

F0550000 Fructose

100 mg

Y0001399 Fulvestrant

120 mg

Y0001413 Fulvestrant for system suitability

40 mg

2443

Yes

+5C 3C

79

F0600000 Fumaric acid

120 mg

0365,0902,1
190

Yes

+5C 3C

79

F0700000 Furosemide

100 mg

0391,2185

Yes

+5C 3C

79

F0702000 Furosemide impurity A

5 mg

0391

Yes

+5C 3C

79

Y0001493 Furosemide for peak identification

10 mg

0391

Yes

+5C 3C

79

Y0001411 Fusidic acid

10 mg

0798

Yes

-20C 5C

79

Y0001394 Fusidic acid for peak identification

5 mg

0798,0848

Yes

-20C 5C

79

New Y0001384 Fusidic acid impurity mixture

See leaflet CHFOS

2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid

0.048 mg

Batch 1 is valid until 31 December 2015

0798,0848

Yes

-20C 5C

79

Y0001280 Gabapentin

300 mg

See leaflet CHNO

2173

Yes

+5C 3C

79

Y0001281 Gabapentin impurity A

20 mg

2-azaspiro[4.5]decan-3-one

2173

Yes

+5C 3C

79

Y0001348 Gabapentin impurity B

20 mg

(1-cyanocyclohexyl)acetic acid ; Batch 1 is valid until 31 August 2015

2173

Yes

-20C 5C

79

Y0001349 Gabapentin impurity D

10 mg

[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid

2173

Yes

+5C 3C

79

G0049000 Galactitol

50 mg

1381

Yes

+5C 3C

79

G0050000 Galactose

60 mg

1215

Yes

+5C 3C

79

Y0001279 Galantamine hydrobromide

10 mg

2366

Yes

+5C 3C

79

Y0001190 Galantamine natural for system suitability

10 mg

2366

Yes

+5C 3C

79

Y0001201 Galantamine racemic mixture

10 mg

2366

Yes

+5C 3C

79

Y0001191 Galantamine synthetic for system suitability

5 mg

G0150000 Gammacyclodextrin

60 mg

Y0001129 Ganciclovir

220 mg

Y0001144 Ganciclovir impurity mixture

0.005 mg

Y0000675 Gemcitabine hydrochloride

50 mg

Y0000676 Gemcitabine impurity A

20 mg

Y0001682 Gemcitabine impurity C

5 mg

Y0000513 Gemfibrozil

5 mg

Y0000514 Gemfibrozil for system suitability

0.196 mg

G0200000 Gentamicin sulfate

25 mg

Y0001363 Gentamicin for peak identification

10 mg

Council of Europe, all rights reserved 2015

2366

Yes

+5C 3C

79

1070,1487

Yes

+5C 3C

79

1752

Yes

+5C 3C

79

1752

Yes

+5C 3C

79

See leaflet

2306

Yes

+5C 3C

79

4-aminopyrimidin-2(1H)-one (cytosine)

2306

Yes

+5C 3C

79

2',2'-difluoro-2'-deoxyuridine

2306

Yes

+5C 3C

79

1694

Yes

+5C 3C

79

See leaflet CHO

see leaflet ; Batch 8 is valid until 30 November 2014

35

1694

Yes

+5C 3C

79

0331,20702

Yes

-20C 5C

79

0331

Yes

-20C 5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001112 Gestodene

Reference Standard

Y0001116 Gestodene impurity I

Effective from 2015/7/1


Batch n Quantity Sale
Information
Monograph Leaflet
per vial Unit
2
100 mg
1 see leaflet ; Batch 1 is valid until 31 January 2015
1726
Yes
1
0.01 mg
1 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-201726
Yes
yn-3-one

Storage
+5C 3C

Extra
Price
charges
79
a

+5C 3C

79

Y0001110 Gestodene for system suitability

10 mg

1726

Yes

+5C 3C

79

Y0001012 Ginkgo dry extract for peak identification

150 mg

Batch 1 is valid until 31 August 2014

1827

Yes

-20C 5C

79

Y0001010 Ginkgolic Acids

20 mg

See leaflet

1827

Yes

-20C 5C

79

Y0001029 Ginseng dry extract HRS

500 mg

2356

Yes

-20C 5C

79

Y0001347 Ginsenoside Rb1

30 mg

G0300000 Gitoxin

30 mg

G0325000 Glibenclamide

100 mg

G0325010 Glibenclamide impurity A

10 mg

4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzene- sulphonamide

Y0000242 Glibenclamide impurity B

20 mg

See leaflet; methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]


sulphonyl]carbamate

Y0001511 Glibenclamide for peak identification

30 mg

Y0001406 Glucosamine hydrochloride

15 mg

G0326000 Gliclazide

20 mg

G0326004 Gliclazide impurity B

25 mg

2-nitroso-octahydrocyclopenta[c]pyrrole

New G0326012 Gliclazide impurity F

50 mg

1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]
urea ; Batch 4 is valid until 31 December 2015

2356

Yes

+5C 3C

79

0078,2168

Yes

+5C 3C

79

0718

Yes

+5C 3C

79

0718

Yes

+5C 3C

79

0718

Yes

+5C 3C

79

0718

Yes

+5C 3C

79

2446

Yes

+5C 3C

79

1524

Yes

+5C 3C

79

1524

Yes

+5C 3C

79

1524

Yes

+5C 3C

79

2708

Yes

+5C 3C

79

2223

Yes

+5C 3C

79

See leaflet CHO

Y0001685 Glucosamine sulfate potassium chloride

10 mg

Y0000515 Glimepiride

110 mg

Y0001742 Glimepiride for impurity A identification

5 mg

2223

Yes

+5C 3C

79

Y0000516 Glimepiride for system suitability

0.012 mg

2223

Yes

+5C 3C

79

G0340000 Glipizide

50 mg

0906

Yes

+5C 3C

79

G0342000 Glipizide impurity A

10 mg

4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide

0906

Yes

+5C 3C

79

Y0000523 Glipizide impurity C

10 mg

ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate

0906

Yes

+5C 3C

79

Y0000643 Glipizide impurity D

10 mg

6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide

0906

Yes

+5C 3C

79

Y0001140 Glipizide impurity mixture

0.002 mg

0906

Yes

+5C 3C

79

Y0001407 Glucosamine sulfate sodium chloride

15 mg

2447

Yes

+5C 3C

79

Y0001381 Glucosamine for system suitability

40 mg

2446,2447,2
708

Yes

+5C 3C

79

G0350500 Glucose

100 mg

0177,0178,0
187,
0188,0204,0
209,
1061,1215,1
570

Yes

+5C 3C

79

750 mg

0178

Yes

+5C 3C

79

New Y0001745 Glucose monohydrate


Council of Europe, all rights reserved 2015

See leaflet ; Batch 1 is valid until 31 July 2015

See leaflet CHO,HO


36

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
G0355000 Glutamic acid

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
50 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0750,0797,1
445, 2076

Yes

+5C 3C

1670

Yes

+5C 3C

79

Yes

+5C 3C

79

79

Y0000517 Glutathione

10 mg

G0360000 Glutethimide - * psy

50 mg

1291

G0400000 Glycerol (85 per cent) - reference spectrum

n/a

0496,0497

Y0001391 Glycerol formal

20 mg

1671

Yes

+5C 3C

79

Y0000794 Glycerol monocaprylate

400 mg

2213

Yes

+5C 3C

79

Y0000795 Glycerol monocaprylocaprate

500 mg

2392

Yes

+5C 3C

79

G0400006 Glycerol monolinoleate

2000 mg

1429

Yes

+5C 3C

79

G0400007 Glycerol mono-oleate

2500 mg

1430

Yes

+5C 3C

79

G0400008 Glycerol monostearate 40-55

2000 mg

0495

Yes

+5C 3C

79

G0400100 Glyceryl trinitrate solution

0.5 mL

1331,1355

Yes

+5C 3C

79

G0400101 Glyceryl trinitrate - reference spectrum

n/a

1331

79

G0450000 Glycine

50 mg

0614, 0813

Yes

+5C 3C

79

Y0001308 Glycopyrronium bromide

10 mg

1783

Yes

+5C 3C

79

Y0001358 Glycopyrronium impurity N

10 mg

See leaflet CHBrNO; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2phenylacetyl)oxy]-1,1-dimethylpyrrolidinium

1783

Yes

+5C 3C

79

Y0000433 Ammonium glycyrrhizate

70 mg

Batch 1 is valid until 30 September 2015

1772

Yes

+5C 3C

79

Y0001309 Glycopyrronium for peak identification

10 mg

1783

Yes

+5C 3C

79

G0460000 Glycyrrhizate (monoammonium)

300 mg

see leaflet ; Batch 3 is valid until 31 August 2014

0277, 2378

Yes

+5C 3C

79

G0525000 Gonadorelin

5 mg

See leaflet CHNO

0827

Yes

-20C 5C

79

Y0000125 Goserelin

1.87 mg

See leaflet CHNO

1636

Yes

-20C 5C

79

Y0000126 Gosereline - reference spectrum

n/a

79

Y0001473 Goserelin for NMR identification

14 mg

Y0000194 Goserelin validation mixture

1 mg

Y0000019 4-D-Ser-goserelin

0.1 mg

G0550000 Gramicidin

250 mg

See leaflet

Y0000396 Granisetron hydrochloride

120 mg

Y0000477 Granisetron impurity A

1 mg

Y0000478 Granisetron impurity B

1 mg

Y0000395 Granisetron impurity E

G0600000 Griseofulvin
Y0000619 Guaiacol
G0700000 Guaifenesin
Council of Europe, all rights reserved 2015

Batch 1 is valid until 30 April 2015

Batch 2 is valid until 31 May 2015

1636
1636

Yes

-20C 5C

79

1636

Yes

-20C 5C

79

1636

Yes

-20C 5C

79

0907,1662,2
0702

Yes

+5C 3C

79

See leaflet ; Batch 1 is valid until 30 September 2014

1695

Yes

+5C 3C

79

2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2Hindazole-3-carboxamide ; Batch 2 is valid until 30 June 2015

1695

Yes

+5C 3C

79

N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide ; Batch 2 is valid until 30 April 2015

1695

Yes

+5C 3C

79

15 mg

(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine

1695

Yes

+5C 3C

79

50 mg

0182

Yes

+5C 3C

79

1500 mg

1978

Yes

+5C 3C

79

100 mg

0615

Yes

+5C 3C

79

Supplied with the Ph. Eur. reference chromatogram ; Batch 1 is valid until 31
July 2015

See leaflet CHO


37

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000117 Halofantrine hydrochloride
Y0000118 Halofantrine impurity C
H0100000 Haloperidol
New Y0001518 Haloperidol for peak identification

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
125 mg
1 See leaflet CHClFNO
1
10 mg
1 [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol
2

60 mg

Monograph Leaflet

Storage

1979

Yes

+5C 3C

Extra
Price
charges
79
a

1979

Yes

+5C 3C

79

0616,1178

Yes

+5C 3C

79

20 mg

0616

Yes

+5C 3C

79

Y0001517 Haloperidol for system suitability

25 mg

0616

Yes

+5C 3C

79

H0100100 Haloperidol decanoate

60 mg

1397,1431

Yes

+5C 3C

79

H0150000 Halothane - reference spectrum

n/a

0393

79

Y0000673 Harpagoside

1.03 mg

See leaflet CHO

1095, 1871

Yes

+5C 3C

79

H0200000 Heparin sodium BRP

2 ml

See leaflet

0569, 20705

Yes

+5C 3C

79

Y0001283 Heparin sodium for NMR identification

30 mg

0333

Yes

+5C 3C

79

Y0001287 Heparin calcium for NMR identification

30 mg

0332

Yes

+5C 3C

79

Y0001282 Heparin for physico-chemical analysis

300 mg

0332, 0333

Yes

+5C 3C

79

H0185000 Heparin Low-Molecular-Mass for assay BRP

1 mg

See leaflet

0828

Yes

+5C 3C

90

H0190000 Heparin Low-Molecular-Mass for calibration CRS

25 mg

See leaflet

0828

Yes

+5C 3C

90

H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP

0.5 ml

See leaflet; Please contact us for information on the type needed for your use

See leaflet,
20714

Yes

+5C 3C

90

Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP

1 mL

To be stored below -50C ; Batch 1 is valid until 30 April 2015

20714,1526,
1935, 1107

Yes

-80C 10C

90

Y0001624 Hepatitis A virus Coating Reagent for ELISA - BRR

1 mL

Yes

-20C 5C

79

New Y0001623 Set of Hepatitis A virus Detection Antibodies for ELISA BRR

275 L

See leaflet ; Batch 1 is valid until 31 May 2015


Batch 2 is valid until 30 October 2015

Yes

-20C 5C

79

Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal


free)

0.5 ml

See leaflet; Ph. Eur. BRPs are established in the context of specific methods.
The method used to establish this BRP (refer to leaflet) is no longer available.
Reference to the BRP has therefore been removed from the relevant
monograph and general chapter of the Ph. Eur. and upon depletion of stocks
this BRP will not be replaced. Users are encouraged to find alternative
reference material to address their future needs.

See leaflet,
20715

Yes

+5C 3C

90

H0210010 Hepatitis B vaccine (rDNA) BRP method B

1 ml

See leaflet; Ph. Eur. BRPs are established in the context of specific methods.
The method used to establish this BRP (refer to leaflet) is no longer available.
Reference to the BRP has therefore been removed from the relevant
monograph and general chapter of the Ph. Eur. and upon depletion of stocks
this BRP will not be replaced. Users are encouraged to find alternative
reference material to address their future needs.

See leaflet,
1056

Yes

+5C 3C

90

H0215000 Hepatitis C Virus RNA for NAT testing BRP

40 mg

See leaflet; For plasma pool testing by NAT

See leaflet,
20621

Yes

-20C 5C

e(d)

242

Y0000063 Heptaminol hydrochloride

150 mg

1980

Yes

+5C 3C

79

Y0000057 Heptaminol impurity A

20 mg

See leaflet CHN; (2RS)-6-methylhept-5-en-2-amine

1980

Yes

+5C 3C

79

Y0001203 Hesperidin

20 mg

See leaflet CHO

2430

Yes

+5C 3C

79

H0330000 Hexamidine diisetionate

20 mg

1436

Yes

+5C 3C

79

H0325000 Hexetidine

100 mg

1221

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

Batch 1 is valid until 31 October 2015

38

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
H0420000 Hexylresorcinol
New Y0001746 Hexylresorcinol for system suitability

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
100 mg
1

Information

Monograph Leaflet

Storage

1437

Yes

+5C 3C

Extra
Price
charges
79
a

1 mg

1437

Yes

-20C 5C

79

H0500000 Hide powder

500 mg

20814

Yes

+5C 3C

79

H0600000 Histamine dihydrochloride

250 mg

0143

Yes

+5C 3C

79

H0750000 Histidine

25 mg

0911

Yes

+5C 3C

79

H0755000 Histidine hydrochloride monohydrate

100 mg

0910

Yes

+5C 3C

79

H0800000 Homatropine hydrobromide

100 mg

0500,0720

Yes

+5C 3C

79

H0830000 Homatropine methylbromide

25 mg

0720

Yes

+5C 3C

79

H0837000 L-Homocysteine thiolactone hydrochloride - reference


spectrum

n/a

1617

79

Y0001383 Homatropine methylbromide for system suitability

5 mg

0720

Yes

+5C 3C

79

Y0001290 Honokiol

20 mg

See leaflet CHO

2567,2568

Yes

-20C 5C

79

H0900000 Human albumin for electrophoresis BRP

1 ml

See leaflet

0255

Yes

-20C 5C

79

Y0000219 Human anti-D immunoglobulin BRP

40 mg

See leaflet

See leaflet,
20713

Yes

-20C 5C

90

Y0000667 Human coagulation factor VII concentrate BRP

25 mg

See leaflet

See leaflet,
20710

Yes

-20C 5C

79

Y0001663 Human coagulation factor VIIa (rDNA)

42 mg

See leaflet

2534

Yes

-20C 5C

79

H0920000 Human coagulation factor VIII concentrate BRP

37 mg

See leaflet

See leaflet,
20704

Yes

-20C 5C

90

H0920500 Human coagulation factor IX concentrate BRP

30 mg

See leaflet; Common standard with FDA and WHO (4th IS)

2.7.11

Yes

-20C 5C

90

Y0001659 Human coagulation factor IX (rDNA)

10 mg

see leaflet

2522

Yes

-20C 5C

79

Y0000191 Human glucagon

2.94 mg

See leaflet CHNOS

1635

Yes

-20C 5C

79

H0950000 Human hepatitis A immunoglobulin BRP

10 mg

See leaflet

See leaflet,
0338, 0769,
1646

Yes

-20C 5C

90

Y0001414 Human Hepatitis B immunoglobulin BRP

100 mg

See leaflet

0722, 1016

Yes

-20C 5C

90

Y0001504 Human immunoglobulin BRP (ACA and Molecular size)

6000 mg

See leaflet,
0338, 0918

Yes

+5C 3C

90

Y0001512 Human Immunoglobulin BRP (Fc Function and


Molecular size)

9000 mg

See leaflet,
0338, 0918

Yes

+5C 3C

90

Y0000488 Human immunoglobulin (molecular size) BRP

700 mg

Each vial contains 0.7 gram of immunoglobulin G

See leaflet,
0338,
0918,1928

Yes

+5C 3C

90

H1000000 Human immunoglobulin for electrophoresis BRP

50 mg

See leaflet

0338,0918

Yes

+5C 3C

79

H1005000 Human Plasma Pools for NAT validation

3502 mg

Set of 103 plasma pool samples

See leaflet,
20621

Yes

-20C 5C

400

H1100000 Human rabies immunoglobulin BRP

170 mg

See leaflet

See leaflet,
0723

Yes

-20C 5C

90

87 mg

See leaflet

H1110000 Human tetanus immunoglobulin BRP


Council of Europe, all rights reserved 2015

Batch 2 is valid until 31 May 2015

39

90
0398
Yes
-20C 5C
c
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000502 Human vaccinia immunoglobulin
H1115000 Hyaluronidase BRP

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
1 ml
3 See leaflet
1
50 mg
1 See leaflet

H1120000 Hydralazine hydrochloride

Y0001151 Hydrastine hydrochloride


H1200000 Hydrochlorothiazide

Information

Monograph Leaflet

Storage

Extra
Price
charges
270
b

See leaflet

Yes

-20C 5C

0912

Yes

+5C 3C

79

0829

Yes

+5C 3C

79

20 mg

20 mg

See leaflet CHClNO

1831,2500

Yes

-20C 5C

79

300 mg

See leaflet CHClNOS

0394

Yes

+5C 3C

79

Y0001494 Hydrochlorothiazide for peak identification

10 mg

0394

Yes

+5C 3C

79

Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc

10 mg

1784

Yes

+5C 3C

79

Y0000710 Hydrocodone for peak identification - * narc

10 mg

1784

Yes

+5C 3C

79

H1300000 Hydrocortisone

100 mg

0335

Yes

+5C 3C

79

Y0001092 Hydrocortisone for peak identification

5 mg

H1400000 Hydrocortisone acetate

125 mg

Y0001482 Hydrocortisone acetate for peak identification

15 mg

H1425000 Hydrocortisone hydrogen succinate

100 mg

H1426000 Hydrogenated wool fat

Y0000446 Hydromorphone hydrochloride - * narc

B0650000 Hydrous benzoyl peroxide - reference spectrum


H1428000 Hydroxocobalamin

0335

Yes

+5C 3C

79

0321,0334,0
335,
0734,0767

Yes

+5C 3C

79

0334

Yes

+5C 3C

79

0768,1131

Yes

-20C 5C

79

250 mg

0969

Yes

+5C 3C

79

10 mg

2099

Yes

+5C 3C

79

n/a

0704

79

10 mg

0913,0914,0
915

Yes

-20C 5C

79

Y0000119 Hydroxycarbamide

360 mg

1616

Yes

+5C 3C

79

H1429400 Hydroxyethyl salicylate

125 mg

1225

Yes

+5C 3C

79

Y0001322 Hydroxyethyl starch (high Mw)

800 mg

See leaflet

1785

Yes

+5C 3C

79

Y0001277 Hydroxyethyl starch (medium MW)

1200 mg

See leaflet

1785

Yes

+5C 3C

79

H1430000 D-alpha-(4-Hydroxy-phenyl)glycine

50 mg

(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A

0813

Yes

+5C 3C

79

H1429700 4-Hydroxyphenoxymethylpenicillin potassium

20 mg

See leaflet CHKNOS

0148,0149

Yes

-20C 5C

79

Y0000186 Hydroxypropylbetadex

200 mg

1804

Yes

+5C 3C

79

Y0001720 Hydroxypropylcellulose

150 mg

0337, 2083

Yes

+5C 3C

79

H1435000 Hydroxyzine hydrochloride

600 mg

0916,1086

Yes

+5C 3C

79

Y0000011 Hymecromone

100 mg

1786

Yes

+5C 3C

79

Y0000012 Hymecromone impurity A

25 mg

Resorcinol

1786

Yes

+5C 3C

79

Y0000013 Hymecromone impurity B

25 mg

7-hydroxy-2-methyl-4H-1-benzopyran-4-one.

1786

Yes

+5C 3C

79

Y0000483 Hyoscine

10 mg

2167

Yes

+5C 3C

79

Y0000484 Hyoscine impurity A

15 mg

(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)

2167

Yes

+5C 3C

79

H1450000 Hyoscine butylbromide

20 mg

Y0000447 Hyoscine butylbromide impurity E

10 mg

79
0737
Yes
+5C 3C
a
(1R,2R,4S,5S,7s)-9-butyl -3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-379
0737
Yes
+5C 3C
a
hydroxy-2-phenylpropanoate (N-butylhyoscine)
40
For extra charges, please see supply terms and conditions.

Council of Europe, all rights reserved 2015

See leaflet

See leaflet ; Batch 1 is valid until 31 July 2014

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
H1500000 Hyoscine hydrobromide

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
50 mg
1

Y0000448 Hyoscine hydrobromide impurity B

10 mg

H1600000 Hyoscyamine sulfate

100 mg

Y0000449 Hyoscyamine impurity E

10 mg

Y0000915 Hypromellose phthalate

10 mg

I0020000 Ibuprofen

Information

Monograph Leaflet

(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl
-propanoate

Storage

Extra
Price
charges
79
a

0106,0500

Yes

+5C 3C

0106

Yes

+5C 3C

79

0501

Yes

+5C 3C

79

0501

Yes

+5C 3C

79

347

Yes

+5C 3C

79

250 mg

0721

Yes

+5C 3C

79

New B1220000 Ibuprofen impurity B

1.15 mL

See leaflet; (2RS)-2-(4-Butylphenyl)propanoic acid ; Batch 7 is valid until 31


January 2015
Batch 8 is valid until 31 October 2015

0721

Yes

+5C 3C

79

Y0000140 Ibuprofen impurity F

5 mg

3-[4-(2-methylpropyl)phenyl]propanoic acid

0721

Yes

+5C 3C

79

Y0000881 Ibuprofen for peak identification

0.09 mg

0721

Yes

+5C 3C

79

I0050000 Idoxuridine

50 mg

0669

Yes

+5C 3C

79

I0060000 Ifosfamide

50 mg

1529

Yes

+5C 3C

79

I0060100 Ifosfamide - reference spectrum

n/a

79

I0060002 Ifosfamide impurity A

100 mg

3-[(2-chloroethyl)amino]propyl dihydrogen phosphate

1529

Yes

-20C 5C

79

I0060004 Ifosfamide impurity B

40 mg

bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate

1529

Yes

+5C 3C

79

I0060010 Ifosfamide impurity E

20 mg

3-chloro-N-(2-chloroethyl)propan-1-amine

1529

Yes

+5C 3C

79

I0060012 Ifosfamide impurity F

10 mg

(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide

1529

Yes

+5C 3C

79

Y0001691 Imatinib mesilate

120 mg

see leaflet CHNSO

2736

Yes

+5C 3C

79

See leaflet CHClNOP

1529

Y0001695 Imatinib impurity A

0.03 mg

(2E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-ene-1-one

2736

Yes

-20C 5C

79

New Y0001693 Imatinib impurity F

10 mg

Batch 1 is valid until 30 October 2015

2736

Yes

+5C 3C

79

Y0001694 Imatinib impurity H

130 mg

1-(pyridin-3-yl)ethan-1-one

2736

Yes

+5C 3C

79

Y0001692 Imatinib for system suitability

5 mg

2736

Yes

+5C 3C

79

I0086000 Imidazole

60 mg

Batch 1 is valid until 30 September 2014

0757,1424,
2270

Yes

+5C 3C

79

I0090000 Imipenem

100 mg

see leaflet

1226

Yes

-20C 5C

79

I0100000 Imipramine hydrochloride

50 mg

0029, 0408,
0889,1787

Yes

+5C 3C

79

Y0001689 Immunoglobulin (anti-A, anti-B antibodies test)


Negative control

50 mg

20620

Yes

-20C 5C

79

Y0001688 Immunoglobulin (anti-A, anti-B antibodies test) Positive


control

46 mg

20620

Yes

-20C 5C

79

Y0000893 Imipramine for system suitability

10 mg

0029

Yes

+5C 3C

79

Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test


BRP

45 mg

20620

Yes

-20C 5C

79

Y0000540 Immunoglobulin panel for anti-D antibodies test BRP

2000 mg

See leaflet,
20626

Yes

-20C 5C

90

Council of Europe, all rights reserved 2015

41

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001205 Imperatorin

Reference Standard

I0150000 Indapamide

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
20 mg
1 See leaflet CHO
5
150 mg
1 See leaflet CHClNOS

Information

Monograph Leaflet
2556

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

1108

Yes

+5C 3C

79

I0150020 Indapamide impurity B

5 mg

4-chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide ; Batch 3 is
valid until 31 August 2014

1108

Yes

+5C 3C

79

Y0000788 Indinavir

100 mg

see leaflet

2214

Yes

+5C 3C

79

Y0000880 Indinavir sulfate - reference spectrum

n/a

2214

79

Y0000746 Indinavir for system suitability

20 mg

2214

Yes

+5C 3C

79

I0200000 Indometacin

50 mg

0092,0922,1
686

Yes

+5C 3C

79

Y0001640 Indometacine impurity mixture

0.002 mg

0092

Yes

+5C 3C

79

Y0000349 Insulin aspart

8 mg

See leaflet

2084

Yes

-20C 5C

90

I0305000 Insulin (bovine)

7.99 mg

See leaflet CHNOS

0854,1637

Yes

-20C 5C

90

Y0001542 Insulin glargine

15 mg

See leaflet

2571

Yes

-20C 5C

79

Y0001544 Insulin glargine for peak identification

3.2 mg

2571

Yes

-20C 5C

79

I0310000 Insulin (human)

8 mg

see leaflet

0838, 0854,
1637, 1638

Yes

-20C 5C

90

Y0000348 Insulin lispro

5.75 mg

See leaflet CHNOS

2085

Yes

-20C 5C

90

I0320000 Insulin (porcine)

8.61 mg

See leaflet CHNOS; For qualitative use see insulin porcine for system
suitability CRS Y0001717

0838,0854,1
637,1638

Yes

-20C 5C

90

Y0001717 Insulin porcine for system suitability

9 mg

For intended use: see leaflet. ; Batch 1 is valid until 31 August 2015

0838,0854,1
637

Yes

-20C 5C

79

I0320301 Interferon alfa-2b

200 L

About 9.74 mg per mL ; Batch 5 is valid until 31 August 2014

1110

Yes

-80C 10C

90

Y0001101 Interferon beta-1a

0.6 mL

See leaflet ; Batch 2 is valid until 31 January 2015

1639

Yes

-80C 10C

90

I0320330 Interferon gamma-1b

0.5 mL

about 1 mg per ml

1440

Yes

-80C 10C

90

Y0001664 Interferon gamma-1b for system suitability

0.6 mg

1440

Yes

-20C 5C

79

I0328000 Iobenguane sulfate

25 mg

1111,1112,11
13,2351

Yes

+5C 3C

79

Y0000839 Iobenguane sulfate - reference spectrum

n/a

2351

79

Y0001294 Iodixanol

60 mg

2215

Yes

+5C 3C

79

Y0001292 Iodixanol impurity C

10 mg

5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide

2215

Yes

+5C 3C

79

Y0001291 Iodixanol impurity E

10 mg

5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

2215

Yes

+5C 3C

79

Y0001293 Iodixanol impurity H

10 mg

5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide

2215

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet

42

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
I0320800 Iohexol

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
150 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1114

Yes

+5C 3C

1114

Yes

+5C 3C

79

1114,2215

Yes

+5C 3C

79

I0320810 Iohexol impurity A

50 mg

5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3dicarboxamide

I0320820 Iohexol impurity J

125 mg

5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3dicarboxamide

Y0000672 Iohexol for peak identification

10 mg

1114

Yes

+5C 3C

79

I0329000 Iopamidol

50 mg

1115

Yes

+5C 3C

79

I0329010 Iopamidol impurity A

10 mg

N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodoisophthalamide

1115, 1754

Yes

+5C 3C

79

Y0000406 Iopamidol impurity H

10 mg

4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide

1115

Yes

+5C 3C

79

I0330000 Iopanoic acid

100 mg

0700

Yes

+5C 3C

79

Y0001297 Iopentol

10 mg

2215

Yes

+5C 3C

79

Y0001020 Iopromide

100 mg

See leaflet CHINO

1753

Yes

+5C 3C

79

Y0001077 Iopromide impurity A

0.125 mg

5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3dicarboxamide

1753

Yes

+5C 3C

79

Y0001021 Iopromide for system suitability 1

5 mg

1753

Yes

+5C 3C

79

Y0001022 Iopromide for system suitability 2

5 mg

1753

Yes

+5C 3C

79

Y0000555 Iotrolan

100 mg

1754

Yes

+5C 3C

79

Y0000658 Iotrolan for system suitability

5 mg

1754

Yes

+5C 3C

79

Y0000141 Ioxaglic acid

125 mg

2009

Yes

+5C 3C

79

Y0000142 Ioxaglic acid impurity A

20 mg

2009

Yes

+5C 3C

79

I0360000 Ipratropium bromide

120 mg

0919

Yes

+5C 3C

79

I0361000 Ipratropium impurity B

10 mg

(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1methylethyl)-8-azoniabicyclo[3.2.1]octane

0919

Yes

+5C 3C

79

Y0000276 Ipratropium impurity A

15 mg

(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]
octane ; Batch 1 is valid until 31 March 2015

0919

Yes

+5C 3C

79

Y0001166 Irbesartan

60 mg

2465

Yes

+5C 3C

79

Y0001156 Irbesartan impurity A

10 mg

1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]
cyclopentanecarboxamide ; Batch 2 is valid until 31 July 2015

2465

Yes

+5C 3C

79

Y0001616 Irisflorentin

15 mg

See leaflet CHO

2561

Yes

+5C 3C

79

I0375000 Isoconazole

200 mg

1018

Yes

+5C 3C

79

I0380000 Isoconazole nitrate

200 mg

1017

Yes

+5C 3C

79

I0400000 Isoemetine hydrobromide

25 mg

0081

Yes

+5C 3C

79

1.4 mL

1666

Yes

+5C 3C

79

New Y0000858 Isoflurane

See leaflet

3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid

Batch 1 is valid until 31 October 2015

Y0000037 Isoflurane - reference spectrum

n/a

1673

79

I0460000 Isoleucine

50 mg

0770

Yes

+5C 3C

79

I0465000 Isomalt

3000 mg

1531

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet
43

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000070 Isomaltooligosaccharide

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
0.9 mg
1

Information

Monograph Leaflet

Storage

1506

Yes

+5C 3C

Extra
Price
charges
79
a

I0500000 Isoniazid

100 mg

0146

Yes

+5C 3C

79

I0599990 Isoprenaline hydrochloride

50 mg

1332

Yes

+5C 3C

79

Y0001577 Isoprenaline impurity A

15 mg

1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone

1332

Yes

+5C 3C

79

I0600000 Isoprenaline sulfate

510 mg

Batch 2 is valid until 30 September 2014

0502

Yes

+5C 3C

79

Y0001728 Isopropyl alcohol

100 mg

0970

Yes

+5C 3C

79

I0725000 Isopropyl hexadecanoate

100 mg

See leaflet CHO

0839

Yes

+5C 3C

79

I0750000 Isopropyl tetradecanoate

2 ml

See leaflet CHO

0725

Yes

+5C 3C

79

Y0001568 Isoquercitroside

15 mg

See leaflet CHO

2528

Yes

+5C 3C

79

I0775000 Isosorbide dinitrate

350 mg

See leaflet CHNO

1117,1118

Yes

+5C 3C

79

I0775010 Isosorbide mononitrate

150 mg

See leaflet CHNO; Isosorbide-5-nitrate. Can only be sent by road.

1117,1118

Yes

+5C 3C

79

I0775020 Isosorbide-2-nitrate

50 mg

1118

Yes

+5C 3C

79

I0800000 Isotretinoin

60 mg

0693,1019

Yes

+5C 3C

79

Y0001218 Isotretinoin for peak identification

10 mg

1019

Yes

+5C 3C

79

I0900000 Isoxsuprine hydrochloride

50 mg

1119

Yes

+5C 3C

79

Y0000366 Isradipine

125 mg

See leaflet CHNO

2110

Yes

+5C 3C

79

Y0000367 Isradipine impurity D

5 mg

methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)


-2,6-dimethylpyridine-3,5-dicarboxylate

2110

Yes

+5C 3C

79

I7000000 Itraconazole

20 mg

1335

Yes

+5C 3C

79

Y0001100 Itraconazole for system suitability

25 mg

1335

Yes

+5C 3C

79

I8000010 Ivermectin

150 mg

See leaflet

1336

Yes

+5C 3C

79

Y0001592 Ivy leaf dry extract HRS

70 mg

See leaflet

2148

Yes

-20C 5C

79

Y0000041 Josamycin

150 mg

See leaflet

1982,1983,2
0702

Yes

-20C 5C

79

Y0001315 Josamycin for peak identification

25 mg

1983

Yes

+5C 3C

79

Y0000042 Josamycin propionate

150 mg

1982,1983,2
0702

Yes

+5C 3C

79

K0100000 Kanamycin B sulfate

20 mg

0032,0033,0
645

Yes

+5C 3C

79

K0200000 Kanamycin monosulfate

150 mg

0032,0033,0
053,
0485,0645,1
289,
1290,20702

Yes

+5C 3C

79

Y0000450 Ketamine hydrochloride - * narc

10 mg

1020

Yes

+5C 3C

79

K0551000 Ketamine impurity A

50 mg

1020,1742

Yes

+5C 3C

79

Y0000246 Ketobemidone hydrochloride - reference spectrum

n/a

79

Y0000244 Ketobemidone impurity B

5 mg

79

Council of Europe, all rights reserved 2015

See leaflet

See leaflet CHNOS,HO ; Batch 2 is valid until 30 June 2015

1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol

1746
1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone
44

1746

Yes

+5C 3C

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000245 Ketobemidone impurity C

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
5 mg
1 1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one

Monograph Leaflet
1746

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

K0600000 Ketoconazole

150 mg

0921,1270

Yes

+5C 3C

79

K2000000 Ketoprofen

50 mg

0922,1157,1
209

Yes

+5C 3C

79

K2000010 Ketoprofen impurity A

10 mg

1-(3-benzoylphenyl)ethanone ; Batch 4 is valid until 31 March 2015

0922

Yes

+5C 3C

79

K2000015 Ketoprofen impurity C

15 mg

3-[(1RS)-1-carboxyethyl]benzoic acid

0922

Yes

+5C 3C

79

Y0000486 Ketorolac trometamol

10 mg

1755

Yes

+5C 3C

79

Y0000626 Ketorolac trometamol for peak identification

5 mg

1755

Yes

+5C 3C

79

Y0001619 Ketotifen hydrogen fumarate

10 mg

1592

Yes

+5C 3C

79

Y0000161 Ketotifen impurity G

0.0225 mg

1592

Yes

+5C 3C

79

Y0001617 Ketotifen for peak identification

15 mg

Y0001200 Kudzuvine root dry extract

200 mg

See leaflet

L0050000 Labetalol hydrochloride

120 mg

Y0001548 Labetalol impurity A

10 mg

L0129000 Lactitol monohydrate

60 mg

Y0000257 Lactobionic acid

100 mg

L0100000 Lactose

100 mg

A1206000 Lactose (anhydrous)

1
1

L0130000 Lactulose
Y0001510 Lactulose for peak identification

4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)
thiophen-9,10-dione

1592

Yes

+5C 3C

79

2434,2483

Yes

-20C 5C

79

See leaflet CHClNO

0923

Yes

+5C 3C

79

2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic
acid

0923

Yes

+5C 3C

79

See leaflet CHO

1337

Yes

+5C 3C

79

1647

Yes

+5C 3C

79

0177,0178,0
187,
0188,0204,0
209,
1215,1570

Yes

+5C 3C

79

100 mg

1061

Yes

+5C 3C

79

100 mg

0187

Yes

+5C 3C

79

3000 mg

0924,1230

Yes

+5C 3C

79

2600 mg

0924

Yes

+5C 3C

79

Y0000425 Lamivudine

150 mg

2217

Yes

+5C 3C

79

Y0000518 Lamivudine for system suitability 1

10 mg

2217

Yes

+5C 3C

79

Y0000426 Lamivudine for system suitability 2

10.3 mg

2217

Yes

+5C 3C

79

Y0001030 Lamotrigine

10 mg

1756

Yes

+5C 3C

79

Y0001032 Lamotrigine impurity E

15 mg

1756

Yes

+5C 3C

79

Y0001031 Lamotrigine for peak identification

20 mg

1756

Yes

+5C 3C

79

Y0001085 Lamotrigine for system suitability

10 mg

1756

Yes

+5C 3C

79

Y0000773 Lansoprazole

60 mg

2219

Yes

+5C 3C

79

Y0000774 Lansoprazole for peak identification

1.01 mg

2219

Yes

+5C 3C

79

Y0001474 Lauric acid

1500 mg

see leaflet

1848, 2579

Yes

+5C 3C

79

Y0000654 Leflunomide

100 mg

see leaflet

2330

Yes

+5C 3C

79

New Y0001750 Lactose monohydrate

Council of Europe, all rights reserved 2015

See leaflet ; Batch 3 is valid until 31 December 2014


See leaflet CHNOS

2,3-dichlorobenzoic acid
Batch 1 is valid until 31 December 2014

45

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000487 Leflunomide impurity A

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
25 mg
1 4-(trifluoromethyl)aniline

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

2330

Yes

+5C 3C

2330

Yes

+5C 3C

79

2334

Yes

+5C 3C

79

0771,0874

Yes

+5C 3C

79

1442

Yes

-20C 5C

79

Y0000674 Leflunomide for peak identification

1 mg

Y0000685 Letrozole

70 mg

L0375000 Leucine

50 mg

L0376000 Leuprorelin

1 mg

L0376001 Leuprorelin - reference spectrum

n/a

1442

79

Y0000048 Levamisole - reference spectrum

n/a

1728

79

L0380000 Levamisole hydrochloride

50 mg

Y0000047 Levamisole hydrochloride for system suitability

15 mg

Batch 4 is valid until 30 September 2015

Y0001253 Levetiracetam

110 mg

Y0001254 Levetiracetam impurity A

10 mg

Y0001255 Levetiracetam impurity B

15 mg

Y0001256 Levetiracetam impurity C

15 mg

Y0001257 Levetiracetam impurity D

L0390000 Levocabastine hydrochloride

Y0001636 Levocabastine for system suitability 1

Y0001637 Levocabastine for system suitability 2

L0399900 Levocarnitine
L0399905 Levocarnitine impurity A

See leaflet CHN


See leaflet CHNO

0726

Yes

+5C 3C

79

0726,1728

Yes

+5C 3C

79

See leaflet ; Batch 1 is valid until 31 December 2014

2535

Yes

+5C 3C

79

(2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid

2535

Yes

+5C 3C

79

(2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide

2535

Yes

+5C 3C

79

pyridin-2-ol / 2-hydroxypyridine

2535

Yes

+5C 3C

79

15 mg

(2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam)

2535

Yes

+5C 3C

79

125 mg

1484

Yes

+5C 3C

79

5.028 mg

1484

Yes

+5C 3C

79

5.005 mg

1484

Yes

+5C 3C

79

125 mg

1339

Yes

+5C 3C

79

50 mg

1339

Yes

+5C 3C

79

L0400000 Levodopa

100 mg

0038

Yes

+5C 3C

79

L0420000 Levodropropizine

60 mg

1535

Yes

+5C 3C

79

L0420002 Levodropropizine impurity A

25 mg

(2R)-3-(4-phenylpiperazin-1-yl)propan-1,2-diol (dextrodropropizine)

1535

Yes

+5C 3C

79

Y0001033 Levodropropizine impurity B

50 mg

1-phenylpiperazine

1535

Yes

+5C 3C

79

Y0001048 Levodropropizine impurity C

300 mg

2,3-epoxypropan-1-ol

1535

Yes

-20C 5C

79

L0500000 Levomepromazine hydrochloride

100 mg

0505

Yes

+5C 3C

79

L0505000 Levomepromazine maleate

50 mg

0925

Yes

+5C 3C

79

L0551000 Levonorgestrel

30 mg

0926

Yes

+5C 3C

79

Y0001379 Levonorgestrel impurity B

15 mg

13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one ;
Batch 1 is valid until 30 November 2014

0926

Yes

+5C 3C

79

Y0001431 Levonorgestrel for system suitability 1

10 mg

Batch 1 is valid until 31 March 2015

0926

Yes

+5C 3C

79

Y0001618 Levonorgestrel for system suitability 2

10 mg

L0570000 Levothyroxine sodium

100 mg

Y0001382 Levothyroxine for peak identification

10 mg

L0595000 Lidocaine

10 mg

Batch 1 is valid until 31 January 2015

L0600000 Lidocaine hydrochloride

40 mg

Batch 2 is valid until 28 February 2015

Council of Europe, all rights reserved 2015

see leaflet; (E)- or (Z)-4-(trimethylammonio)but-2-enoate ; Batch 2 is valid


until 30 June 2015

see leaflet ; Batch 3 is valid until 31 January 2015

46

0926

Yes

+5C 3C

79

0401,0728

Yes

-20C 5C

79

0401

Yes

-20C 5C

79

0727

Yes

+5C 3C

79

0227,1242,1
363

Yes

+5C 3C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
L0650000 Lincomycin hydrochloride
Y0001393 Lincomycin hydrochloride for system suitability
New L0700000 Liothyronine sodium

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
4
100 mg
1 See leaflet ; Batch 3 is valid until 30 October 2014
2

10 mg

60 mg

Y0000860 Liothyronine for peak identification

0.0046 mg

L0702000 Lisinopril dihydrate

50 mg

Y0001234 Lisinopril impurity F

0.01 mg

Y0001701 Lisinopril for peak identification

10 mg

Y0001709 Lisinopril for system suitability A

10 mg

L0720000 Lithium clavulanate

125 mg

L0720800 Lithocholic acid

60 mg

Y0000112 Lobeline hydrochloride

L0745000 Lomustine

Y0001438 Long pepper for system suitability HRS


L0750000 Loperamide hydrochloride

Monograph Leaflet

See leaflet ; Batch 7 is valid until 31 December 2015

(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)

Storage

Extra
Price
charges
79
a

0582,0583,0
996

Yes

+5C 3C

0583

Yes

-20C 5C

79

0401,0728

Yes

-20C 5C

79

0728

Yes

-20C 5C

79

1120

Yes

+5C 3C

79

1120

Yes

+5C 3C

79

1120

Yes

+5C 3C

79

1120

Yes

+5C 3C

79

1140,1653

Yes

+5C 3C

79

1189,1275

Yes

+5C 3C

79

50 mg

1988

Yes

+5C 3C

79

50 mg

0928

Yes

+5C 3C

79

600 mg

2477, 2453

Yes

+5C 3C

79

50 mg

0921,0929,1
729

Yes

+5C 3C

79

Y0000322 Loperamide hydrochloride for system suitability

15 mg

0929

Yes

+5C 3C

79

Y0000341 Loperamide oxide monohydrate

20 mg

1729

Yes

+5C 3C

79

Y0001498 Lopinavir

200 mg

2615

Yes

+5C 3C

79

Y0001506 Lopinavir for peak identification

10 mg

2615

Yes

+5C 3C

79

Y0001505 Lopinavir for system suitability

10 mg

2615

Yes

+5C 3C

79

Y0000688 Loratadine

60 mg

2124

Yes

+5C 3C

79

Y0000604 Loratadine impurity F

10 mg

ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate

2124

Yes

+5C 3C

79

Y0000605 Loratadine impurity H

50 mg

ethyl 4-oxopiperidine-1-carboxylate

2124

Yes

+5C 3C

79

Y0000603 Loratadine for system suitability

20 mg

2124

Yes

+5C 3C

79

L0750500 Lorazepam - * psy

15 mg

Batch 1 is valid until 31 March 2015

1121

Yes

+5C 3C

79

Y0000718 Lorazepam impurity D

10 mg

(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione

1121

Yes

+5C 3C

79

Y0000576 Lorazepam for system suitability - * psy

0.8 mg

1121

Yes

+5C 3C

79

Y0001062 Losartan potassium

50 mg

2232

Yes

+5C 3C

79

Y0001072 Losartan impurity D

10 mg

2-butyl-4-chloro-1H-imidazole-5-carbaldehyde ; Batch 2 is valid until 31


August 2015

2232

Yes

+5C 3C

79

Y0001076 Losartan for system suitability

0.0015 mg

Batch 2 is valid until 30 September 2015

L0790000 Lovastatin

60 mg

See leaflet CHO

Y0001136 Lovastatin for peak identification

20 mg

Council of Europe, all rights reserved 2015

See leaflet; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO ; Batch


5 is valid until 30 November 2014

Batch 1 is valid until 30 September 2015


See leaflet CHNO

47

2232

Yes

+5C 3C

79

1538,1563

Yes

-20C 5C

79

1538

Yes

-20C 5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001284 Lufenuron

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
140 mg
1 See leaflet CHClFNO

Information

Monograph Leaflet

Storage
+5C 3C

Extra
Price
charges
79
a

2177

Yes

2177

Yes

+5C 3C

79

2177

Yes

+5C 3C

79

Y0001261 Lufenuron for peak identification

0.4028 mg

Y0001265 Lufenuron impurity G

15 mg

L0800000 Lynestrenol

50 mg

0558

Yes

+5C 3C

79

Y0001034 Lynestrenol for peak identification

20 mg

0558

Yes

+5C 3C

79

Y0000397 Lysine acetate

60 mg

2114

Yes

+5C 3C

79

L0900000 Lysine hydrochloride

50 mg

0930, 1654

Yes

+5C 3C

79

Y0001369 Macrogol 30 dipolyhydroxystearate

100 mg

2584

Yes

+5C 3C

79

Y0000745 Macrogol 40 sorbitol heptaoleate

20 mg

2396

Yes

+5C 3C

79

Y0001684 High-molecular-mass macrogol CRS

10 mg

2444

Yes

+5C 3C

79

Y0001157 Macrogol polyvinyl alcohol grafted copolymer

400 mg

2523

Yes

+5C 3C

79

M0088000 Magnesium aspartate dihydrate

60 mg

1445

Yes

+5C 3C

79

Y0001289 Magnolol

20 mg

See leaflet CHO

2567,2568

Yes

-20C 5C

79

M0120000 Malathion

250 mg

See leaflet CHOPS

1343

Yes

-20C 5C

79

M0120005 Malathion impurity A

15 mg

see leaflet; diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl]


butane dioate ; Batch 2 is valid until 30 April 2015

1343

Yes

-20C 5C

79

M0120010 Malathion impurity B

10 mg

diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate

1343

Yes

-20C 5C

79

M0100000 Maleic acid

100 mg

Batch 1 is valid until 31 May 2015

0365,0925

Yes

+5C 3C

79

Y0000143 Malic acid - reference spectrum

n/a

79

M0160000 Maltitol

1200 mg

See leaflet CHO

1235,1236

Yes

+5C 3C

79

M0200000 Mannitol

1200 mg

See leaflet CHO

0435,0559,1
381, 1531

Yes

+5C 3C

79

M0206000 Maprotiline hydrochloride

100 mg

1237

Yes

+5C 3C

79

M0206040 Maprotiline impurity D

25 mg

1237

Yes

+5C 3C

79

Y0000819 Marbofloxacin

10 mg

2233

Yes

+5C 3C

79

Y0000820 Marbofloxacin for peak identification

20 mg

2233

Yes

+5C 3C

79

M0210000 Measles vaccine (live) BRP

400 mg

1057,0213,2
442

Yes

-20C 5C

90

M0215000 Mebendazole

20 mg

1208,1254,
0845

Yes

+5C 3C

79

Y0000144 Mebendazole for system suitability

20 mg

0845

Yes

+5C 3C

79

Y0001086 Mebrofenin

120 mg

2393

Yes

+5C 3C

79

M0220000 Meclozine dihydrochloride

150 mg

0622

Yes

+5C 3C

79

Y0001310 Meclozine impurity B

15 mg

4-chlorobenzhydrol

0622

Yes

+5C 3C

79

Y0001311 Meclozine impurity H

15 mg

1-(4-chlorobenzhydryl)piperazine

0622

Yes

+5C 3C

79

M0240000 Medronic acid

20 mg

0641, 2350

Yes

+5C 3C

79

60 l

Y0001107 Medronic acid impurity A


Council of Europe, all rights reserved 2015

2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl
phenyl carbonate

2080

3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2- en-1-amine

See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of
each vial is 80 mg.

Tris(1-methylethoxy)phosphane
48

79
2350
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001106 Medronic acid impurity B

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
40 l
1 Tetrakis(1-methylethyl)methhylenediphosphonate

Monograph Leaflet

Storage

2350

Yes

+5C 3C

Extra
Price
charges
79
a

M0250000 Medroxyprogesterone acetate

100 mg

0673

Yes

+5C 3C

79

Y0001484 Medroxyprogesterone acetate for peak identification

25 mg

0673

Yes

+5C 3C

79

Y0000598 Medroxyprogesterone acetate for system suitability

10 mg

0673

Yes

-20C 5C

79

M0252600 Mefenamic acid

50 mg

1240

Yes

+5C 3C

79

Y0001081 Mefenamic acid impurity A

100 mg

1240

Yes

+5C 3C

79

M0253000 Mefloquine hydrochloride

100 mg

1241

Yes

+5C 3C

79

Y0001514 Megestrol acetate

120 mg

1593

Yes

+5C 3C

79

Y0001594 Megestrol acetate for impurity K identification

0.01 mg

1593

Yes

+5C 3C

79

Y0001507 Megestrol acetate for peak identification

25 mg

1593

Yes

+5C 3C

79

Y0001524 Megestrol acetate for system suitability

50 mg

1593

Yes

+5C 3C

79

Y0001209 Meglumine

10 mg

2055

Yes

+5C 3C

79

Y0001670 Meldonium dihydrate

10 mg

2624

Yes

+5C 3C

79

Y0001671 Meldonium impurity A

25 mg

Trimethylammonium bromide

2624

Yes

+5C 3C

79

Y0001672 Meldonium impurity B

25 mg

1,1,1-trimethylhydrazinium bromide

2624

Yes

+5C 3C

79

Y0001673 Meldonium impurity C

25 mg

see leaflet CHNOBr; 2-(3-methoxy-3-oxopropyl)-1,1,1trimethylhydrazin-1-ium

2624

Yes

+5C 3C

79

Y0001674 Meldonium impurity D

25 mg

see leaflet CHNOBr; 3-(2,2,2,-trimethylhydrazinium)ethylpropionate


bromide

2624

Yes

+5C 3C

79

Y0001675 Meldonium impurity E

25 mg

see leaflet CHBrNO; 3-(2,2,2,-trimethylhydrazinium)prop-2-yl-propionate


bromide

2624

Yes

+5C 3C

79

Y0001676 Meldonium impurity F

25 mg

see leaflet CHNO; 3-hydroxy-1,1-dimethyl-4,5,-dihydro-1H-pyrazolium-1betaine hydrate

2624

Yes

+5C 3C

79

Y0001080 Meloxicam

50 mg

2373

Yes

+5C 3C

79

Y0001035 Meloxicam impurity A

5 mg

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide ;


Batch 1 is valid until 31 March 2015

2373

Yes

+5C 3C

79

Y0001036 Meloxicam impurity B

5 mg

5-methylthiazol-2-amine ; Batch 1 is valid until 31 July 2014

2373

Yes

+5C 3C

79

Y0001037 Meloxicam impurity C

5 mg

N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide

2373

Yes

+5C 3C

79

Y0001039 Meloxicam impurity D

5 mg

N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide

2373

Yes

+5C 3C

79

Y0001158 Melphalan hydrochloride

100 mg

see leaflet

1698

Yes

+5C 3C

79

Y0001513 Melphalan - reference spectrum

1 uc

1698

79

Y0001457 Melphalan for system suitability

10 mg

1698

Yes

+5C 3C

79

M0300000 Menadione

100 mg

0507

Yes

+5C 3C

79

M0350000 Menthol

150 mg

0619,0623

Yes

+5C 3C

79

M0370000 Mepivacaine hydrochloride

100 mg

1242

Yes

+5C 3C

79

M0370020 Mepivacaine impurity B

60 mg

+5C 3C

79

Council of Europe, all rights reserved 2015

2,3-dimethylaniline
See leaflet CHO

(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
49

1242

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
M0400000 Meprobamate - * psy

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
100 mg
1

Information

Monograph Leaflet

Storage

0407,1689

Yes

+5C 3C

Extra
Price
charges
79
j

M0500000 Mepyramine maleate

1000 mg

0278

Yes

+5C 3C

79

Y0000679 Mepyramine impurity A

10 mg

N-(4-methoxybenzyl)pyridin-2-amine

0278

Yes

+5C 3C

79

Y0000680 Mepyramine impurity C

10 mg

pyridin-2-amine

0278

Yes

+5C 3C

79

Y0001252 Meropenem trihydrate

110 mg

See leaflet

2234

Yes

+5C 3C

79

Y0000297 Mesalazine

125 mg

1699,1993

Yes

+5C 3C

79

Y0001563 Mesalazine impurity A

15 mg

1699

Yes

+5C 3C

79

Y0001569 Mesalazine impurity C

15 mg

1699

Yes

+5C 3C

79

Y0001574 Mesalazine for system suitability

10 mg

1699

Yes

+5C 3C

79

Y0001040 Mesityl oxide

100 mg

2358

+5C 3C

79

Y0000337 Mesna - reference spectrum

n/a

1674

79

Y0000316 Mesna impurity C

10 mg

2-(acetylsulphanyl)ethanesulphonic acid

1674

Yes

+5C 3C

79

Y0000317 Mesna impurity D

10 mg

2,2'-(disulphanediyl)bis(ethanesulphonic acid)

1674

Yes

+5C 3C

79

Y0000227 Meso-rich exametazime

0.5 mg

1925

Yes

+5C 3C

79

Y0000097 Mesterolone

120 mg

See leaflet CHO

1730

Yes

+5C 3C

79

Y0000096 Mesterolone impurity A

30 mg

17-hydroxy-1alpha-methylandrost-4-en-3-one

1730

Yes

+5C 3C

79

M0600000 Mestranol

100 mg

0509

Yes

+5C 3C

79

Y0000301 Metacresol - reference spectrum

n/a

2077

79

M0600900 Metamizole sodium

10 mg

1346

Yes

+5C 3C

79

M0600905 Metamizole impurity A

15 mg

4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one ; Batch 3
is valid until 20 February 2015

1346

Yes

+5C 3C

79

Y0001481 Metamizole impurity E

0.01 mg

[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]
methanesulfonic acid (4-N-desmethylmetamizole). ; Batch 2 is valid until 30
September 2015

1346

Yes

+5C 3C

79

M0605000 Metformin hydrochloride

50 mg

0931

Yes

+5C 3C

79

Y0001590 Metformin impurity A

25 mg

Cyanoguanidine

0931

Yes

+5C 3C

79

Y0001600 Metformin impurity F

2 mL

Dimethylamine hydrochloride
N-methylmethanamine ; Batch 1 is valid until 30 June 2015

0931

Yes

+5C 3C

79

Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A

200 mg

1128

Yes

+5C 3C

79

Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B

200 mg

1128

Yes

+5C 3C

79

M0610030 Methacrylic acid-ethylacrylate copolymer (1:1),


dispersion 30%-ref.sp

n/a

1129

79

M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum

n/a

1127

79

M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum

n/a

1130

79

M0800000 Methadone hydrochloride - reference spectrum

n/a

0408,1787

79

Y0000428 Methanol - reference spectrum

n/a

1989

79

Council of Europe, all rights reserved 2015

2-aminophenol

50

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000754 Methenamine

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
10 mg
1

Information

Monograph Leaflet

Storage

1545

Yes

+5C 3C

Extra
Price
charges
79
a

M0960000 Methionine

50 mg

0788,1027

Yes

+5C 3C

79

M0950000 DL-Methionine

50 mg

0624

Yes

+5C 3C

79

M1000000 Methotrexate

100 mg

See leaflet CHNO ; Batch 6 is valid until 30 June 2015

0560

Yes

+5C 3C

79

Y0000663 Methotrexate impurity C

10 mg

(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine) ; Batch
1 is valid until 30 September 2015

0560

Yes

+5C 3C

79

M1000008 Methotrexate impurity D

10 mg

4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic
acid (N10-methylpteroic acid)

0560

Yes

+5C 3C

79

Y0000664 Methotrexate impurity E

10 mg

4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-aminoN10-methylpteroic acid, APA)

0560

Yes

+5C 3C

79

Y0000602 Methotrexate for peak identification

20 mg

0560

Yes

+5C 3C

79

Y0001668 Methotrexate for system suitability

100 mg

0560

Yes

+5C 3C

79

M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate

0.5 ml

0318

Yes

+5C 3C

79

M1556000 Methyl 12-hydroxystearate

100 mg

1497

Yes

+5C 3C

79

Y0001488 Methyl methacrylate

50 mg

1975

Yes

+5C 3C

79

Y0000398 Methyl nicotinate

25 mg

2129

Yes

+5C 3C

79

M1650000 Methyl parahydroxybenzoate

150 mg

0409,1262,2
134,1999

Yes

+5C 3C

79

M1770180 Methyl ricinoleate

125 mg

0051,2367

Yes

+5C 3C

79

M1770200 Methyl stearate

100 mg

0051,1497,
2367

Yes

+5C 3C

79

M1300000 Methylatropine bromide

100 mg

0919

Yes

+5C 3C

79

M1500000 Methyldopa

50 mg

0045

Yes

+5C 3C

79

Y0001083 Methyldopa for system suitability

0.024 mg

0045

Yes

+5C 3C

79

Y0001374 Racemic methyldopa

5 mg

0045

Yes

+5C 3C

79

M1550000 Methylene chloride

2 ml

0932

Yes

+5C 3C

79

Y0000776 Methylergometrine maleate

10 mg

1788

Yes

+5C 3C

79

Y0000777 Methylergometrine for system suitability

0.53 mg

1788

Yes

+5C 3C

79

M1625000 Methylnitrosoindoline

110 mg

1108

Yes

+5C 3C

79

Y0001017 Methylphenidate hydrochloride - * narc

40 mg

2235

Yes

+5C 3C

79

Y0001490 Methylphenidate impurity C

10 mg

2235

Yes

+5C 3C

79

Y0000910 Methylphenidate impurity mixture

0.04 mg

2235

Yes

+5C 3C

79

M1700000 Methylphenobarbital - * psy

500 mg

M1750000 Methylprednisolone

120 mg

Y0001602 Methylprednisolone for system suitability

10 mg

M1755000 Methylprednisolone acetate

100 mg

M1755200 Methylprednisolone hydrogen succinate

125 mg

Council of Europe, all rights reserved 2015

See leaflet ; Batch 3 is valid until 30 September 2014

(2RS)-2-phenyl-2-[(2R)-piperidin-2-yl]ethanamide

0189

Yes

+5C 3C

79

0312, 0561

Yes

+5C 3C

79

0561

Yes

+5C 3C

79

0933

Yes

+5C 3C

79

0768,1131

Yes

+5C 3C

79

See leaflet

51

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
M1755220 Methylprednisolone hydrogen succinate for
performance test

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
50 mg
1

Information

Monograph Leaflet
1131

Yes

+5C 3C

Yes

+5C 3C

Y0001376 2-methylpyrazine

100 mg

2446,2447,2
708

Y0000190 N-Methylpyrrolidone - reference spectrum

n/a

1675

Y0000418 Methylrosanilinium chloride

40 mg

1990

Yes

Y0000407 Methylrosanilinium for system suitability

10 mg

1990

Yes

M1800000 Methyltestosterone

100 mg

0410

Y0000861 Methyltestosterone for system suitability

10 mg

0410

M1800900 Methylthioninium chloride

50 mg

15 mg

M1800902 Methylthioninium impurity A

20 mg

M1808000 Metixene hydrochloride

75 mg

M1824990 Metoclopramide

100 mg

M1825000 Metoclopramide hydrochloride

50 mg

M1824995 Metoclopramide impurity A

25 mg

M1825010 Metoclopramide impurity E

40 mg

Y0000701 Metolazone

80 mg

Y0000702 Metolazone for system suitability

10 mg

Y0000171 Metoprolol succinate - reference spectrum

n/a

M1830000 Metoprolol tartrate

60 mg

Y0000145 Metoprolol impurity A

5 mg

M1845000 Metrifonate

100 mg

M1850000 Metronidazole

50 mg

Y0000087 Metronidazole impurity A

10 mg

M1851000 Metronidazole benzoate

50 mg

Y0000069 Metronidazole benzoate - reference spectrum

n/a

0934

M1860000 Mexiletine hydrochloride

100 mg

Y0000202 Mexiletine impurity C

2 mg

Y0000203 Mexiletine impurity D

2 mg

M1875000 Mianserin hydrochloride

100 mg

Y0001041 Mianserin impurity B

Y0000862 Mianserin for system suitability


M1880000 Miconazole

New Y0001744 Methylthioninium for system suitability

M1900000 Miconazole nitrate


Council of Europe, all rights reserved 2015

See leaflet CHClNS,xHO

Storage

Extra
Price
charges
79
a
a

79

79

+5C 3C

79

+5C 3C

79

Yes

+5C 3C

79

Yes

+5C 3C

79

1132

Yes

+5C 3C

79

1132

Yes

+5C 3C

79

1132

Yes

+5C 3C

79

1347

Yes

+5C 3C

79

1348

Yes

+5C 3C

79

0674,0856,1
303

Yes

+5C 3C

79

4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide

1348

Yes

+5C 3C

79

N,N-diethylethane-1,2-diamine

1575

Yes

+5C 3C

79

See leaflet CHClNOS

1757

Yes

+5C 3C

79

1757

Yes

+5C 3C

79

1448

79

3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium

1028

Yes

+5C 3C

79

1028,1448

Yes

+5C 3C

79

1133

Yes

+5C 3C

79

0675,0934

Yes

+5C 3C

79

0675, 0934

Yes

+5C 3C

79

1424

Yes

+5C 3C

79

79

1029

Yes

+5C 3C

79

see leaflet CHNO; 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]


dipropan-2-amine ; Batch 1 is valid until 4 February 2015

1029

Yes

+5C 3C

79

(2RS)-2-(2,6-dimethylphenoxy)propan-1-amine

1029

Yes

+5C 3C

79

Batch 2 is valid until 30 October 2014

0846

Yes

+5C 3C

79

10 mg

(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]
azepine-8-sulfonic acid

0846

Yes

+5C 3C

79

1.01 mg

0846

Yes

+5C 3C

79

70 mg

0935

Yes

+5C 3C

79

150 mg

(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

2-methyl-4-nitroimidazole ; Batch 2 is valid until 30 September 2015

52

79
0513,1148
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
M2200000 Midazolam - * psy

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
50 mg
1

Y0000562 Midazolam impurity C

Y0000599 Midazolam for system suitability - * psy


Y0001687 Milk thistle dry extract HRS

Information

0.08 mg

1 mg

120 mg

See leaflet

M2280000 Minocycline hydrochloride

125 mg

See leaflet CHClNO

M2300000 Minoxidil

50 mg

Y0001432 Minoxidil for system suitability

10 mg

Y0000705 Mirtazapine

10 mg

Y0000721 Mirtazapine for system suitability

10 mg

Y0000490 Misoprostol

60 mg

Y0001162 Misoprostol for system suitability

5 mg

Y0000378 Mitomycin

120 mg

See leaflet CHNO

New M2305000 Mitoxantrone hydrochloride

Monograph Leaflet

acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine-3-carboxylique

Storage

0936,1065

Yes

+5C 3C

0936

Yes

+5C 3C

Extra
Price
charges
79
j
a

79

0936

Yes

+5C 3C

79

1860,2071

Yes

-20C 5C

79

1030

Yes

+5C 3C

79

0937

Yes

+5C 3C

79

0937

Yes

+5C 3C

79

2338

Yes

+5C 3C

79

2338

Yes

+5C 3C

79

1731

Yes

-20C 5C

79

1731

Yes

-20C 5C

79

1655

Yes

+5C 3C

79

See leaflet CHO

60 mg

See leaflet ; Batch 3 is valid until 30 November 2015

1243

Yes

+5C 3C

79

M2305005 Mitoxantrone impurity A

5 mg

1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]
anthracene-9,10-dione

1243

Yes

+5C 3C

79

Y0000635 Modafinil

110 mg

See leaflet CHNOS

2307

Yes

+5C 3C

79

Y0000636 Modafinil for system suitability

0.1 mg

2307

Yes

+5C 3C

79

Y0000251 Molgramostim

0.3 ml

1641

Yes

-80C 10C

79

Y0000821 Molsidomine

5 mg

1701

Yes

+5C 3C

79

Y0000822 Molsidomine impurity B

10 mg

N-nitrosomorpholine

1701

Yes

+5C 3C

79

Y0000823 Molsidomine impurity D

10 mg

morpholine-4-carbaldehyde

1701

Yes

+5C 3C

79

M2900000 Mometasone furoate

100 mg

1449

Yes

+5C 3C

79

Y0001436 Montelukast dicyclohexylamine

150 mg

2583

Yes

+5C 3C

79

Y0001433 Montelukast racemate

10 mg

2583

Yes

+5C 3C

79

Y0001434 Montelukast sodium

20 mg

2583

Yes

+5C 3C

79

Y0001435 Montelukast for peak identification

20 mg

2583

Yes

+5C 3C

79

Y0000028 Morantel hydrogen tartrate

50 mg

Y0000451 Morphine hydrochloride trihydrate - * narc

25 mg

Y0000452 Morphine sulfate - * narc

40 mg

Y0000830 Morphine for system suitability - * narc

15 mg

Batch 2 is valid until 31 March 2015

Y0000772 Moxidectin

70 mg

See leaflet ; Batch 2 is valid until 31 January 2015

Y0000747 Moxidectin for system suitability

10 mg

Y0000703 Moxifloxacin hydrochloride

110 mg

10 mg

Batch 1 is valid until 31 January 2015


53

Y0000717 Moxifloxacin for peak identification


Council of Europe, all rights reserved 2015

13.45 mg protein per ml CHNOS

See leaflet ; Batch 1 is valid until 31 July 2015

1546

Yes

+5C 3C

79

0097, 1839,
1841,
01/2015:184
0, 0777

Yes

+5C 3C

79

1244,1784

Yes

+5C 3C

79

1244, 0097

Yes

+5C 3C

79

1656

Yes

-20C 5C

79

Batch 1 is valid until 31 August 2014

1656

Yes

+5C 3C

79

See leaflet CHClFNO

2254

Yes

+5C 3C

79

See leaflet

79
2254
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000226 Moxonidine

Reference Standard

Y0000222 Moxonidine impurity A

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
50 mg
1 See leaflet CHClNO
1
10 mg
1 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine

M3600000 Mumps vaccine (live) BRP

165 mg

M3805000 Mupirocin - reference spectrum

n/a

M3805500 Mupirocin calcium - reference spectrum

n/a

M3806000 Mupirocin lithium

100 mg

See leaflet CHOLi

Y0000489 Mycophenolate mofetil

30 mg

Batch 2 is valid until 30 August 2014

Y0000519 Mycophenolate mofetil for peak identification

10 mg

Y0000692 Mycoplasma fermentans BRP

1 ml

Y0000690 Mycoplasma hyorhinis BRP

1 ml

Y0000691 Mycoplasma orale BRP

Y0000689 Mycoplasma synoviae BRP

Y0000485 Myo-inositol
N0020000 Nabumetone

See leaflet

Monograph Leaflet

Storage
+5C 3C

Extra
Price
charges
79
a

1758

Yes

1758

Yes

+5C 3C

79

0538,1057,
2442

Yes

-80C 10C

90

79

1450

79

1450,1451

Yes

+5C 3C

79

1700

Yes

+5C 3C

79

1700

Yes

+5C 3C

79

20607

Yes

-80C 10C

120

20607

Yes

-80C 10C

120

1 ml

20607

Yes

-80C 10C

120

1 ml

20607

Yes

-80C 10C

120

1020 mg

See leaflet

1805

Yes

+5C 3C

79

60 mg

See leaflet CHO

1350

Yes

+5C 3C

79

N0020020 Nabumetone impurity D

10 mg

(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one

1350

Yes

+5C 3C

79

New N0020030 Nabumetone impurity F

10 mg

See leaflet; 6,6'-dimethoxy-2,2'-binaphthalenyl ; Batch 4 is valid until 31


October 2015

1350

Yes

+5C 3C

79

Y0000146 Nadolol

100 mg

1789

Yes

+5C 3C

79

Y0001215 Nadolol impurity mixture

0.01 mg

1789

Yes

+5C 3C

79

N0025000 Nadroparin calcium

250 mg

0828,1134

Yes

+5C 3C

79

Y0000077 Naftidrofuryl - reference spectrum

n/a

79

Y0000120 Naftidrofuryl impurity A

10 mg

2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid

1594

Yes

+5C 3C

79

Y0000121 Naftidrofuryl impurity B

25 mg

ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate

1594

Yes

+5C 3C

79

Y0000331 Naftidrofuryl impurity F

10 mg

2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)


propanoate

1594

Yes

+5C 3C

79

N0050000 Nalidixic acid

100 mg

0701

Yes

+5C 3C

79

N0075000 Naloxone hydrochloride dihydrate

100 mg

0729,2099

Yes

+5C 3C

79

25 mg

0729

Yes

+5C 3C

79

Y0000695 Naloxone for peak identification

5.075 mg

0729

Yes

+5C 3C

79

Y0000400 Naltrexone hydrochloride

50 mg

1790

Yes

+5C 3C

79

Y0000410 Naltrexone impurity C

15 mg

1790

Yes

+5C 3C

79

Y0000542 Nandrolone decanoate

5 mg

1992

Yes

-20C 5C

79

Y0000547 Nandrolone decanoate for peak identification

10 mg

1992

Yes

-20C 5C

79

Y0000548 Nandrolone decanoate for system suitability

10 mg

1992

Yes

-20C 5C

79

N0080000 Naphazoline hydrochloride

50 mg

0730,1162

Yes

+5C 3C

79

N0100000 Naphazoline nitrate

10 mg

0147

Yes

+5C 3C

79

New Y0001571 Naloxone impurity D

Council of Europe, all rights reserved 2015

1451

1594

Batch 1 is valid until 31 October 2015

N-(3-butenyl)-noroxymorphone

54

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
N0200000 Naphazoline impurity A

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
5
15 mg
1 N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide
(naphthylacetylethylenediamine)

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0147,0730

Yes

+5C 3C

0731,1702

Yes

+5C 3C

79

0731,1702

Yes

+5C 3C

79

0731,1702

Yes

+5C 3C

79

N0250000 Naproxen

50 mg

Y0000399 Naproxen (racemic)

10 mg

Y0000631 Naproxen impurity L

10 mg

1-(6-methoxynaphthalen-2-yl)ethanone

Y0001378 Naringin

20 mg

See leaflet CHO

2563

Yes

+5C 3C

79

Y0001437 Nateglinide

200 mg

See leaflet CHNO

2575

Yes

+5C 3C

79

Y0001440 Nateglinide impurity A

10 mg

trans-4-(1-methylethyl)cyclohexanecarboxylic acid

2575

Yes

+5C 3C

79

Y0001441 Nateglinide impurity B

15 mg

N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (Lphenylalanine isomer)

2575

Yes

+5C 3C

79

Y0001442 Nateglinide impurity C

10 mg

N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)

2575

Yes

+5C 3C

79

N0300000 Neamine

0.5 mg

see leaflet ; Batch 4 is valid until 30 April 2015

0180,0197

Yes

+5C 3C

79

N0399000 Neohesperidin-dihydrochalcone

125 mg

See leaflet CHO

1547

Yes

-20C 5C

79

N0399004 Neohesperidin-dihydrochalcone impurity B

10 mg

See leaflet CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --Dglucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1benzopyran-4-one (neodiosmin)

1547

Yes

+5C 3C

79

N0400000 Neomycin sulfate

50 mg

Not to be used for microbiological assay

0032,0033,0
053,
0180,0197,0
485, 0645

Yes

-20C 5C

79

N0401000 Neomycin sulfate for microbiological assay

25 mg

See leaflet

20702

Yes

-20C 5C

79

N0500000 Neostigmine bromide

50 mg

0046

Yes

+5C 3C

79

N0550000 Neostigmine metilsulfate

50 mg

0626

Yes

+5C 3C

79

Y0001639 Neostigmine impurity A

0.0025 mg

0046,0626

Yes

+5C 3C

79

N0559000 Netilmicin sulfate

25 mg

See leaflet; This Reference Standard will be removed from monographs 1351
on 01/07/2015.

1351,20702

Yes

-20C 5C

79

Y0000520 Nevirapine (Anhydrous)

30 mg

See leaflet CHNO

2255, 2479

Yes

+5C 3C

79

Y0001499 Nevirapine hemihydrate

15 mg

2479

Yes

+5C 3C

79

Y0000521 Nevirapine for peak identification

0.058 mg

2255, 2479

Yes

+5C 3C

79

Y0000388 Newcastle Disease Vaccine (inactivated) BRP

40 mg

0870

Yes

-20C 5C

180

Y0001373 Nicergoline

50 mg

1998

Yes

+5C 3C

79

Y0001356 Nicergoline impurity D

20 mg

1998

Yes

+5C 3C

79

Y0001362 Nicergoline for peak identification

1 mg

1998

Yes

+5C 3C

79

Y0001352 Nicergoline for system suitability

10 mg

1998

Yes

+5C 3C

79

N0560000 Niclosamide (anhydrous)

50 mg

0679,0680

Yes

+5C 3C

79

New Y0001761 Nicorandil

5 mg

2332

Yes

-20C 5C

79

New Y0001762 Nicorandil impurity A

5 mg

2332

Yes

-20C 5C

79

Council of Europe, all rights reserved 2015

Batch 2 is valid until 31 August 2015

The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody
5-bromopyridine-3-carboxylic acid

55

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
N0600000 Nicotinamide

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
50 mg
1

Information

Monograph Leaflet
0047

Storage

Extra
Price
charges
79
a

Yes

+5C 3C

79

1792

Yes

+5C 3C

79

N0590000 Nicotine - reference spectrum

n/a

N0590200 Nicotine ditartrate

120 mg

Y0001425 Nicotine ditartrate dihydrate

15 mg

2599

Yes

+5C 3C

79

Y0001023 Nicotine for system suitability

1 mg

1452, 1792,
2599

Yes

-20C 5C

79

N0700000 Nicotinic acid

100 mg

0459

Yes

+5C 3C

79

Y0001268 Nicotinic acid impurity mixture

0.12 mg

0459

Yes

+5C 3C

79

N0750000 Nifedipine

50 mg

0627,1013

Yes

+5C 3C

79

N0750010 Nifedipine impurity A

25 mg

Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate

0627

Yes

+5C 3C

79

N0750015 Nifedipine impurity B

25 mg

Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate

0627

Yes

+5C 3C

79

Y0000824 Niflumic acid

10 mg

2115

Yes

+5C 3C

79

Y0000825 Niflumic acid impurity A

10 mg

2-chloropyridine-3-carboxylic acid

2115

Yes

+5C 3C

79

Y0000826 Niflumic acid impurity B

10 mg

2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide

2115

Yes

+5C 3C

79

Y0000827 Niflumic acid impurity E

15 mg

6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid

2115

Yes

+5C 3C

79

Y0000836 Nifuroxazide

10 mg

1999

Yes

+5C 3C

79

N0800000 Nikethamide

1 ml

0233

Yes

+5C 3C

79

Y0000829 Nilutamide

110 mg

See leaflet CHFNO

2256

Yes

+5C 3C

79

Y0000894 Nilutamide impurity B

5 mg

4-nitro-3-(trifluoromethyl)aniline

2256

Yes

+5C 3C

79

N0845000 Nimesulide

100 mg

1548

Yes

+5C 3C

79

N0845008 Nimesulide impurity D

0.004 mg

1548

Yes

+5C 3C

79

Y0001237 Nimesulide for peak identification

10 mg

1548

Yes

+5C 3C

79

N0850000 Nimodipine

50 mg

1245

Yes

+5C 3C

79

N0850010 Nimodipine impurity A

1 mL

2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)


pyridine-3,5-dicarboxylate

1245

Yes

+5C 3C

79

N0900000 Nitrazepam - * psy

100 mg

Batch 1 is valid until 30 September 2015

0415,0898

Yes

+5C 3C

79

N0905000 Nitrendipine

60 mg

1246

Yes

+5C 3C

79

N0905005 Nitrendipine impurity A

30 mg

1246

Yes

+5C 3C

79

Y0001456 Nitrendipine for peak identification

10 mg

1246

Yes

+5C 3C

79

N0930000 Nitric oxide - reference spectrum

n/a

1550

79

N0950000 Nitrofural

150 mg

See leaflet CHNO ; Batch 1 is valid until 31 August 2015

1135

Yes

+5C 3C

79

Y0001570 Nitrofural impurity B

30 mg

See leaflet CHON; (5-nitrofuran-2-yl)methylene diacetate

1135

Yes

+5C 3C

79

Y0001377 Nitrofural for peak identification

0.11 mg

1135

Yes

+5C 3C

79

N1000000 Nitrosotriaminopyrimidine

50 mg

0058

Yes

+5C 3C

79

N1090000 Nizatidine

250 mg

1453

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

1452,1792
See leaflet CHN x 2 CHO

4-nitro-2-phenoxyaniline

ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate;


(nitrophenylpyridine analogue)

See leaflet CHNOS


56

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
N1090060 Nizatidine impurity F

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 (EZ)-N-methyl-N'-[2-[[[4-[[[2-[[(EZ)-1-(methylamino)-2-nitroethenyl]amino]
ethyl]sulfanyl]methyl]thiazol-2-yl]methyl]sulfanyl]ethyl]-2-nitroethene-1,1diamine

Monograph Leaflet

Storage

1453

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001278 Nizatidine for system suitability

10 mg

1453

Yes

+5C 3C

79

N1080000 Nomegestrol acetate

100 mg

1551

Yes

+5C 3C

79

N1080005 Nomegestrol acetate impurity A

50 mg

Y0001314 1-nonadecanol

425 mg

Y0000670 Nonivamide

10 mg

Y0000755 Nonoxinol 9

10 mg

N1100000 Noradrenaline tartrate

Y0000681 Noradrenaline impurity D


Y0000682 Noradrenaline impurity E

1551

Yes

+5C 3C

79

0801,0802,0
847

Yes

+5C 3C

79

1859,2336,2
337, 2529

Yes

+5C 3C

79

1454

Yes

+5C 3C

79

200 mg

0254,0285,0
732, 2303

Yes

+5C 3C

79

15 mg

+5C 3C

79

10 mg

4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) 0285,0732


2-chloro-1-(3,4-dihydroxyphenyl)ethanone
0285,0732

Yes

Yes

+5C 3C

79

Y0000686 Noradrenaline impurity F

10 mg

N-benzyl-1-phenylmethanamine

0285,0732

Yes

+5C 3C

79

N1130000 Norcyclobenzaprine

25 mg

0941

Yes

+5C 3C

79

N1140000 Nordazepam -* psy

50 mg

Dipotassium clorazepate impurity B. This reference standard will be deleted


from mono 1466 on july 2015 1st

0898,1466

Yes

+5C 3C

79

N1200000 Norethisterone

25 mg

Batch 2 is valid until 30 November 2014

0234,1212,0
926

Yes

+5C 3C

79

Y0000522 Norethisterone for system suitability

10 mg

0234

Yes

-20C 5C

79

N1225000 Norethisterone acetate

100 mg

0850

Yes

+5C 3C

79

Y0001532 Norethisterone acetate for system suitability

2.585 mg

0850

Yes

+5C 3C

79

N1230000 Norfloxacin

50 mg

1248

Yes

+5C 3C

79

N1230010 Norfloxacin impurity A

20 mg

1460

Yes

+5C 3C

79

Y0001301 Norfloxacin for peak identification

10 mg

1248

Yes

+5C 3C

79

Y0001015 Norfloxacin for system suitability

8 mg

1248

Yes

+5C 3C

79

Y0001609 Norflurane - reference spectrum

1 mg

79

Y0000724 Norgestimate

10 mg

1732

Yes

+5C 3C

79

Y0000725 Norgestimate for system suitability

5 mg

1732

Yes

+5C 3C

79

N1250000 Norgestrel

30 mg

0940

Yes

+5C 3C

79

N1279000 Norpseudoephedrine hydrochloride - * psy

50 mg

0683

Yes

+5C 3C

79

N1280000 Nortriptyline hydrochloride

10 mg

0941

Yes

+5C 3C

79

Y0001296 Nortriptyline for system suitability

20 mg

0941

Yes

+5C 3C

79

N1300000 Noscapine

100 mg

0102,0515,0
516

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

6alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate

See leaflet CHNO

7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(corresponding also to pefloxacin impurity F)

Cathine hydrochloride

57

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
N1400000 Nystatin

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
7
100 mg
1 See leaflet

O0100900 Octoxinol 10

Y0000368 Octyl gallate


O0101000 Octyldodecanol

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
c

0517,1292,2
0702

Yes

-20C 5C

1553

Yes

+5C 3C

79

2057

Yes

+5C 3C

79

1136

Yes

+5C 3C

79

300 mg

30 mg

400 mg

O0120000 Ofloxacin

50 mg

1455

Yes

+5C 3C

79

O0120010 Ofloxacin impurity A

20 mg

(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]
benzoxazine-6-carboxylic acid (FPA) ; Batch 2 is valid until 31 August 2015

1455

Yes

+5C 3C

79

O0120050 Ofloxacin impurity E

20 mg

(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido
[1,2,3-de][1,4]benzoxazine-6-carboxylic acid

1455

Yes

+5C 3C

79

Y0001370 Olanzapine

200 mg

See leaflet ; Batch 1 is valid until 30 September 2015

2258

Yes

+5C 3C

79

Y0001392 Olanzapine impurity A

5 mg

5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile

2258

Yes

+5C 3C

79

Y0001380 Olanzapine for system suitability

10 mg

2258

Yes

+5C 3C

79

Y0001204 Oleanolic acid

20 mg

See leaflet

2463

Yes

+5C 3C

79

Y0001479 Oleic acid

2000 mg

See leaflet CHO

2579, 1848

Yes

+5C 3C

79

Y0000805 Oleuropein

20 mg

See leaflet CHO

1878

Yes

+5C 3C

79

Y0001405 Olmesartan medoxomil

100 mg

see leaflet ; Batch 1 is valid until 31 May 2015

2600

Yes

+5C 3C

79

Y0001424 Olmesartan medoxomil for system suitability

10 mg

Batch 1 is valid until 31 July 2014

2600

Yes

+5C 3C

79

O0146000 Olsalazine sodium

70 mg

1457

Yes

+5C 3C

79

O0146010 Olsalazine sodium for performance test

60 mg

O0150000 Omeprazole

50 mg

Y0001043 Omeprazole magnesium

10 mg

O0151000 Omeprazole impurity D

10 mg

Y0000218 Ondansetron hydrochloride dihydrate

Y0001042 Omeprazole for peak identification

Y0001345 Ondansetron impurity A

See leaflet CHO

1457

Yes

+5C 3C

79

See leaflet

0942,1032,2
372,
2374,2787

Yes

-20C 5C

79

2374

Yes

+5C 3C

79

Omeprazole sulphone

0942,1032,
2372, 2374,
2787

Yes

-20C 5C

79

200 mg

See leaflet CHClNO

10 mg

10 mg

Y0000195 Ondansetron impurity D

15 mg

Y0001326 Ondansetron impurity E

Y0001320 Ondansetron impurity F

Y0001346 Ondansetron impurity G


Y0000197 Ondansetron for LC system suitability
Council of Europe, all rights reserved 2015

2016

Yes

+5C 3C

79

0942, 1032,
2372, 2374,
2787

Yes

-20C 5C

79

(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one

2016

Yes

+5C 3C

79

9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one ; Batch 2 is valid


until 31 August 2014

2016

Yes

+5C 3C

79

10 mg

Imidazole

2016

Yes

+5C 3C

79

10 mg

2016

Yes

+5C 3C

79

10 mg

2016

Yes

+5C 3C

79

10 mg

(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one (C-demethylondansetron)
58

79
2016
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000196 Ondansetron for TLC system suitability

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
2
30 mg
1 Batch 1 is valid until 30 September 2015

Monograph Leaflet

Storage

2016

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001125 Orbifloxacin

200 mg

2259

Yes

+5C 3C

79

Y0001147 Orbifloxacin impurity mixture

0.0008 mg

2259

Yes

+5C 3C

79

O0180000 Orciprenaline sulfate

100 mg

1033,1332

Yes

+5C 3C

79

Y0000895 Orciprenaline for system suitability

5 mg

1033

Yes

+5C 3C

79

Y0001501 Orientvine stem HRS

600 mg

2450

Yes

+5C 3C

79

Y0000101 Orphenadrine citrate

100 mg

1759

Yes

+5C 3C

79

Y0000100 Orphenadrine hydrochloride

100 mg

Y0000102 Orphenadrine impurity E

60 mg

Y0001181 Orphenadrine for peak identification

0.42 mg

Y0001337 Oseltamivir phosphate (impurity B free)

300 mg

Y0001338 Oseltamivir impurity A

10 mg

Y0001339 Oseltamivir impurity B

10 mg

Y0001340 Oseltamivir impurity C

Y0001341 Oseltamivir impurity H

Y0001207 Osthole
O0200000 Ouabain

1760

Yes

+5C 3C

79

1759,1760

Yes

+5C 3C

79

1759,1760

Yes

+5C 3C

79

See leaflet CHNOP

2422

Yes

+5C 3C

79

(3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid

2422

Yes

+5C 3C

79

ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate

2422

Yes

+5C 3C

79

10 mg

(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid

2422

Yes

+5C 3C

79

30 mg

tributylphosphane oxide

2422

Yes

+5C 3C

79

20 mg

See leaflet CHO

2557

Yes

+5C 3C

79

150 mg

See leaflet CHO

0048

Yes

+5C 3C

79

Y0000638 Oxacillin sodium monohydrate

110 mg

See leaflet CHNNaOS

2260

Yes

+5C 3C

79

Y0000560 Oxacillin for peak identification

10 mg

2260

Yes

+5C 3C

79

Y0000271 Oxaliplatin

250 mg

See leaflet CHNOPt

2017

Yes

+5C 3C

79

Y0000272 Oxaliplatin impurity B

22 mg

See leaflet CHNOPtS; ditosylato diaminocyclohexane platinum complex

2017

Yes

+5C 3C

79

New Y0000273 Oxaliplatin impurity C

25 mg

(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethane-dioato(2-)kO1,kO2]dihydroxyplatinum ; Batch 5 is valid until 31 October 2015

2017

Yes

+5C 3C

79

Y0000274 Oxaliplatin impurity D

10 mg

(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin)

2017

Yes

+5C 3C

79

O0225000 Oxazepam - * psy

50 mg

0778

Yes

+5C 3C

79

Y0000543 Oxazepam for peak identification

0.008 mg

0778

Yes

+5C 3C

79

Y0001576 Oxcarbazepine

120 mg

2577

Yes

+5C 3C

79

Y0001549 Oxcarbazepine impurity mixture

0.008 mg

2577

Yes

+5C 3C

79

Y0000350 Oxeladin hydrogen citrate

50 mg

1761

Yes

+5C 3C

79

Y0000404 Oxeladin impurity C

10 mg

2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate

1761

Yes

+5C 3C

79

Y0000390 Oxeladin impurity D

20 mg

2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate

1761

Yes

+5C 3C

79

O0225800 Oxfendazole CRS

50 mg

1458

Yes

+5C 3C

79

Y0000224 Oxfendazole impurity B

10 mg

1458

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (metamethylbenzyl isomer)

See leaflet CHNO

See leaflet; methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate


59

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000225 Oxfendazole with impurity D

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
10 mg
1

Information

Monograph Leaflet

Storage

1458

Yes

+5C 3C

Extra
Price
charges
79
a

O0260000 Oxibendazole

100 mg

1386

Yes

+5C 3C

79

Y0000709 Oxitropium bromide

50 mg

2170

Yes

+5C 3C

79

Y0000715 Oxitropium bromide impurity B

15 mg

(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)

2170

Yes

+5C 3C

79

Y0000713 Oxitropium bromide impurity D

10 mg

(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)

2170

Yes

+5C 3C

79

O0240000 Oxolinic acid

50 mg

1353

Yes

+5C 3C

79

O0240005 Oxolinic acid impurity A

20 mg

8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid

1353

Yes

+5C 3C

79

O0240010 Oxolinic acid impurity B

20 mg

ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate

O0250000 Oxprenolol hydrochloride

50 mg

O0270000 Oxybuprocaine hydrochloride

100 mg

O0288000 Oxybutynin hydrochloride

50 mg

O0288005 Oxybutynin impurity A

20 mg

Y0000492 Oxycodone hydrochloride - * narc

100 mg

Y0000453 Oxycodone impurity D

50 mg

O0290000 Oxymetazoline hydrochloride

80 mg

Y0001044 Oxymetazoline impurity A

15 mg

N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]
acetamide

O0400000 Oxytetracycline

100 mg

See leaflet CHNO

O0500000 Oxytetracycline hydrochloride

20 mg

O0700000 Oxytocin

41 mg

O0770000 Oxytocin/Desmopressin validation mixture

20 mg

Y0000698 Paclitaxel

40 mg

Y0000699 Paclitaxel impurity C

5 mg

Y0000700 Paclitaxel natural for peak identification

10 mg

Y0000719 Paclitaxel semi-synthetic for peak identification

10 mg

Y0000739 Paclitaxel semi-synthetic for system suitability

1.013 mg

P0090000 Palmitic acid

100 mg

Y0000524 Pamidronate disodium pentahydrate

10 mg

Y0001632 Pancreas powder (amylase) BRP

2000 mg

See leaflet

Y0001631 Pancreas powder (lipase) BRP

2000 mg

P0200000 Pancreas powder (protease) BRP

2000 mg

Council of Europe, all rights reserved 2015

1353

Yes

+5C 3C

79

0628,0876,1
072

Yes

+5C 3C

79

Batch 1 is valid until 30 November 2014

1251

Yes

+5C 3C

79

Batch 1 is valid until 31 July 2014

1354

Yes

+5C 3C

79

See leaflet CHClNO; 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3enyl)-2- cyclohexyl-2-hydroxyacetate hydrochloride

1354

Yes

+5C 3C

79

1784, 1793

Yes

+5C 3C

79

1793

Yes

+5C 3C

79

0943

Yes

+5C 3C

79

0943

Yes

+5C 3C

79

0198,0199

Yes

+5C 3C

79

0198,1030

Yes

+5C 3C

79

0779,0780

Yes

-20C 5C

90

0712,0779,0
780

Yes

-20C 5C

79

See leaflet CHNO

1794

Yes

+5C 3C

79

N-debenzoyl-N-hexanoylpaclitaxel

1794

Yes

+5C 3C

79

1794

Yes

+5C 3C

79

1794

Yes

+5C 3C

79

1794

Yes

+5C 3C

79

0229,0882,1
474,
1663,2058

Yes

+5C 3C

79

1779

Yes

+5C 3C

79

0350

Yes

+5C 3C

79

See leaflet

0350

Yes

+5C 3C

79

See leaflet

0350

Yes

+5C 3C

79

7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17methylmorphinan-6-one (14-hydroxycodeinone)

see leaflet ; Batch 4 is valid until 31 January 2015

Batch 1 is valid until 31 March 2015

60

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P0250000 Pancuronium bromide

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
20 mg
1 Vecuronium impurity B

Information

Monograph Leaflet

Storage

0681,1769

Yes

+5C 3C

Extra
Price
charges
79
a

Y0000577 Pancuronium bromide for system suitability

20 mg

0681

Yes

+5C 3C

79

Y0000835 Pantoprazole sodium sesquihydrate

20 mg

2296

Yes

+5C 3C

79

New Y0001001 Pantoprazole for system suitability

0.506 mg

2296

Yes

+5C 3C

79

P0270000 Papaverine hydrochloride

25 mg

0102,0573

Yes

+5C 3C

79

P0300000 Paracetamol

50 mg

0049

Yes

+5C 3C

79

Y0000780 Paraffin (hard)

10 mg

1034

Yes

+5C 3C

79

Y0000058 Paraffin (liquid) - reference spectrum

n/a

0239,0240

79

Y0000913 Paraffin (White soft)

10 mg

1799

Yes

+5C 3C

79

Y0000912 Paraffin (Yellow soft)

10 mg

1554

Yes

+5C 3C

79

P0305000 Parnaparin sodium

200 mg

1252

Yes

+5C 3C

79

Y0000578 Paroxetine hydrochloride (anhydrous)

100 mg

2283

Yes

+5C 3C

79

Y0000579 Paroxetine hydrochloride (anhydrous) impurity C

10 mg

(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluo- rophenyl)
piperidine (N-benzylparoxetine)

2283

Yes

+5C 3C

79

Y0000581 Paroxetine hydrochloride (anhydrous) impurity H

10 mg

[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol

2283

Yes

+5C 3C

79

Y0000281 Paroxetine hydrochloride hemihydrate

200 mg

See leaflet CHClFNO

2018,2283

Yes

+5C 3C

79

Y0000233 Paroxetine impurity A

15 mg

(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine
(desfluoroparoxetine) ; Batch 4 is valid until 30 September 2015

2018,2283

Yes

+5C 3C

79

New Y0000256 Paroxetine impurity D

10 mg

See leaflet; (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)


piperidine
((+)-trans-paroxetine) ; Batch 2 is valid until 30 October 2015

2018,2283

Yes

+5C 3C

79

Y0000580 Paroxetine impurity E

5 mg

(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophe- nyl)piperidine
(cis-paroxetine)

2283

Yes

+5C 3C

79

Y0000630 Paroxetine for system suitability

5 mg

2018

Yes

+5C 3C

79

P0309000 Pefloxacin mesilate dihydrate

200 mg

1460

Yes

+5C 3C

79

P0309020 Pefloxacin impurity B

10 mg

1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydro- quinoline-3carboxylic acid (chlorinated homologue of pefloxacin)

1460

Yes

+5C 3C

79

P0309030 Pefloxacin impurity C

0.01 mg

1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydro- quinoline-3carboxylic acid (isopefloxacin)

1460

Yes

+5C 3C

79

Y0001539 Pemetrexed disodium heptahydrate

200 mg

See leaflet

2637

Yes

+5C 3C

79

Y0001538 Pemetrexed for system suitability

20 mg

2637

Yes

+5C 3C

79

2637

Yes

+5C 3C

79

1461

Yes

+5C 3C

79

1461

Yes

+5C 3C

79

New Y0001535 Pemetrexed impurity mixture

Batch 5 is valid until 31 October 2015

0.002 mg

P0307000 Penbutolol sulfate

100 mg

P0307005 Penbutolol impurity A

20 mg

P0310000 Penicillamine

100 mg

0566

Yes

+5C 3C

79

P0320000 Penicillamine disulfide

100 mg

See leaflet CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3methylbutanoic] acid

0566

Yes

+5C 3C

79

P0400100 Pentaerythrityl tetranitrate diluted

600 mg

See leaflet CHNO

1355

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

Batch 1 is valid until 31 December 2015


See leaflet CHNO; (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1dimethylethyl) amino]propan-2-ol

61

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P0405000 Pentamidine diisetionate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
30 mg
1

Information

Monograph Leaflet
1137,1436

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

P0405500 Pentazocine - reference spectrum

n/a

1462

79

P0405510 Pentazocine hydrochloride - reference spectrum

n/a

1463

79

Y0000417 Pentazocine lactate - reference spectrum

n/a

2000

Y0001051 Pentetate sodium calcium

100 mg

2353

Yes

+5C 3C

P0500000 Pentobarbital - * psy

500 mg

0200,0419

Yes

P0510000 Pentoxifylline

100 mg

0851

Yes

Y0000076 Pentoxyverine hydrogen citrate - reference spectrum

n/a

Y0000098 Pentoxyverine impurity A

10 mg

1-phenylcyclopentanecarboxylic acid

1621

Y0000099 Pentoxyverine impurity B

10 mg

2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)

P0525000 Pepsin powder

2000 mg

See leaflet

Y0000010 Pergolide mesilate

150 mg

See leaflet CHNOS

Y0000238 Perindopril tert-butylamine

40 mg

Y0000237 Perindopril impurity A

10 mg

Y0000771 Perindopril for peak identification

5 mg

Y0000207 Perindopril for stereochemical purity

40 mg

Y0001733 Permethrin (25:75)

350 mg

Y0001741 Permethrin for system suitability

60 mg

P0550000 Perphenazine

100 mg

Y0001045 Perphenazine for system suitability

5 mg

Y0000021 Pertussis toxin BRP

0.05 mg

P0600000 Pethidine hydrochloride - reference spectrum

n/a

P0600002 Pethidine impurity A

20 mg

P0800000 Phenazone

20 mg

Y0001138 Phenazone impurity A

20 mg

P0850000 Pheniramine maleate

250 mg

Y0001428 Pheniramine impurity A

20 mg

P0900000 Phenobarbital - * psy

200 mg

Y0001350 Phenobarbital impurity A

15 mg

Y0001351 Phenobarbital impurity B

15 mg

P0950000 Phenoxyethanol

1 mL

P1000000 Phenoxymethylpenicillin

250 mg

Council of Europe, all rights reserved 2015

79

79

+5C 3C

79

+5C 3C

79

79

Yes

+5C 3C

79

1621

Yes

+5C 3C

79

0682

Yes

+5C 3C

79

1555

Yes

+5C 3C

79

2019

Yes

+5C 3C

79

2019

Yes

+5C 3C

79

2019

Yes

+5C 3C

79

2019

Yes

+5C 3C

79

1762

Yes

+5C 3C

79

1762

Yes

+5C 3C

79

0629,0904

Yes

+5C 3C

79

0629

Yes

+5C 3C

79

See leaflet,
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329

Yes

-20C 5C

90

79

1621

(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid

see leaflet

See leaflet

0420
1-methyl-4-phenylpiperidine (MPP)
5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one

0420

Yes

+5C 3C

79

0421

Yes

+5C 3C

79

0421

Yes

+5C 3C

79

1357, 0977

Yes

+5C 3C

79

1357

Yes

+5C 3C

79

0189,0201,0
630

Yes

+5C 3C

79

0201

Yes

+5C 3C

79

0201

Yes

+5C 3C

79

0781

Yes

+5C 3C

79

0148

Yes

+5C 3C

79

2-benzylpyridine

See leaflet CHNO

62

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P1100000 Phenoxymethylpenicillin potassium

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
4
250 mg
1 See leaflet CHKNOS

Y0001127 Phentolamine mesilate

P1109000 Phentolamine mesilate - reference spectrum


Y0001251 Phentolamine for system suitability
P1150000 Phenylalanine
P1200000 Phenylbutazone

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0113,0114,0
148, 0149

Yes

+5C 3C

Yes

+5C 3C

79

10 mg

1138

n/a

1138

79

10 mg

1138

Yes

+5C 3C

79

60 mg

0782,2575

Yes

+5C 3C

79

100 mg

0422,1574

Yes

+5C 3C

79

Y0000147 Phenylbutazone impurity B

20 mg

0422

Yes

+5C 3C

79

P1240000 Phenylephrine

60 mg

1035

Yes

+5C 3C

79

P1250000 Phenylephrine hydrochloride

50 mg

0632,1205

Yes

+5C 3C

79

Y0000683 Phenylephrine hydrochloride for peak identification

2.0044 mg

0632,1035

Yes

+5C 3C

79

Y0000229 Phenylmercuric acetate - reference spectrum

n/a

2042

79

P1255100 Phenylmercuric borate - reference spectrum

n/a

0103

79

P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor

50 mg

P1290000 Phenytoin

100 mg

P1300000 Phenytoin sodium

250 mg

Y0001167 Phenytoin for system suitability

20 mg

Y0000493 Phloroglucinol (anhydrous)

220 mg

Y0000761 Pholcodine - * narc

10 mg

Y0000798 Pholcodine for peak identification - * narc

10 mg

Y0000766 Phthalic acid

20 mg

P1500000 Phthalylsulfathiazole

100 mg

P1600000 Physostigmine salicylate

100 mg

P1609000 Phytomenadione

150 mg

Y0001104 Picosulfate for system suitability

0.5 mg

P1645000 Picotamide monohydrate

125 mg

P1645005 Picotamide impurity A

25 mg

Y0001508 Picrotin

40 mg

Y0001528 Picrotoxinin

40 mg

See leaflet CHO

Y0000124 Pidolate impurity B

110 mg

(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentane-dioic acid

Y0000123 Pidolic acid

125 mg

P1650000 Pilocarpine hydrochloride

50 mg

P1700000 Pilocarpine nitrate

50 mg

Y0000106 Pilocarpine nitrate for system suitability

Y0000525 Pimobendan

Y0000401 Pimobendan for system suitability

Council of Europe, all rights reserved 2015

(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione

Batch 3 is valid until 31 May 2015

Norephedrin hydrochloride

0683

Yes

+5C 3C

79

1253,1988

Yes

+5C 3C

79

0521

Yes

+5C 3C

79

0521,1253

Yes

+5C 3C

79

2301,2302

Yes

+5C 3C

79

0522

Yes

+5C 3C

79

0522

Yes

+5C 3C

79

2348

Yes

+5C 3C

79

0352

Yes

+5C 3C

79

0286

Yes

+5C 3C

79

1036

Yes

+5C 3C

79

1031

Yes

+5C 3C

79

1358

Yes

+5C 3C

79

1358

Yes

+5C 3C

79

2486

Yes

+5C 3C

79

2486

Yes

+5C 3C

79

1619

Yes

+5C 3C

79

1619

Yes

+5C 3C

79

0633

Yes

+5C 3C

79

0104

Yes

+5C 3C

79

20 mg

0104,0633

Yes

+5C 3C

79

10 mg

2179

Yes

+5C 3C

79

0.1 mg

2179

Yes

+5C 3C

79

Batch 1 is valid until 30 September 2015


Batch 1 is valid until 30 June 2015

benzene-1,2-dicarboxylic acid

see leaflet; Vitamin K1

4-methoxybenzene-1,3-dicarboxylic acid

63

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
P1750000 Pimozide

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
150 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1254

Yes

+5C 3C

0634,0871

Yes

+5C 3C

79

2601

Yes

+5C 3C

79

P1800000 Pindolol

100 mg

Y0001520 Pioglitazone hydrochloride

120 mg

Y0001519 Pioglitazone for system suitability

15 mg

2601

Yes

+5C 3C

79

Y0001476 Pipemidic acid trihydrate

15 mg

1743

Yes

+5C 3C

79

Y0000061 Pipemidic acid trihydrate - reference spectrum

n/a

79

P1890000 Piperacillin

100 mg

1168,1169

Yes

+5C 3C

79

P1900000 Piperazine adipate

250 mg

0423

Yes

+5C 3C

79

P2000000 Piperazine citrate

250 mg

0424

Yes

+5C 3C

79

P2100000 Piperazine hydrate

250 mg

0425

Yes

+5C 3C

79

Y0001217 Piperine

30 mg

See leaflet CHNO

2453,2477

Yes

+5C 3C

79

Y0000288 Piracetam

150 mg

See leaflet CHNO

1733

Yes

+5C 3C

79

Y0000038 Pirenzepine dihydrochloride monohydrate

250 mg

2001

Yes

+5C 3C

79

P2120000 Piretanide

100 mg

1556

Yes

+5C 3C

79

Y0001458 Piretanide for system suitability

10 mg

1556

Yes

+5C 3C

79

P2130000 Piroxicam

50 mg

0944

Yes

+5C 3C

79

Y0001475 Piroxicam for system suitability

15 mg

0944

Yes

+5C 3C

79

P2150000 Pivampicillin

50 mg

see leaflet

0808,0852

Yes

+5C 3C

79

P2152000 Pivmecillinam hydrochloride

100 mg

See leaflet CHClNOS

1359

Yes

-20C 5C

79

P2152015 Pivmecillinam impurity C

10 mg

methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)


methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate

1359

Yes

+5C 3C

79

P2155001 Plastic additive 01

2 ml

(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate

90001,9000
2, 30114

Yes

+5C 3C

79

P2155003 Plastic additive 03

100 mg

N,N'-ethylenedialcanamide

90001,30114

Yes

+5C 3C

79

E0800000 Plastic additive 04

500 mg

Epoxidised soya oil

90001,30114

Yes

+5C 3C

79

P2155005 Plastic additive 05

500 mg

Epoxidised linseed oil

90001,30114

Yes

+5C 3C

79

P2155008 Plastic additive 08

500 mg

ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]

Yes

+5C 3C

79

P2155009 Plastic additive 09

250 mg

See leaflet; pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)


propionate]

30103,3010
4,
30105,3010
30103,3010

Yes

+5C 3C

79

P2155010 Plastic additive 10

250 mg

4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1dimethylethyl)phenol]

Yes

+5C 3C

79

P2155011 Plastic additive 11

500 mg

Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate

Yes

+5C 3C

79

P2155012 Plastic additive 12

250 mg

Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R

Yes

+5C 3C

79

P2155013 Plastic additive 13

250 mg

1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5triazine-2,4,6-trione

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet CHClNOS

1743
See leaflet CHNOS

64

5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5, 30106

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P2155014 Plastic additive 14

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
2
250 mg
1 2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R

Monograph Leaflet

Storage

Extra
Price
charges
79
a

30103,3010
5, 30106

Yes

+5C 3C

30103,3010
4,
30105,3010
30103,3010

Yes

+5C 3C

79

Yes

+5C 3C

79

30103,3010
5, 30106

Yes

+5C 3C

79

30103

Yes

+5C 3C

79

30103,3010
5,
30106,3010
30103,

Yes

+5C 3C

79

Yes

+5C 3C

79

Yes

+5C 3C

79

P2155015 Plastic additive 15

500 mg

Dioctadecyl disulphide

P2155016 Plastic additive 16

250 mg

Didodecyl 3,3'-thiodipropionate R

P2155017 Plastic additive 17

250 mg

Dioctadecyl 3,3'-thiodipropionate R

P2155018 Plastic additive 18

50 mg

O0140000 Plastic additive 20

100 mg

Oleamide R

E1260000 Plastic additive 21

100 mg

Erucamide R

P2155022 Plastic additive 22

100 mg

Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6tetramethylpiperidin-4-ol


Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6tetramethylpiperidin-1-yl)ethanol

P2155023 Plastic additive 23

200 mg

di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.

30110,30111

Yes

+5C 3C

79

P2160000 Poliomyelitis vaccine (inactivated) BRP

0.5 ml

See leaflet

0214,2066,2
065,
2328,2061,2
067,
1934,2329,2
0720

Yes

-80C 10C

90

P2161000 Poliomyelitis vaccine (oral) BRP

1 ml

See leaflet

See leaflet,
0215

Yes

-20C 5C

90

P2163920 Poloxamer 124

30 mg

1464

Yes

+5C 3C

79

P2164009 Poloxamer 188

100 mg

1464

Yes

+5C 3C

79

P2164020 Poloxamer 237

100 mg

1464

Yes

+5C 3C

79

P2164021 Poloxamer 338

100 mg

1464

Yes

+5C 3C

79

P2164030 Poloxamer 407

100 mg

1464

Yes

+5C 3C

79

Y0001557 Poly (vinyl acetate)

100 mg

1962

Yes

+5C 3C

79

Y0000792 Poly(vinyl acetate) dispersion 30 per cent

1500 mg

2152

Yes

+5C 3C

79

Y0001550 Poly(vinyl alcohol)

100 mg

1961

Yes

+5C 3C

79

P2600000 Poly(vinyl chloride)

100 mg

90001,9000
2, 30114

Yes

+5C 3C

79

P2170000 Polyacrylate - reference spectrum

n/a

79

P2400000 Polymyxin B sulfate

25 mg

see leaflet ; Batch 5 is valid until 31 January 2015

Yes

+5C 3C

79

25 mg

See leaflet

Y0000355 Polymyxin B sulfate for microbiological assay


Council of Europe, all rights reserved 2015

5, 30106

30105,
30106,
30107
30103

0733

65

0203

79
20702
Yes
-20C 5C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001712 Polyoxypropylene stearyl ether

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
250 mg
1

Information

Monograph Leaflet
2602

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

Y0000289 Polysorbate 20 - reference spectrum

n/a

0426

79

Y0000290 Polysorbate 40 - reference spectrum

n/a

1914

79

Y0000291 Polysorbate 60 - reference spectrum

n/a

0427

79

Y0000007 Polysorbate 80 - reference spectrum

n/a

0428

79

P2649610 Potassium clavulanate - reference spectrum

n/a

Y0001168 Potassium clavulanate impurity G

5 mg

Y0000315 Potassium hydrogen aspartate hemihydrate

50 mg

P2650000 Potassium sorbate

100 mg

Y0001275 Potassium sucrose octasulfate

100 mg

P2660000 Povidone

50 mg

Y0000466 Povidone (iodinated)

10 mg

Y0001266 Pramipexole dihydrochloride monohydrate

5 mg

Y0001267 Pramipexole impurity D

5 mg

Y0001187 Pramipexole for system suitability

15 mg

Y0000215 Pravastatin sodium - reference spectrum

n/a

Y0000223 Pravastatin impurity A

0.1 mg

(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin)

2059

Yes

Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine

30 mg

See leaflet CHO

2059

P2669000 Prazepam -* psy

50 mg

P2670000 Praziquantel

200 mg

Y0001533 Praziquantel for system suitability

10 mg

P2680000 Prazosin hydrochloride

30 mg

Batch 1 is valid until 20 January 2015

P2698000 Prednicarbate

100 mg

See leaflet CHO

Y0001630 Prednicarbate for system suitability A

10 mg

P2700000 Prednisolone

150 mg

Y0001359 Prednisolone for peak identification

10 mg

Y0001355 Prednisolone for system suitability

10 mg

P2800000 Prednisolone acetate

120 mg

Y0000582 Prednisolone acetate for peak identification

P2804000 Prednisolone hexanoate

P2805000 Prednisolone pivalate

Council of Europe, all rights reserved 2015

79

1653,1140

1140
Yes

-20C 5C

79

2076

Yes

+5C 3C

79

0618

Yes

+5C 3C

79

1796

Yes

+5C 3C

79

0685

Yes

+5C 3C

79

1142

Yes

+5C 3C

79

2416

Yes

+5C 3C

79

2416

Yes

+5C 3C

79

2416

Yes

+5C 3C

79

2059

79

-20C 5C

79

Yes

-20C 5C

79

1466

Yes

+5C 3C

79

0855

Yes

+5C 3C

79

0855

Yes

+5C 3C

79

0856

Yes

+5C 3C

79

1467

Yes

+5C 3C

79

1467

Yes

+5C 3C

79

0335,0353,0
354, 0735

Yes

+5C 3C

79

0353

Yes

+5C 3C

79

0353

Yes

+5C 3C

79

0734,0736,0
933,
0975,1467,0
334

Yes

+5C 3C

79

10 mg

0734

Yes

+5C 3C

79

10 mg

1212

Yes

+5C 3C

79

120 mg

0734,0736

Yes

+5C 3C

79

Batch 1 is valid until 31 August 2014

See leaflet CHKOS

(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine ; Batch 1 is
valid until 30 September 2015

See leaflet

See leaflet ; Batch 7 is valid until 31 July 2014

Batch 1 is valid until 31 July 2014

66

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P2810000 Prednisolone sodium phosphate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
4
100 mg
1

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0549,0735,0
810

Yes

+5C 3C

0354

Yes

+5C 3C

79

P2900000 Prednisone

100 mg

P2920000 Pregnenolone isobutyrate

200 mg

Batch 5 is valid until 31 May 2015

0593,0993,2
397

Yes

-20C 5C

79

Y0000263 Prekallikrein activator in albumin BRP

200 mg

See leaflet ; Batch 3 is valid until 31 October 2014

See leaflet,
20615

Yes

-20C 5C

90

P2939000 Prilocaine

150 mg

1362

Yes

+5C 3C

79

P2939060 Prilocaine hydrochloride

100 mg

1363

Yes

+5C 3C

79

Y0001408 Prilocaine impurity B

80 mg

2-methylbenzenamine hydrochloride

1362,1363

Yes

+5C 3C

79

P2939025 Prilocaine impurity E

25 mg

(RS)-N-(methylphenyl)-2-(propylamino)propanamide

1362,1363

Yes

+5C 3C

79

Y0001681 Prilocaine for peak identification

20 mg

1363

Yes

+5C 3C

79

P2940000 Primaquine diphosphate

500 mg

0635

Yes

+5C 3C

79

P2950000 Primidone

150 mg

0584

Yes

+5C 3C

79

Y0000369 Primidone for peak identification

10 mg

0584

Yes

+5C 3C

79

P3000000 Probenecid

100 mg

0243

Yes

+5C 3C

79

P3050000 Procainamide hydrochloride

100 mg

0567

Yes

+5C 3C

79

P3090000 Procaine benzylpenicillin

250 mg

P3100000 Procaine hydrochloride

100 mg

P3200000 Prochlorperazine maleate

100 mg

P3300000 Progesterone

110 mg

See leaflet

Y0001667 Progesterone for impurity H identification

20 mg

see leaflet

Y0001666 Progesterone for peak identification

5 mg

Y0001665 Progesterone for system suitability

5 mg

Y0000179 Proguanil hydrochloride - reference spectrum

n/a

Y0000181 Proguanil impurity C

10 mg

1,5-bis(4-chlorophenyl)biguanide

2002

Yes

Y0000182 Proguanil impurity D

10 mg

1,5-bis(1-methylethyl)biguanide

2002

Yes

P3350000 Proline

60 mg

P3390000 Promazine hydrochloride

40 mg

P3400000 Promethazine hydrochloride

50 mg

Y0000769 Promethazine impurity D

15 mg

Y0000797 Promethazine for peak identification

5 mg

P3490000 Propacetamol hydrochloride - reference spectrum

n/a

Y0000455 Propafenone hydrochloride

10 mg

Y0000456 Propafenone impurity B

10 mg

Y0000278 Propanol - reference spectrum

n/a

Council of Europe, all rights reserved 2015

See leaflet

0115

Yes

+5C 3C

79

0050

Yes

+5C 3C

79

0244

Yes

+5C 3C

79

01/2015:0429

Yes

+5C 3C

79

0429

Yes

+5C 3C

79

0429

Yes

+5C 3C

79

0429

Yes

+5C 3C

79

2002

79

+5C 3C

79

+5C 3C

79

See leaflet ; Batch 2 is valid until 31 December 2014

0785

Yes

+5C 3C

79

0475,1365

Yes

+5C 3C

79

0524

Yes

+5C 3C

79

0524

Yes

+5C 3C

79

0524

Yes

+5C 3C

79

1366

79

Batch 1 is valid until 30 September 2014


(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide

(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3phenylprop-2-en-1-one

2103

Yes

+5C 3C

79

2103

Yes

+5C 3C

79

79

2036
67

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000016 Propofol

Reference Standard

Y0000018 Propofol impurity J

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
6
650 mg
1 See leaflet ; Batch 5 is valid until 31 December 2014
4
20 mg
1 2,6-bis (1-methylethyl)-1,4-benzoquinone ; Batch 3 is valid until 31 January
2015

Monograph Leaflet

Storage

Extra
Price
charges
79
a

1558

Yes

+5C 3C

1558

Yes

+5C 3C

79

Y0000017 Propofol for peak identification

0.1 ml

1558

Yes

+5C 3C

79

P3500000 Propranolol hydrochloride

30 mg

0568,0923

Yes

+5C 3C

79

P3600000 Propranolol hydrochloride for performance test

15 mg

0568

Yes

+5C 3C

79

Y0001547 Propylene glycol

150 mg

1403,1804,2
645

Yes

+5C 3C

79

Y0000318 Propylene glycol dilaurate

100 mg

2087

Yes

+5C 3C

79

Y0000319 Propylene glycol monolaurate

100 mg

1915

Yes

+5C 3C

79

P3640000 Propyl gallate

50 mg

Batch 2 is valid until 31 August 2014

1039

Yes

+5C 3C

79

P3650000 Propyl parahydroxybenzoate

150 mg

See leaflet CHO

0431,0852,1
263

Yes

+5C 3C

79

P3700000 Propylthiouracil

100 mg

0525

Yes

+5C 3C

79

P3750000 Propyphenazone

200 mg

0636

Yes

+5C 3C

79

P3760000 Protirelin

5.03 mg

See leaflet CHNO

1144

Yes

-20C 5C

79

P3760020 D-His-Protirelin

0.1 mg

approx. 0.1 mg per vial

1144

Yes

-20C 5C

79

P3800000 Proxyphylline

100 mg

0526

Yes

+5C 3C

79

P3850000 Pseudoephedrine hydrochloride - * Drug Precursor

50 mg

0487,1367

Yes

+5C 3C

79

Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak


identification

100 mg

2108

Yes

+5C 3C

79

Y0001537 Purified quillaia saponins

30 mg

1843

Yes

-20C 5C

79

P3900000 Purpureaglycoside A

25 mg

0117

Yes

+5C 3C

79

P4000000 Purpureaglycoside B

25 mg

0117

Yes

+5C 3C

79

Y0000402 Pyrantel embonate

10 mg

1680

Yes

+5C 3C

79

Y0000403 Pyrantel impurity A

20 mg

1680

Yes

+5C 3C

79

P4050000 Pyrazinamide

30 mg

0859

Yes

+5C 3C

79

P4099900 Pyridostigmine bromide

30 mg

1255

Yes

+5C 3C

79

P4099910 Pyridostigmine impurity A

20 mg

pyridin-3-yl-dimethylcarbamate

1255

Yes

+5C 3C

79

Y0001486 Pyridostigmine impurity B

10 mg

3-hydroxy-1-methylpyridinium

1255

Yes

+5C 3C

79

P4100000 Pyridoxine hydrochloride

100 mg

Batch 1 is valid until 30 April 2015

0245

Yes

+5C 3C

79

Y0001226 Pyridoxine impurity A

5 mg

6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol ; Batch 2 is valid until 31


December 2014

0245

Yes

+5C 3C

79

P4200000 Pyrimethamine

250 mg

0288

Yes

+5C 3C

79

Y0000659 Pyrrolidone

20 mg

2180

Yes

+5C 3C

79

Y0001009 Quercetin dihydrate

25 mg

1827

Yes

+5C 3C

79

Y0001657 Quetiapine fumarate

50 mg

2541

Yes

+5C 3C

79

2.005 mg

Y0001419 Quetiapine for system suitability


Council of Europe, all rights reserved 2015

Star anise oil

1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine

See leaflet CHO ; Batch 2 is valid until 31 July 2015

68

79
2541
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001564 Quillaia saponin for assay

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
30 mg
1 See leaflet CHNO; monoammonium glycyrrhizate

Monograph Leaflet

Storage

1843

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001491 Quinapril hydrochloride

30 mg

1763

Yes

+5C 3C

79

Y0001502 Quinapril for peak identification

5.075 mg

1763

Yes

+5C 3C

79

Y0001503 Quinapril for system suitability

5.125 mg

1763

Yes

+5C 3C

79

Q0100000 Quinidine sulfate

300 mg

0017,0018,0
019

Yes

+5C 3C

79

Q0200000 Quinine sulfate

300 mg

0017,0018,0
019

Yes

+5C 3C

79

R0100000 Rabies vaccine (inactivated) for veterinary use BRP

86 mg

See leaflet

See leaflet,
0451

Yes

-20C 5C

90

Y0000896 Racecadotril

110 mg

See leaflet CHNOS

2171

Yes

+5C 3C

79

Y0000897 Racecadotril impurity A

1.1 mL

See leaflet CHCOSH; ethanethioic acid

2171

Yes

+5C 3C

79

Y0000898 Racecadotril impurity G

10 mg

benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate

2171

Yes

+5C 3C

79

Y0000902 Racecadotril for peak identification

5 mg

2171

Yes

+5C 3C

79

Y0001134 Raloxifene hydrochloride

110 mg

2375

Yes

+5C 3C

79

Y0001135 Raloxifene for peak identification

10 mg

2375

Yes

+5C 3C

79

R0145000 Ramipril

20 mg

1368

Yes

+5C 3C

79

R0145005 Ramipril impurity A

10 mg

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3- phenylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril
methylester)

1368

Yes

+5C 3C

79

R0145010 Ramipril impurity B

10 mg

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole- 2-carboxylic acid (ramipril
isopropyl ester)

1368

Yes

+5C 3C

79

R0145015 Ramipril impurity C

10 mg

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid
(hexahydroramipril)

1368

Yes

+5C 3C

79

R0145020 Ramipril impurity D

10 mg

1368

Yes

+5C 3C

79

R0150000 Ranitidine hydrochloride

100 mg

ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1Hcyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril


diketopiperazine)

0946,1453

Yes

+5C 3C

79

Y0000416 Ranitidine impurity J

0.00025
mg

0946

Yes

-20C 5C

79

Y0000411 Ranitidine for system suitability

20 mg

0946

Yes

-20C 5C

79

Y0001565 Recombinant Major Allergen rBet v 1

0.01025 mg 1

See leaflet

1063

Yes

-20C 5C

90

Y0001566 Recombinant Major Allergen rPhl p 5a

0.00856 mg 1

See leaflet

1063

Yes

-20C 5C

90

Y0000457 Repaglinide

20 mg

2135

Yes

+5C 3C

79

Y0000459 Repaglinide impurity E

10 mg

2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2oxoethyl]benzoic acid

2135

Yes

+5C 3C

79

6 mg

Batch 2 is valid until 31 October 2015

2135

Yes

+5C 3C

79

100 mg

See leaflet CHNO

0528

Yes

+5C 3C

79

1.4 mL

Batch 5 is valid until 30 November 2015


69

New Y0000458 Repaglinide for system suitability


R0200000 Reserpine
New R0250000 Residual solvent solution class 1
Council of Europe, all rights reserved 2015

See leaflet CHClNOS

1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1diamine)

79
20424
Yes
+5C 3C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000767 Resorcinol

Reference Standard

Y0001194 Resveratrol

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
20 mg
1 benzene-1,3-diol
1
20 mg
1 See leaflet CHO

Information

Monograph Leaflet
2348

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

2433

Yes

-20C 5C

79

0218,0219,0
220,
1192,1193,
2398

Yes

-20C 5C

79

0217,0218,0
219, 0220

Yes

+5C 3C

79

2109

Yes

+5C 3C

79

0292,0786

Yes

+5C 3C

79

0292

Yes

+5C 3C

79

0786

Yes

+5C 3C

79

2090

Yes

+5C 3C

79

See leaflet CHNO

1657

Yes

+5C 3C

79

1-(2-methylpropyl)piperidin-4-one

1657

Yes

+5C 3C

79

0052

Yes

+5C 3C

79

0052

Yes

+5C 3C

79

0432,20702

Yes

-20C 5C

79

0432

Yes

+5C 3C

79

0432

Yes

+5C 3C

79

2362

Yes

+5C 3C

79

2362

Yes

+5C 3C

79

79

2020

Yes

+5C 3C

79

2572

Yes

+5C 3C

79

2572

Yes

+5C 3C

79

2572

Yes

+5C 3C

79

1559

Yes

+5C 3C

79

3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone)

1559

Yes

+5C 3C

79

Batch 4 is valid until 30 June 2015

1559

Yes

+5C 3C

79

See leaflet CHNOS

2136

Yes

+5C 3C

79

R0300000 Retinol acetate

1000 mg

R0290000 Retinol esters

100 mg

Y0000377 Ribavirin

150 mg

See leaflet CHNO

R0600000 Riboflavin

130 mg

Vitamin B2

Y0000757 Riboflavin for peak identification

0.12 mg

R0630000 Riboflavin sodium phosphate

250 mg

Y0000662 Ribonucleic acid

100 mg

See leaflet

Y0000149 Rifabutin

150 mg

Y0000184 Rifabutin impurity A

20 mg

R0700000 Rifampicin

100 mg

R0800000 Rifampicin quinone

100 mg

R1000000 Rifamycin sodium

150 mg

see leaflet CHNNaO ; Batch 3 is valid until 30 September 2015

R0900000 Rifamycin B

25 mg

See leaflet CHNO; Rifamycin impurity A ; Batch 2 is valid until 31 July


2015

R0950000 Rifamycin S

100 mg

Y0001074 Rifaximin

160 mg

Y0001075 Rifaximin for system suitability

10 mg

Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum

n/a

2020

Y0000187 Rilmenidine for system suitability

30 mg

Y0001541 Risedronate sodium 2.5-hydrate

15 mg

Y0001558 Risedronate impurity A

15 mg

See leaflet

Y0001540 Risedronate impurity E

15 mg

2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid)

R1000600 Risperidone

50 mg

Y0001276 Risperidone impurity K

0.015 mg

Y0000370 Risperidone for system suitability

20 mg

Y0000714 Ritonavir

80 mg

See leaflet

See leaflet

Y0000706 Ritonavir for peak identification

10 mg

2136

Yes

+5C 3C

79

New Y0001516 Rivastigmine hydrogen tartrate

350 mg

See leaflet CHNO ; Batch 1 is valid until 30 September 2015

2629,2630

Yes

+5C 3C

79

Y0001515 Rivastigmine impurity D

10 mg

3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)enantiomer)

2629,2630

Yes

+5C 3C

79

Y0001485 Rivastigmine for system suitability

1.0114 mg

2629,2630

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

70

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001302 Rizatriptan benzoate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
200 mg
1 See leaflet CHNO

Information

Monograph Leaflet
2585

Y0001303 Rizatriptan for system suitability

15 mg

R1300000 RK 13 cells

1 ml

Y0001580 Rocuronium bromide

10 mg

Y0000527 Rocuronium for peak identification

10 mg

Y0000742 Ropivacaine hydrochloride monohydrate

10 mg

Y0000743 Ropivacaine impurity G

5 mg

(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)ropivacaine)

Y0000786 Rosmarinic acid

50 mg

See leaflet CHO ; Batch 2 is valid until 30 September 2015

Y0001719 Rosuvastatin Calcium

100 mg

Y0001722 Rosuvastatin impurity G

10 mg

Y0001721 Rosuvastatin for system suitability

15 mg

R1500000 Roxithromycin

125 mg

Y0000220 Roxithromycin for system suitability

10 mg

R2000000 Rubella vaccine (live) BRP

90 mg

See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of
each vial is 18 mg.

Y0000494 Ruscogenins

10 mg

See leaflet

Y0000105 Rutoside trihydrate

100 mg

See leaflet CHO

S0040000 Saccharin

30 mg

S0050000 Saccharin sodium

50 mg

S0100000 Salbutamol

50 mg

Y0000030 Salbutamol impurity B

10 mg

(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol

Y0000071 Salbutamol impurity D

10 mg

5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde

Y0000031 Salbutamol impurity F

10 mg

See leaflet; 1,1'-[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis[2-[(1,1dimethylethyl)amino]ethanol] ; Batch 4 is valid until 31 August 2014

Y0000034 Salbutamol impurity G

5 mg

Y0000032 Salbutamol impurity I

0.006 mg

Y0001186 Salbutamol impurity J

S0150000 Salbutamol sulfate

50 mg

Y0001288 Salbutamol sulfate for system suitability

10 mg

Batch 1 is valid until 31 August 2014

Y0000669 Salicin

50 mg

See leaflet CHO

S0200000 Salicylic acid

100 mg

Council of Europe, all rights reserved 2015

2585
cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines 0162,1057

Yes

Storage
+5C 3C

Extra
Price
charges
79
a

Yes

+5C 3C

79

Yes

Liquid nitrogen

100

1764

Yes

-20C 5C

79

1764

Yes

-20C 5C

79

2335

Yes

+5C 3C

79

2335

Yes

+5C 3C

79

1447,2382,
2524

Yes

+5C 3C

79

See leaflet CHCaFNOS

2631

Yes

+5C 3C

79

(3S,5R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl
(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid

2631

Yes

+5C 3C

79

2631

Yes

+5C 3C

79

1146

Yes

+5C 3C

79

See leaflet CHNO

1146

Yes

+5C 3C

79

1057,0162,2
442

Yes

-80C 10C

90

1847

Yes

+5C 3C

79

1795,1874,2
184,
2427,2639

Yes

+5C 3C

79

0947

Yes

+5C 3C

79

0787

Yes

+5C 3C

79

0529,1033

Yes

+5C 3C

79

0529

Yes

+5C 3C

79

0529,0687

Yes

+5C 3C

79

0529,0687

Yes

+5C 3C

79

2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxy- methyl)phenyl]
ethanone

0529

Yes

+5C 3C

79

(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol

0529

Yes

+5C 3C

79

0687

Yes

+5C 3C

79

0687

Yes

+5C 3C

79

0687

Yes

+5C 3C

79

2312,1583

Yes

+5C 3C

79

0366,1185

Yes

+5C 3C

79

0.00045 mg 1

71

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000405 Salicylic acid impurity B
Y0000422 Salmeterol xinafoate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
10 mg
1 4-hydroxyisophthalic acid
2
70 mg
1 see leaflet

Information

Monograph Leaflet

Storage

Extra
Price
charges
79
a

0366

Yes

+5C 3C

1765

Yes

+5C 3C

79

1765

Yes

+5C 3C

79

Y0001625 Salmeterol xinafoate for peak identification

15 mg

Y0000423 Salmeterol xinafoate for system suitability

25 mg

Batch 1 is valid until 30 September 2014

1765

Yes

+5C 3C

79

Y0001559 Salvianolic acid B

15 mg

See leaflet CHO

2663

Yes

+5C 3C

79

Y0001052 Santonin

20 mg

See leaflet

1391,1809

Yes

+5C 3C

79

Y0001049 Saquinavir mesilate

70 mg

See leaflet CHNOS

2267

Yes

+5C 3C

79

Y0001056 Saquinavir for system suitability

0.3033 mg

2267

Yes

+5C 3C

79

Y0001483 Saw palmetto extract HRS

8000 mg

1848, 2579

Yes

-20C 5C

79

Y0000814 Selamectin

120 mg

2268

Yes

+5C 3C

79

Y0001734 Selamectin for peak identification

5 mg

2268

Yes

+5C 3C

79

Y0001661 Selamectin impurity B

0.005 mg

(2aE,2S,4E,5S,6S,6R,7S,8E,11R,15S,17aR,20Z,20aR,20bS)6-cyclohexyl-7-[(2,6-didsoxy-3-O-mthyl-L-arabino-hexopyranosyl)oxy]-20b-hydroxy20-(hydroxyimino)-5,6,8,19-ttramthyl5,6,6,7,10,11,14,15,17a,20,20a,20b-dodcahydrospiro[
2H,17H-11,15-mthanofuro[4,3,2-pq][2,6]benzodioxacyclooctadcine13,2-pyran]-17-one ((5Z,25R)-25cyclohexyl-4-O-d(2,6-didsoxy-3-O-mthyl--L-arabinohexopyranosyl)5-dmthoxy-25-d(1-mthylpropyl)-5(hydroxyimino)avermectine A1a)

2268

Yes

+5C 3C

79

Y0000815 Selamectin for system suitability

5 mg

This Reference Standard has been replaced with Selamectin impurity B CRS
Y0001661 and Selamectin for peak identification CRS Y00001734. ; Batch 1 is
valid until 25 September 2014

2268

Yes

+5C 3C

79

S0360000 Selegiline hydrochloride

50 mg

1260

Yes

+5C 3C

79

S0360090 (RS)-Selegiline hydrochloride

25 mg

1260

Yes

+5C 3C

79

S0400000 Senna extract

50 mg

0206,0207,0
208, 1261

Yes

-20C 5C

79

S0450000 Serine

50 mg

0788,1027

Yes

+5C 3C

79

S0460000 Sertaconazole nitrate

125 mg

Y0000828 Sertraline hydrochloride

200 mg

Y0001285 Sertraline impurity E

15 mg

Y0000866 Sertraline for peak identification

5.4 mg

Y0000867 Sertraline for system suitability

6.18 mg

Y0000371 Sestamibi labelling kit

22 mg

Y0001046 Sevoflurane

1 mL

Y0001578 Sildenafil citrate

100 mg

Council of Europe, all rights reserved 2015

see leaflet ; Batch 1 is valid until 30 April 2015

1148

Yes

+5C 3C

79

1705

Yes

+5C 3C

79

1705

Yes

+5C 3C

79

1705

Yes

+5C 3C

79

1705

Yes

+5C 3C

79

1926

Yes

+5C 3C

79

Batch 1 is valid until 31 May 2015

2269

Yes

+5C 3C

79

See leaflet

2270

Yes

+5C 3C

79

See leaflet ; Batch 2 is valid until 30 September 2014


Batch 3 is valid until 31 March 2015

72

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001579 Sildenafil impurity A

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 5-[2-ethoxy-5[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2methylpropyl)-6,7-dihydro-1H-pyrazol[4,3-d]pyrimidin-7-one

S0500000 Silicone elastomer

2000 mg

S0600000 Silicone oil


S0650000 Simvastatin

1 mL

200 mg

Y0001066 Simvastatin for peak identification

10 mg

Y0001208 Sinomenine

20 mg

See leaflet CHNO

New S0660000 Sisomicin sulfate

Batch 2 is valid until 31 May 2015


See leaflet ; Batch 4 is valid until 30 June 2015

Monograph Leaflet

Storage

Extra
Price
charges
79
a

2270

Yes

+5C 3C

30109

Yes

+5C 3C

79

30108

Yes

+5C 3C

79

1563

Yes

-20C 5C

79

1563

Yes

-20C 5C

79

2450

Yes

+5C 3C

79

60 mg

See leaflet CHNOS ; Batch 2 is valid until 30 November 2015

0331,1351

Yes

-20C 5C

79

Y0001615 Beta-sitosterol

25 mg

See leaflet CHO

2579

Yes

-20C 5C

79

Y0001727 Sodium alendronate trihydrate

150 mg

see leaflet CHNNaOP,3HO

1564

Yes

+5C 3C

79

Y0001678 Sodium alendronate for system suitability

5 mg

1564

Yes

+5C 3C

79

S0695000 Sodium amidotrizoate

125 mg

1150

Yes

+5C 3C

79

Y0001669 Sodium aminosalicylate dihydrate

10 mg

1993

Yes

+5C 3C

79

Y0000300 Sodium aminosalicylate dihydrate - reference spectrum

n/a

79

Y0000039 Sodium ascorbate

50 mg

1791

Yes

+5C 3C

79

S0700000 Sodium calcium edetate

100 mg

0231

Yes

+5C 3C

79

S0710000 Sodium cetostearyl sulfate

100 mg

0847

Yes

+5C 3C

79

S0750000 Sodium cromoglicate

10 mg

0562

Yes

+5C 3C

79

Y0001300 Sodium cromoglicate for system suitability

20 mg

0562

Yes

+5C 3C

79

S0760000 Sodium cyclamate

100 mg

0774

Yes

+5C 3C

79

Y0001410 Sodium fusidate

10 mg

0848

Yes

+5C 3C

79

S0780000 Sodium hyaluronate BRP

300 mg

0912

Yes

+5C 3C

79

S0781000 Sodium hyaluronate - reference spectrum

n/a

1472

79

Y0001468 Sodium iodohippurate

15 mg

2352

Yes

+5C 3C

79

Y0000620 Sodium laurilsulfate

40 mg

0802

Yes

+5C 3C

79

Y0000808 Sodium phenylbutyrate

5 mg

2183

Yes

+5C 3C

79

Y0000809 Sodium phenylbutyrate impurity C

10 mg

4-cyclohexylbutanoic acid

2183

Yes

+5C 3C

79

Batch 1 is valid until 31 October 2015

1031

Yes

+5C 3C

79

79

New S0785000 Sodium picosulfate

Batch 1 is valid until 31 December 2014

50 mg

Y0000210 Sodium polystyrene sulfonate - reference spectrum

n/a

1909

Y0000268 Sodium propionate - reference spectrum

n/a

2041

79

S0800000 Sodium salicylate

100 mg

0413

Yes

+5C 3C

79

S0808000 Sodium stearyl fumarate

50 mg

1567

Yes

+5C 3C

79

S0808060 Sodium stearyl maleate

10 mg

1567

Yes

+5C 3C

79

S0900000 Sodium taurocholate BRP

10000 mg

0350

Yes

+5C 3C

79

S0930000 Sodium valproate

50 mg

0678

Yes

+5C 3C

79

2.52 mg

2779

Yes

+5C 3C

79

New Y0001743 Solifenacin for system suitability


Council of Europe, all rights reserved 2015

Batch 4 is valid until 31 August 2014

73

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
New Y0001763 Solifenacin succinate

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
5 mg
1

Information

Monograph Leaflet
2779

Yes

Storage
+5C 3C

Extra
Price
charges
79
b

S0945000 Somatostatin

2.09 mg

See leaflet ; Batch 5 is valid until 31 July 2014

0949

Yes

-20C 5C

90

S0947000 Somatropin

55 mg

See leaflet

0950,
0951,0952

Yes

-20C 5C

150

Y0000711 Somatropin/desamidosomatropin resolution mixture

33 mg

See leaflet

0950,0951,0
952

Yes

-20C 5C

150

S0950000 Sorbic acid

10 mg

0592

Yes

+5C 3C

79

Y0000385 1,4-Sorbitan

50 mg

See leaflet CHO

S1000000 Sorbitol

1250 mg

See leaflet

Y0000114 Sotalol hydrochloride

25 mg

Y0000115 Sotalol impurity B

20 mg

Y0001011 Spanish sage oil for peak identification

250 mg

Y0000597 Spectinomycin hydrochloride

100 mg

Y0000549 Spectinomycin for system suitability

20 mg

Y0000655 Spectinomycin sulfate tetrahydrate

10 mg

Y0001126 Spike lavender oil

400 l

S1100000 Spiramycin

200 mg

See leaflet

Y0000381 Spirapril hydrochloride monohydrate

60 mg

See leaflet CHClNOS

Y0000332 Spirapril for system suitability

15 mg

S1200000 Spironolactone

160 mg

Y0001295 Spironolactone for system suitability

2.057 mg

Y0000185 Squalane

250 l

Y0001050 St. John's wort dry extract

500 mg

S1250000 Stanozolol

50 mg

S1250010 Stanozolol impurity A

10 mg

Y0001420 Stanozolol impurity B

10 mg

S1300000 Starch BRP

50000 mg

Y0000408 Stavudine

100 mg

Y0001683 Stavudine impurity I

5 mg

Y0000421 Stavudine for system suitability

10 mg

Council of Europe, all rights reserved 2015

N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide ; Batch 1 is
valid until 31 March 2015

2048

Yes

+5C 3C

79

0435,0436,0
437,
1235,1236,1
337,
1381,1531,2
048

Yes

+5C 3C

79

2004

Yes

+5C 3C

79

2004

Yes

+5C 3C

79

1849

Yes

+5C 3C

79

1152, 1658

Yes

-20C 5C

79

1152, 1658

Yes

-20C 5C

79

1658

Yes

-20C 5C

79

See leaflet

2419

Yes

+5C 3C

79

0179,0293,1
982,20702

Yes

-20C 5C

79

1766

Yes

+5C 3C

79

1766

Yes

+5C 3C

79

0688

Yes

+5C 3C

79

0688

Yes

+5C 3C

79

See leaflet CH

1630

Yes

+5C 3C

79

see leaflet

1874

Yes

-20C 5C

79

1568

Yes

+5C 3C

79

1568

Yes

+5C 3C

79

1568

Yes

+5C 3C

79

0350

Yes

+5C 3C

79

2130

Yes

+5C 3C

79

2130

Yes

+5C 3C

79

2130

Yes

+5C 3C

79

See leaflet; Spironolactone CRS 2 is suitable for monograph 01/2008:0688


only.

17-hydroxy-17-methyl-5-androstan-3-one (mestanolone)

see leaflet

74

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
S1340000 Stearic acid

Reference Standard

S1350000 Stearyl alcohol

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
3
100 mg
1 Plastic additive 19

250 mg

Information

Monograph Leaflet

See leaflet CHO

Storage

0229,0882,1
474, 1663,
2058,
30103,
30105,
30106,3010
0702,0753,0
7
801,

Yes

+5C 3C

Yes

+5C 3C

Extra
Price
charges
79
a

79

0802,0847,0
969,
1123,1340,1
411
Y0000868 Streptokinase for system suitability

30 l

0356

Yes

-20C 5C

79

S1400000 Streptomycin sulfate

100 mg

See leaflet

0032,0033,0
053,
0485,20702

Yes

-20C 5C

79

Y0001195 Strychnine

40 mg

see leaflet

2513,2514

Yes

+5C 3C

79

Y0001324 Sucralfate

10 mg

1796

Yes

+5C 3C

79

Y0001344 Sucralose

550 mg

See leaflet CHClO

2368

Yes

+5C 3C

79

Y0001342 Sucralose impurity B

0.5 mg

1,6-dichloro-1,6-dideoxy-?-D-fructofuranosyl 6-chloro-6-deoxy-?-Dglucopyranoside (1',6,6'-trichloro-1',6,6'-trideoxysucrose) ; Batch 1 is valid


until 31 May 2015

2368

Yes

+5C 3C

79

S1600000 Sucrose

100 mg

0177,0178,0
187,0188,02
04,0209,106
1,1570,2318
, 2319

Yes

+5C 3C

79

S1608100 Sufentanil - reference spectrum

n/a

1569

79

S1609000 Sufentanil citrate - reference spectrum

n/a

150 mg

See leaflet ; Batch 1 is valid until 30 November 2015

Y0000529 Sulbactam sodium

10 mg

See leaflet

Y0000550 Sulbactam for peak identification

20 mg

S1700000 Sulfacetamide sodium

50 mg

S1800000 Sulfadiazine

Y0001480 Sulfadiazine for identification of impurity F

Y0001469 Sulfadiazine impurity A


Y0001677 Sulfadimethoxine
Y0001679 Sulfadimethoxine for peak identification
S1900000 Sulfadimidine

79

2209, 2211,
2212

Yes

-20C 5C

79

2209

Yes

+5C 3C

79

2209

Yes

+5C 3C

79

0107,0295

Yes

+5C 3C

79

100 mg

0294

Yes

+5C 3C

79

15 mg

0294

Yes

+5C 3C

79

20 mg

pyrimidin-2-amine

0294

Yes

+5C 3C

79

60 mg

see leaflet

2741

Yes

+5C 3C

79

10 mg

2741, 2745

Yes

+5C 3C

79

100 mg

0295

Yes

+5C 3C

79

Y0001495 Sulfadimidine for peak identification

50 mg

0295

Yes

+5C 3C

79

S1950000 Sulfadoxine

50 mg

0740

Yes

+5C 3C

79

New Y0000528 Sulbactam

Council of Europe, all rights reserved 2015

1269

75

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
S1975000 Sulfafurazole

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
100 mg
1

Information

Monograph Leaflet

Storage

0741

Yes

+5C 3C

Extra
Price
charges
79
a

S1975600 Sulfaguanidine

60 mg

0295,1476

Yes

+5C 3C

79

S2000000 Sulfamerazine

100 mg

0358,1571

Yes

+5C 3C

79

S2050000 Sulfamethizole

100 mg

0637

Yes

+5C 3C

79

S2100000 Sulfamethoxazole

50 mg

0108

Yes

+5C 3C

79

Y0000412 Sulfamethoxazole impurity A

5 mg

N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide

0108

Yes

+5C 3C

79

Y0000413 Sulfamethoxazole impurity F

5 mg

4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide

0108

Yes

+5C 3C

79

S2150000 Sulfamethoxypyridazine

50 mg

0638

Yes

+5C 3C

79

S2151000 Sulfanilamide

100 mg

1571

Yes

+5C 3C

79

S2159100 Sulfapyridine

20 mg

S2155000 Sulfasalazine

250 mg

See leaflet CHNOS

S2155010 Sulfasalazine derivative for resolution

20 mg

2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic
acid

S2158000 Sulfathiazole

100 mg

S2159000 Sulfinpyrazone

30 mg

S2159010 Sulfinpyrazone impurity A

20 mg

S2159015 Sulfinpyrazone impurity B

20 mg

Y0001238 Sulfinpyrazone for system suitability

0.5 mg

S2180000 Sulindac

50 mg

S2190000 Sulpiride

100 mg

S2191000 Sulpiride impurity A

20 mg

[(2RS)-1-ethylpyrrolidin-2-yl]methanamine

New S2192000 Sulpiride impurity B

20 mg

methyl 2-methoxy-5-sulphamoylbenzoate

Y0000530 Sultamicillin

10 mg

Y0000532 Sultamicillin for peak identification

10 mg

Y0000531 Sultamicillin tosilate

200 mg

See leaflet

Y0000022 Sumatriptan succinate

50 mg

Y0000026 Sumatriptan impurity mixture

3 mg

Y0000027 Sumatriptan for system suitability

2.02 mg

S2200000 Suxamethonium chloride

1000 mg

S2400000 Suxibuzone

50 mg

S2400004 Suxibuzone impurity B

10 mg

(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate

S2400006 Suxibuzone impurity C

10 mg

4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione

S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet.


use) BRP

1 mg

See leaflet

S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet.


use) BRP

1 mg

See leaflet

Y0001417 Tadalafil

200 mg

see leaflet ; Batch 1 is valid until 31 August 2015

Council of Europe, all rights reserved 2015

0863

Yes

+5C 3C

79

0863,1457

Yes

+5C 3C

79

0863

Yes

+5C 3C

79

0742

Yes

+5C 3C

79

0790

Yes

+5C 3C

79

1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione

0790

Yes

+5C 3C

79

1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione

0790

Yes

+5C 3C

79

0790

Yes

+5C 3C

79

0864

Yes

+5C 3C

79

1045,1348

Yes

+5C 3C

79

1045,1490

Yes

+5C 3C

79

1045

Yes

+5C 3C

79

2211

Yes

+5C 3C

79

See leaflet CHFOS; Contains 0.3% m/m of E-isomer

2211

Yes

+5C 3C

79

2211,2212

Yes

+5C 3C

79

See leaflet CHNOS

1573

Yes

-20C 5C

79

Batch 7 is valid until 30 September 2015

1573

Yes

-20C 5C

79

1573

Yes

-20C 5C

79

0248

Yes

+5C 3C

79

1574

Yes

+5C 3C

79

1574

Yes

+5C 3C

79

1574

Yes

+5C 3C

79

See leaflet,
0064

Yes

+5C 3C

e(b)

90

See leaflet,
0064

Yes

+5C 3C

e(b)

90

2606

Yes

+5C 3C

79

76

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
T0010000 Talampicillin hydrochloride

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
50 mg
1

Information

Monograph Leaflet

Storage

0808,0852

Yes

+5C 3C

Extra
Price
charges
79
a

T0014000 Tamoxifen citrate

80 mg

1046

Yes

+5C 3C

79

T0015000 Tamoxifen citrate for performance test

10 mg

1046

Yes

+5C 3C

79

Y0000650 Tamsulosin hydrochloride

10 mg

2131

Yes

+5C 3C

79

Y0000651 Tamsulosin impurity D

10 mg

2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]
benzenesulfonamide

2131

Yes

+5C 3C

79

Y0000652 Tamsulosin impurity H

10 mg

(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine

2131

Yes

+5C 3C

79

Y0000653 Tamsulosin racemate

15 mg

2131

Yes

+5C 3C

79

Y0001560 Tanshinone IIa

15 mg

See leaflet CHO

2663

Yes

+5C 3C

79

Y0001102 Teicoplanin

50 mg

see leaflet ; Batch 1 is valid until 31 January 2015

2358

Yes

-20C 5C

79

Y0001047 Teicoplanin for identification

40 mg

2358

Yes

-20C 5C

79

Y0000648 Telmisartan

30 mg

2154

Yes

+5C 3C

79

Y0000649 Telmisartan for peak identification

10 mg

2154

Yes

+5C 3C

79

Y0001003 Telmisartan for system suitability

0.26 mg

2154

Yes

+5C 3C

79

T0040000 Temazepam - * psy

50 mg

0954

Yes

+5C 3C

79

Y0000344 Temazepam impurity C

5 mg

(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate

0954

Yes

+5C 3C

79

Y0000345 Temazepam impurity D

5 mg

(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one

0954

Yes

+5C 3C

79

Y0000346 Temazepam impurity F

10 mg

(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione ; Batch 1 is valid until 28 February 2015

0954

Yes

+5C 3C

79

Y0000347 Temazepam impurity G

5 mg

(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione

0954

Yes

+5C 3C

79

T0040800 Tenoxicam

100 mg

1156

Yes

+5C 3C

79

Y0001114 Tenoxicam impurity mixture

0.0042 mg

1156

Yes

+5C 3C

79

Y0000621 Terazosin hydrochloride dihydrate

40 mg

2021

Yes

+5C 3C

79

Y0000622 Terazosin impurity A

10 mg

2-chloro-6,7-dimethoxyquinazolin-4-amine

2021

Yes

+5C 3C

79

Y0000665 Terazosin impurity E

10 mg

2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)

2021

Yes

+5C 3C

79

Y0000623 Terazosin impurity L

10 mg

1-(furan-2-ylcarbonyl)piperazine

2021

Yes

+5C 3C

79

Y0000624 Terazosin impurity N

10 mg

See leaflet CHNO; 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine

2021

Yes

+5C 3C

79

Y0000666 Terazosin for system suitability

0.5 mg

2021

Yes

+5C 3C

79

Y0000535 Terbinafine hydrochloride

10 mg

1734

Yes

+5C 3C

79

New Y0001143 Terbinafine for system suitability

10 mg

1734

Yes

+5C 3C

79

T0050000 Terbutaline sulfate

100 mg

0690, 2451

Yes

+5C 3C

79

T0050015 Terbutaline impurity C

15 mg

0690

Yes

+5C 3C

79

T0060000 Terconazole

250 mg

1270

Yes

+5C 3C

79

T0071000 Terfenadine

100 mg

0955

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

Batch 1 is valid until 30 November 2015


1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]ethanone

77

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
T0080000 Terfenadine impurity A

Effective from 2015/7/1


Batch n Quantity Sale
Information
Monograph Leaflet
per vial Unit
2
20 mg
1 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]
0955
Yes
butan-1-one

Storage
+5C 3C

Extra
Price
charges
79
a

T0100000 Testosterone

30 mg

1373, 1048

Yes

+5C 3C

79

Y0000342 Testosterone for impurity D identification

20 mg

1373

Yes

+5C 3C

79

Y0000343 Testosterone for system suitability

20 mg

1373

Yes

+5C 3C

79

T0210000 Testosterone caproate

50 mg

T0240000 Testosterone decanoate

50 mg

Y0000696 Testosterone decanoate for system suitability

0.4 mg

T0250000 Testosterone enantate

100 mg

Y0001313 Testosterone enantate impurity H

10 mg

Y0001312 Testosterone enantate for peak identification

10 mg

Y0001317 Testosterone enantate for system suitability

2 mg

T0260000 Testosterone isocaproate

50 mg

Y0000716 Testosterone isocaproate for system suitability

5 mg

T0300000 Testosterone propionate

60 mg

Y0001409 Testosterone propionate for system suitability

5 mg

T0400000 Tetanus vaccine (adsorbed)

30 mg

T0500000 Tetracaine hydrochloride

100 mg

Y0001002 Tetracaine for system suitability

2 mg

T0550000 Tetracosactide

20.4 mg

See leaflet CHNOS

T0600000 Tetracycline hydrochloride

100 mg

See leaflet CHClNO

Y0001165 Tetrandrine

20 mg

Y0001087 Tetra-O-acetyl-mannose triflate

60 mg

Y0000015 Tetrazepam - reference spectrum

n/a

Y0000008 Tetrazepam impurity C

20 mg

Y0000460 Tetryzoline hydrochloride

10 mg

Y0000723 Thebaine - * narc

15 mg

T0700000 Theobromine

25 mg

1048

Yes

+5C 3C

79

1048, 1736

Yes

-20C 5C

79

1736

Yes

-20C 5C

79

1048

Yes

-20C 5C

79

1048

Yes

-20C 5C

79

1048

Yes

-20C 5C

79

See leaflet CHO

delta-5-testosterone-3,17-dienantate

See leaflet CHO


See leaflet CHO

1048

Yes

-20C 5C

79

1048,1737

Yes

+5C 3C

79

1737

Yes

+5C 3C

79

0297

Yes

+5C 3C

79

0297

Yes

+5C 3C

79

See leaflet,
20708

Yes

-20C 5C

90

0057

Yes

+5C 3C

79

0057

Yes

+5C 3C

79

0644

Yes

-20C 5C

79

0173,0198,0
199,
0210,0211,1
654

Yes

+5C 3C

79

See leaflet CHNO

2478

Yes

+5C 3C

79

See leaflet CHFOS

2294

Yes

-20C 5C

79

79

1738

Yes

+5C 3C

79

See leaflet

1738
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

2101

Yes

+5C 3C

79

0777,1839,1
840,1841

Yes

+5C 3C

79

0298

Yes

+5C 3C

79

Yes

+5C 3C

79

79

see leaflet

T0800000 Theophylline

100 mg

0300,0301

Y0000294 Theophylline - reference spectrum

n/a

0299,0302

Y0000336 Thiamazole

125 mg

0884,1706

Yes

+5C 3C

79

Y0000372 Thiamazole impurity A

15 mg

2,2-dimethoxy-N-methylethanamine

1706

Yes

+5C 3C

79

Y0000373 Thiamazole impurity C

20 mg

See leaflet; 1-methyl-2-(methylsulphanyl)-1H-imidazole

1706

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

78

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000467 Thiamine hydrochloride
New Y0001749 Thiamine for system suitability

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
2
10 mg
1

Information

Monograph Leaflet
Yes

0303

Yes

+5C 3C

79

0303,0531

Yes

+5C 3C

79

79

0.5 mg

10 mg

Y0000060 Thiamine nitrate - reference spectrum

n/a

0531

New Y0001758 Thiamine nitrate

+5C 3C

Extra
Price
charges
79
a

0303

Y0000059 Thiamine impurity E

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4methylthiazol-2(3H)-thione

Storage

15 mg

0534

Yes

+5C 3C

79

T1100000 Thiamphenicol

125 mg

0109

Yes

+5C 3C

79

Y0000546 Thioctic acid

110 mg

See leaflet ; Batch 1 is valid until 31 December 2014

1648

Yes

+5C 3C

79

Y0000545 Thioctic acid containing impurity B

25 mg

Batch 1 is valid until 31 October 2014

1648

Yes

+5C 3C

79

Y0000592 Thioctic acid for system suitability

10 mg

1648

Yes

+5C 3C

79

Y0000109 Thiomersal

30 mg

1625

Yes

+5C 3C

79

T1200000 Thiopental

500 mg

0212

Yes

+5C 3C

79

Y0001478 Thiopental for system suitability

10 mg

0212

Yes

+5C 3C

79

Y0000704 Thioridazine

10 mg

2005

Yes

+5C 3C

79

T1300000 Thioridazine hydrochloride

100 mg

0586

Yes

+5C 3C

79

Y0000541 Thioridazine for system suitability

0.21 mg

0586, 2005

Yes

+5C 3C

79

T1305100 Thioxanthene

20 mg

1347

Yes

+5C 3C

79

T1305000 Thioxanthone

10 mg

1347

Yes

+5C 3C

79

T1340000 Threonine

50 mg

1049

Yes

+5C 3C

79

T1350000 Thymol

50 mg

0791

Yes

+5C 3C

79

T1410000 Tiabendazole

50 mg

0866

Yes

+5C 3C

79

Y0000379 Tiamulin - reference spectrum

n/a

79

Y0000333 Tiamulin hydrogen fumarate

500 mg

1659,1660

Yes

+5C 3C

79

Y0000414 Tiamulin for peak identification

10 mg

1659

Yes

+5C 3C

79

Y0000151 Tianeptine sodium - reference spectrum

n/a

2022

79

Y0000153 Tianeptine impurity A

30 mg

2022

Yes

+5C 3C

79

Y0000152 Tianeptine for system suitability

30 mg

2022

Yes

+5C 3C

79

T1405000 Tiapride hydrochloride

60 mg

1575

Yes

+5C 3C

79

T1405050 Tiapride N-oxide

20 mg

1575

Yes

+5C 3C

79

T1410900 Tiaprofenic acid

50 mg

1157

Yes

+5C 3C

79

T1410910 Tiaprofenic acid impurity C

20 mg

1157

Yes

+5C 3C

79

Y0000748 Tibolone - reference spectrum

n/a

1739

79

Y0000668 Tibolone for system suitability

10 mg

1739

Yes

+5C 3C

79

Y0000465 Ticarcillin monosodium

250 mg

see leaflet ; Batch 1 is valid until 10 December 2014

0956

Yes

-20C 5C

79

T1420010 Ticarcillin impurity A

50 mg

See leaflet; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid


(decarboxyticarcillin)

0956

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

1660
See leaflet CHNOS

ethyl 7-bromoheptanoate

(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
T1423000 Ticlopidine hydrochloride

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
3
50 mg
1

Information

Monograph Leaflet
1050

Yes

+5C 3C

1050

Yes

+5C 3C

T1423025 Ticlopidine impurity F

10 mg

Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum

n/a

1767

Y0000644 (R)-timolol

20 mg

0572

Yes

T1450000 Timolol maleate

100 mg

0572

Yes

Y0001270 Timolol for system suitability

5.045 mg

0572

Yes

T1470000 Tinidazole

100 mg

Y0000899 Tinidazole impurity A

15 mg

2-methyl-5-nitro-1H-imidazole

1051

T1471000 Tinidazole impurity B

20 mg

1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole

1051

6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine

Batch 1 is valid until 31 July 2014

Storage

Extra
Price
charges
79
a
a

79

79

+5C 3C

79

+5C 3C

79

+5C 3C

79

+5C 3C

79

Yes

+5C 3C

79

Yes

+5C 3C

79

Yes

+5C 3C

79

79

1051

T1490000 Tinzaparin sodium

250 mg

1271

Y0000292 Tioconazole - reference spectrum

n/a

2074

Y0000282 Tioconazole for system suitability

50 mg

2074

Yes

+5C 3C

79

Y0001188 Tiotropium bromide monohydrate

10 mg

2420

Yes

+5C 3C

79

Y0001216 Tiotropium impurity F

15 mg

dithiophen-2-ylmethanone

2420

Yes

+5C 3C

79

10 mg

Batch 1 is valid until 30 November 2015

2420

Yes

+5C 3C

79

Y0001179 Tiotropium impurity mixture

0.08 mg

Batch 1 is valid until 30 September 2015

2420

Yes

+5C 3C

79

Y0001700 Tizanidine hydrochloride

100 mg

See leaflet CHClNS

2578

Yes

+5C 3C

79

Y0001698 Tizanidine impurity B

10 mg

N-(5-chloro-2,1,3-benzothiadiazol-4-yl)thiouree

2578

Yes

+5C 3C

79

T1500000 Tobramycin

49 mg

See leaflet CHNO; Suitable for LC assay only

0645

Yes

+5C 3C

79

Y0001210 Tobramycin for identification

250 mg

Suitable for identification tests only

0645

Yes

+5C 3C

79

T1550000 alpha-Tocopherol

500 mg

See leaflet CHO ; Vitamin E

0692,1256,2
0432

Yes

+5C 3C

79

T1600000 alpha-Tocopheryl acetate

500 mg

See leaflet CHO

0439,0691,1
257

Yes

+5C 3C

79

50 mg

Batch 2 is valid until 31 October 2015

0692

Yes

+5C 3C

79

New Y0001189 Tiotropium for system suitability

New Y0000383 All-rac-alpha-tocopherol for peak identification


Y0000384 All-rac-alpha-tocopheryl acetate for peak identification

30 mg

T1610000 RRR-alpha-Tocopheryl hydrogen succinate

150 mg

See leaflet CHO

0439

Yes

+5C 3C

79

1258,1259

Yes

+5C 3C

79

T1700000 Tolbutamide

100 mg

0304

Yes

+5C 3C

79

Y0000154 Tolfenamic acid

100 mg

2039

Yes

+5C 3C

79

T1707000 Tolnaftate

60 mg

1158

Yes

+5C 3C

79

Y0001123 Tolnaftate for system suitability

10 mg

1158

Yes

+5C 3C

79

Y0001696 Tolterodine tartrate

5 mg

2781

Yes

+5C 3C

79

Y0001699 Tolterodine impurity E

5 mg

2781

Yes

+5C 3C

79

Y0001697 Tolterodine for system suitability

5 mg

2781

Yes

+5C 3C

79

Y0000461 Torasemide anhydrous

10 mg

2132

Yes

+5C 3C

79

Y0001366 Torasemide impurity E

0.0006 mg

2132

Yes

+5C 3C

79

Y0000462 Torasemide for system suitability

5 mg

2132

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate
80

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000155 Tramadol hydrochloride

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
3
75 mg
1

Information

Monograph Leaflet

Storage

1681

Yes

+5C 3C

Extra
Price
charges
79
a

Y0000156 Tramadol impurity A

25 mg

(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol

1681

Yes

+5C 3C

79

Y0000157 Tramadol impurity E

15 mg

(2RS)-2-[(dimethylamino)methyl]cyclohexanone

1681

Yes

+5C 3C

79

Y0000072 Tramazoline hydrochloride monohydrate

20 mg

1597

Yes

+5C 3C

79

Y0000065 Tramazoline impurity A

15 mg

N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine

1597

Yes

+5C 3C

79

Y0000066 Tramazoline impurity B

10 mg

See leaflet; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one

1597

Yes

+5C 3C

79

Y0000501 Trandolapril

10 mg

2245

Yes

+5C 3C

79

Y0000495 Trandolapril impurity C

10 mg

(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)

2245

Yes

+5C 3C

79

Y0000496 Trandolapril impurity D

10 mg

ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro
pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril
diketopiperazine)

2245

Yes

+5C 3C

79

T1810000 Tranexamic acid

50 mg

0875

Yes

+5C 3C

79

T1820000 Trapidil

50 mg

1576

Yes

+5C 3C

79

T1820002 Trapidil impurity A

20 mg

5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol

1576

Yes

+5C 3C

79

T1820004 Trapidil impurity B

20 mg

1,2,4-triazol-3-amine

1576

Yes

+5C 3C

79

Y0001172 Trehalose dihydrate

250 mg

See leaflet CHO,2HO

2297

Yes

+5C 3C

79

T1850000 Tretinoin

50 mg

0693,1019,1
385

Yes

+5C 3C

79

G0400010 Triacetin - reference spectrum

n/a

1106

79

T1899990 Triamcinolone

150 mg

1376

Yes

+5C 3C

79

Y0000050 Triamcinolone impurity C

10 mg

9-fluoro-11,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione

T1900000 Triamcinolone acetonide

150 mg

See leaflet CHFO

Y0001459 Triamcinolone acetonide for system suitability

10 mg

1376

Yes

+5C 3C

79

0533,0867,1
075

Yes

+5C 3C

79

0533

Yes

+5C 3C

79

T1950000 Triamcinolone hexacetonide

100 mg

0533,0867

Yes

+5C 3C

79

Y0000837 Triamterene

10 mg

0058

Yes

+5C 3C

79

Y0000870 Triamterene impurity B

0.5 mg

0058

Yes

+5C 3C

79

T1975000 Triazolam - * psy

10 mg

1065

Yes

+5C 3C

79

Y0000165 Tribenoside

150 mg

See leaflet

1740

Yes

-20C 5C

79

Y0000166 Tribenoside impurity A

70 mg

See leaflet CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-alpha-Dglucofuranose

1740

Yes

-20C 5C

79

Y0001628 Tribenoside impurity D

35 mg

Benzyl ether

1740

+5C 3C

79

Y0001055 Tributyl acetylcitrate

1 mL

1770

Yes

+5C 3C

79

Y0000799 Tributyl acetylcitrate for peak identification

25 mg

1770

Yes

+5C 3C

79

T1977990 Tricaprin

150 mg

1410

Yes

-20C 5C

79

Council of Europe, all rights reserved 2015

2,7-diamino-6-phenylpteridin-4-ol

81

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
T1977995 Tricaproin

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
40 mg
1

Information

Monograph Leaflet

Storage

1410

Yes

-20C 5C

Yes

-20C 5C

T1978000 Tricaprylin

225 mg

1410

Y0000111 Trichloroacetic acid - reference spectrum

n/a

1967

Extra
Price
charges
79
c
c

79

79

T1985000 Trichlorotrifluoroethane

2.5 ml

0393

Yes

+5C 3C

79

Y0001737 Triclabendazole

10 mg

2609

Yes

+5C 3C

79

Y0001723 Triclabendazole for system suitability

0.012 mg

2609

Yes

+5C 3C

79

T1986000 Triethyl citrate - reference spectrum

n/a

1479

79

T2000000 Trifluoperazine hydrochloride

100 mg

0059

Yes

+5C 3C

79

T2005000 Triflusal

50 mg

1377

Yes

+5C 3C

79

1377

Yes

+5C 3C

79

2032

Yes

+5C 3C

79

1626

Yes

+5C 3C

79

1626

Yes

+5C 3C

79

T2005010 Triflusal impurity B

15 mg

Y0000720 Triglycerol diisostearate

200 mg

Y0000108 Trihexyphenidyl hydrochloride

100 mg

Y0000068 Trihexyphenidyl impurity A

20 mg

2-hydroxy-4-(trifluoromethyl)benzoic acid

1-phenyl-3-(piperidin-1-yl)propan-1-one

T2009000 Trilaurin

1250 mg

1410

Yes

-20C 5C

79

Y0001319 Trimebutine maleate

10 mg

2182

Yes

+5C 3C

79

Y0001260 Trimebutine for system suitability

1.017 mg

2182

Yes

+5C 3C

79

Y0000092 Trimetazidine dihydrochloride - reference spectrum

n/a

1741

79

Y0000093 Trimetazidine for system suitability

50 mg

T2100000 Trimethadione

250 mg

T2200000 Trimethoprim

50 mg

T2200010 Trimethoprim impurity B

15 mg

Y0000684 Trimethoprim for system suitability

Y0001497 3-Trimethylsilyl-1-propanesulfonic acid sodium salt

120 mg

T2450000 Trimethyltetradecylammonium bromide

200 mg

T2500000 Trimipramine maleate

100 mg

Y0000759 Trimipramine for peak identification

0.51 mg

500 mg

Y0000279 Tri-n-butyl phosphate

300 l

Y0001113 Triolein

30 mg

T2501200 Tristearin

100 mg

T2545000 Trolamine

2250 mg

Y0001184 Trolamine impurity A

250 mg

Y0001183 Trolamine impurity B

1 ml

T2550000 Trometamol

100 mg

T2580000 Tropicamide

50 mg

Y0001247 Tropicamide impurity C

10 mg

New T2500100 Trimyristin

Council of Europe, all rights reserved 2015

See leaflet CHNO


(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone

0.00075 mg 1

1741

Yes

+5C 3C

79

0440

Yes

+5C 3C

79

0060

Yes

+5C 3C

79

0060

Yes

+5C 3C

79

0060

Yes

+5C 3C

79

2645, 2165

Yes

+5C 3C

79

0378

Yes

+5C 3C

79

0534

Yes

+5C 3C

79

0534

Yes

+5C 3C

79

1410

Yes

-20C 5C

79

1682

Yes

+5C 3C

79

2454

Yes

-20C 5C

79

1410

Yes

-20C 5C

79

1577

Yes

+5C 3C

79

Ethanolamine

1577

Yes

+5C 3C

79

Diethanolamine

1577

Yes

+5C 3C

79

1053

Yes

+5C 3C

79

1159,1197

Yes

+5C 3C

79

1159

Yes

+5C 3C

79

See leaflet CHOSSi,Na

Batch 1 is valid until 30 November 2015


See leaflet CHO

(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)


82

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001248 Tropicamide impurity D (Phenylacetic acid -*Drug
Precursor)

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
10 mg
1 Phenylacetic acid

Information

Monograph Leaflet

Storage

1159

Yes

+5C 3C

Extra
Price
charges
79
i

Y0001316 Tropicamide for peak identification

10 mg

1159

Yes

+5C 3C

79

T2580300 Tropine

50 mg

1308, 2102

Yes

+5C 3C

79

Y0000616 Tropisetron hydrochloride

40 mg

2102

Yes

+5C 3C

79

Y0000618 Tropisetron impurity B

10 mg

2102

Yes

+5C 3C

79

Y0000429 Trospium chloride

10 mg

1798

Yes

+5C 3C

79

Y0000432 Trospium impurity A

20 mg

hydroxydiphenylacetic acid (benzilic acid)

1798

Yes

+5C 3C

79

Y0000431 Trospium impurity B

20 mg

(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate

1798

Yes

+5C 3C

79

Y0000430 Trospium impurity C

5 mg

(1R,3R,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] ;
Batch 2 is valid until 30 September 2014

1798

Yes

+5C 3C

79

Y0000497 Troxerutin

30 mg

2133

Yes

+5C 3C

79

T2600000 Trypsin BRP

100 mg

See leaflet

0476,0579,0
580, 0694

Yes

+5C 3C

79

T2610000 Tryptophan

100 mg

see leaflet

1272, 2290

Yes

+5C 3C

79

T2880000 Tylosin

150 mg

see leaflet

1273,1274,1
661, 20702

Yes

+5C 3C

79

T2880100 Tylosin D

5 mg

1273,1274,1
661

Yes

+5C 3C

79

1H-indole-3-carboxylic acid

T2880200 Tylosin tartrate - reference spectrum

n/a

1274

79

Y0000498 Tylosin phosphate for peak identification

10 mg

1273,1274,1
661

Yes

+5C 3C

79

T2900000 Tyrosine

50 mg

1161, 1384

Yes

+5C 3C

79

T3000000 Tyrothricin

20 mg

0907,1662

Yes

+5C 3C

79

U0020000 Ubidecarenone

50 mg

1578

Yes

+5C 3C

79

U0020008 Ubidecarenone impurity D

5 mg

1578

Yes

+5C 3C

79

U0020001 Ubidecarenone for system suitability

1 mg

1578

Yes

+5C 3C

79

U0100000 Uracil arabinoside

60 mg

0760

Yes

+5C 3C

79

U0600000 Urea

100 mg

0743

Yes

+5C 3C

79

U0800000 Ursodeoxycholic acid

100 mg

1189,1275

Yes

+5C 3C

79

Y0001163 Ursodeoxycholic acid for system suitability

1.26 mg

1275

Yes

+5C 3C

79

Y0001523 Ursolic acid

25 mg

See leaflet CHO

Y0000834 Valaciclovir hydrochloride (anhydrous)

100 mg

See leaflet CHNOCl

Y0001096 Valaciclovir impurity D

10 mg

Y0001097 Valaciclovir impurity E

10 mg

Y0001098 Valaciclovir impurity F para-toluenesulfonate

12 mg

Council of Europe, all rights reserved 2015

5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4dione

2439

Yes

+5C 3C

79

1768,2751

Yes

+5C 3C

79

2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate

1768

Yes

+5C 3C

79

2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)
carbonyl]-L-valinate

1768

Yes

+5C 3C

79

2-hydroxyethyl L-valinate

1768

Yes

+5C 3C

79

83

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001099 Valaciclovir impurity G

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
10 mg
1 N,N-dimethylpyridin-4-amine

Information

Monograph Leaflet

Storage

1768,2751

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001662 Valaciclovir impurity P

5 mg

1768

Yes

+5C 3C

79

Y0001655 Valaciclovir impurity S

15 mg

2751

Yes

+5C 3C

79

Y0001225 Valaciclovir for system suitability

10 mg

Y0000583 Valerian dry extract

400 mg

V0030000 Valine

50 mg

Y0000584 Valnemulin hydrochloride

10 mg

Y0000586 Valnemulin impurity E

10 mg

Y0000585 Valnemulin for peak identification

10.25 mg

Y0000533 Valnemulin hydrogen tartrate

120 mg

V0033000 Valproic acid

100 mg

Y0001422 Valproic acid for system suitability

10 mg

Y0001132 Valsartan

10 mg

Y0001131 Valsartan for peak identification

10 mg

Y0001145 Valsartan for system suitability

0.202 mg

V0045000 Vancomycin hydrochloride

100 mg

V0050000 Vanillin

100 mg

Y0001648 Vardenafil for system suitability

10 mg

Y0001647 Vardenafil hydrochloride


TRIHYDRATE

120 mg

Y0001198 Varicella vaccine ( live)

420 mg

Y0000561 Vecuronium bromide

10 mg

Y0000625 Vecuronium for peak identification

10 mg

Y0001093 Vedaprofen

5 mg

Y0001118 Vedaprofen impurity mixture

Y0000587 Venlafaxine hydrochloride

Y0000588 Venlafaxine for system suitability


V0100000 Verapamil hydrochloride

See leaflet

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)
See leaflet CHNOS
Batch 1 is valid until 30 September 2014
Batch 1 is valid until 20 February 2015

1768,2751

Yes

+5C 3C

79

0453,1898,1
899,2400,25
26
0796

Yes

-20C 5C

79

Yes

+5C 3C

79

2137

Yes

+5C 3C

79

2137

Yes

+5C 3C

79

2137

Yes

+5C 3C

79

2137

Yes

+5C 3C

79

1378

Yes

+5C 3C

79

0678,1378

Yes

+5C 3C

79

2423

Yes

+5C 3C

79

2423

Yes

+5C 3C

79

2423

Yes

+5C 3C

79

1058,20702

Yes

-20C 5C

79

0747

Yes

+5C 3C

79

2782

Yes

+5C 3C

79

See leaflet

2782

Yes

+5C 3C

79

See leaflet

0648, 2442

Yes

-80C 10C

90

1769

Yes

+5C 3C

79

1769

Yes

+5C 3C

79

2248

Yes

+5C 3C

79

0.006 mg

2248

Yes

+5C 3C

79

50 mg

2119

Yes

+5C 3C

79

1.002 mg

2119

Yes

+5C 3C

79

100 mg

0573

Yes

+5C 3C

79

V0100018 Verapamil impurity I

5 mg

(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl]
(methyl)amino]ethyl]-3-methylbutanenitrile hydrochloride

0573

Yes

+5C 3C

79

V0100026 Verapamil impurity M

10 mg

5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]

0573

Yes

+5C 3C

79

Y0000661 Verbenalin

11 mg

See leaflet CHO

1854

Yes

+5C 3C

79

V0180000 VERO cells

1 ml

Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of


live measles, mumps and rubella vaccines

0213,0538,1
057

Yes

Liquid nitrogen

100

Council of Europe, all rights reserved 2015

See leaflet

84

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001400 Vigabatrin

Reference Standard

Effective from 2015/7/1


Batch n Quantity Sale
per vial Unit
1
10 mg
1

Information

Monograph Leaflet

Storage

2305

Yes

+5C 3C

Extra
Price
charges
79
a

Y0001401 Vigabatrin impurity A

25 mg

See leaflet CHNO; (5RS)-5-ethenylpyrrolidin-2-one

2305

Yes

-20C 5C

79

Y0001402 Vigabatrin impurity B

20 mg

(2E)-2-(2-aminoethyl)but-2-enoic acid

2305

Yes

+5C 3C

79

Y0001404 Vigabatrin impurity D

50 mg

4-aminobutanoic acid

2305

Yes

+5C 3C

79

Y0001403 Vigabatrin impurity E

10 mg

2-[(2RS)-2-aminobut-3-enyl]propanedioic acid

2305

Yes

+5C 3C

79

V0300000 Vinblastine sulfate

5.01 mg

See leaflet CHNOS

0748,0749

Yes

-80C 10C

79

V0305000 Vinblastine sulfate - reference spectrum

n/a

79

V0400000 Vincristine sulfate

4.96 mg

79

V0405000 Vincristine sulfate - reference spectrum

n/a

79

V0500000 Vindesine sulfate

5 mg

79

V0500010 Vindesine sulfate - reference spectrum

n/a

79

Y0000463 Vinorelbine tartrate

50 mg

Batch 2 is valid until 30 September 2015

2107

Yes

-80C 10C

79

Y0000464 Vinorelbine impurity B

7 mg

4-O-deacetylvinorelbine ; Batch 3 is valid until 30 September 2015

2107

Yes

-80C 10C

79

Y0000589 Vinpocetine

10 mg

2139

Yes

+5C 3C

79

Y0000590 Vinpocetine impurity A

10 mg

(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (ethyl vincaminate)

2139

Yes

+5C 3C

79

Y0000591 Vinpocetine impurity B

10 mg

(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido
[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)

2139

Yes

+5C 3C

79

Y0000790 Vinpocetine impurity C

15 mg

ethyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine) ; Batch 1 is valid until 31 August 2015

2139

Yes

+5C 3C

79

Y0000760 Vinpocetine impurity D

10 mg

(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo
[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)

2139

Yes

+5C 3C

79

Y0000793 Vinyl acetate

200 mg

2152,2523

Yes

+5C 3C

79

New Y0001395 Voriconazole

120 mg

See leaflet CHFNO ; Batch 2 is valid until 30 November 2015

2576

Yes

+5C 3C

79

Y0001396 Voriconazole impurity B

10 mg

(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)
butan-2-ol

2576

Yes

+5C 3C

79

Y0001398 Voriconazole impurity D

10 mg

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4triazol-1-yl)butan-2-ol (epi-voriconazole)

2576

Yes

+5C 3C

79

Y0001397 Voriconazole impurity E

50 mg

[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid
((+-)-camphorsulfonic acid)

2576

Yes

+5C 3C

79

0748
0748,0749

see leaflet

Yes

-80C 10C

0749
1276

See leaflet CHNOS

Yes

-80C 10C

1276

W0100000 Warfarin sodium

10 mg

0698

Yes

+5C 3C

79

Y0000778 Warfarin sodium clathrate

10 mg

0699

Yes

+5C 3C

79

Y0001599 Wedelolactone

15 mg

2564

Yes

-20C 5C

79

X0075000 Xylazine hydrochloride

125 mg

1481

Yes

+5C 3C

79

Y0000158 Xylazine impurity C

50 mg

1481

Yes

+5C 3C

79

Y0001224 Xylazine impurity mixture

0.02 mg

1481

Yes

+5C 3C

79

Council of Europe, all rights reserved 2015

See leaflet
2,6-dimethylphenyl isothiocyanate
85

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
X0080000 Xylitol

Reference Standard

X0100000 Xylometazoline hydrochloride

Effective from 2015/7/1


Batch n Quantity Sale
Information
per vial Unit
2
500 mg
1 See leaflet
3
100 mg
1 Batch 2 is valid until 31 December 2014

Monograph Leaflet

Storage
+5C 3C

Extra
Price
charges
79
a

1381

Yes

0972,1162

Yes

+5C 3C

79

1162

Yes

+5C 3C

79

1278

Yes

+5C 3C

79

2172

Yes

+5C 3C

79

2611

Yes

+5C 3C

79

X0101000 Xylometazoline impurity A

15 mg

X0200000 Xylose

100 mg

Y0000656 Yohimbine hydrochloride

20 mg

Y0001715 Zanamivir hydrate

5 mg

Y0001703 Zanamivir impurity F

10 mg

see leaflet CHClN

2611

Yes

+5C 3C

79

Y0001702 Zanamivir for assay

50 mg

see leaflet CHNO

2611

Yes

+5C 3C

79

Y0001708 Zanamivir for system suitability

10 mg

2611

Yes

+5C 3C

79

60 mg

see leaflet ; Batch 2 is valid until 30 November 2015

1059

Yes

+5C 3C

79

Z1904000 Zidovudine impurity B

5 mg

1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1,3)dione ; Batch 2 is valid until 30 June 2015

1059

Yes

+5C 3C

79

Y0001654 Zidovudine impurity D

15 mg

Triphenylmethanol / Trityl alcohol / Triphenylcarbinol

1059

Yes

+5C 3C

79

Y0001641 Zidovudine for system suitability

10 mg

1059

Yes

+5C 3C

79

Z2000000 Zinc acexamate

50 mg

1279

Yes

+5C 3C

79

Z2000010 Zinc acexamate impurity A

50 mg

6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid

1279

Yes

+5C 3C

79

Y0001286 Ziprasidone hydrochloride monohydrate

100 mg

see leaflet CHClNOS

2421,2649

Yes

+5C 3C

79

Y0001626 Ziprasidone mesilate trihydrate

30 mg

2649

Yes

+5C 3C

79

Y0001272 Ziprasidone for system suitability 1

10 mg

2421, 2649

Yes

+5C 3C

79

Y0001241 Ziprasidone for system suitability 2

0.465 mg

2421, 2649

Yes

+5C 3C

79

Z2500000 Zolpidem tartrate - * psy

200 mg

1280

Yes

+5C 3C

79

Z2500010 Zolpidem impurity A

10 mg

1280

Yes

+5C 3C

79

Z3000000 Zopiclone -* psy

40 mg

1060

Yes

+5C 3C

79

Z3001000 Zopiclone oxide

20 mg

1060

Yes

+5C 3C

79

Y0000062 Zuclopenthixol decanoate - reference spectrum

n/a

1707

79

Y0000083 Zuclopenthixol impurity B

10 mg

Y0000534 Zuclopenthixol for system suitability

0.26 mg

New Z1900000 Zidovudine

Council of Europe, all rights reserved 2015

N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide ;
Batch 1 is valid until 31 January 2015
See leaflet CHClNO

N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]
acetamide ; Batch 3 is valid until 30 October 2014

2-chloro-9H-thioxanthen-9-one

86

1707

Yes

+5C 3C

79

1707

Yes

+5C 3C

79

For extra charges, please see supply terms and conditions.